<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2682396-A1" country="EP" doc-number="2682396" kind="A1" date="20140108" family-id="39494666" file-reference-id="317082" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146586299" ucid="EP-2682396-A1"><document-id><country>EP</country><doc-number>2682396</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-13180460-A" is-representative="NO"><document-id mxw-id="PAPP154848491" load-source="docdb" format="epo"><country>EP</country><doc-number>13180460</doc-number><kind>A</kind><date>20080131</date><lang>EN</lang></document-id><document-id mxw-id="PAPP188910951" load-source="docdb" format="original"><country>EP</country><doc-number>13180460.1</doc-number><date>20080131</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140556739" ucid="EP-08728652-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>08728652</doc-number><kind>A</kind><date>20080131</date></document-id></priority-claim><priority-claim mxw-id="PPC140555659" ucid="US-70153707-A" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>70153707</doc-number><kind>A</kind><date>20070131</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989318720" load-source="docdb">B01J  20/22        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989319797" load-source="docdb">B01J  20/286       20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989320070" load-source="docdb">B01F  17/00        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989320149" load-source="docdb">B01J  20/292       20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989321644" load-source="docdb">B01J  20/32        20060101ALI20131129BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989322370" load-source="docdb">C07F   9/6512      20060101AFI20131129BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1611583905" load-source="docdb" scheme="CPC">C07F   9/6512      20130101 LI20180802BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1611583906" load-source="docdb" scheme="CPC">C07F   9/58        20130101 LI20180802BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2004748060" load-source="docdb" scheme="CPC">Y02P  20/542       20151101 LA20151103BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091439167" load-source="docdb" scheme="CPC">C07F   9/65121     20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091440236" load-source="docdb" scheme="CPC">B01J  20/3248      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091440347" load-source="docdb" scheme="CPC">C07F   9/5449      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091441543" load-source="docdb" scheme="CPC">B01J  20/3282      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091445053" load-source="docdb" scheme="CPC">B01J  20/3246      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091445812" load-source="docdb" scheme="CPC">B01J  20/29        20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091445997" load-source="docdb" scheme="CPC">B01J  20/3251      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091446221" load-source="docdb" scheme="CPC">B01J2220/84        20130101 LA20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091446383" load-source="docdb" scheme="CPC">B01J  20/22        20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091446941" load-source="docdb" scheme="CPC">B01J2220/54        20130101 LA20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091447287" load-source="docdb" scheme="CPC">B01J  20/3285      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091447414" load-source="docdb" scheme="CPC">C07F   9/5407      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091447870" load-source="docdb" scheme="CPC">B01J2220/64        20130101 LA20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091447915" load-source="docdb" scheme="CPC">B01J  20/3255      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091448626" load-source="docdb" scheme="CPC">C07F   9/581       20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091448712" load-source="docdb" scheme="CPC">B01J  20/292       20130101 FI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091448979" load-source="docdb" scheme="CPC">B01J2220/58        20130101 LA20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091449167" load-source="docdb" scheme="CPC">C07D 233/54        20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091449364" load-source="docdb" scheme="CPC">B01J  20/3092      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091449732" load-source="docdb" scheme="CPC">B01J  20/3204      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091450527" load-source="docdb" scheme="CPC">B01J  20/286       20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091450994" load-source="docdb" scheme="CPC">B01J  20/3287      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091451187" load-source="docdb" scheme="CPC">B01J  20/3276      20130101 LI20150218BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2091451932" load-source="docdb" scheme="CPC">B01J  20/3253      20130101 LI20150218BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132363530" lang="DE" load-source="patent-office">Hochstabile diionische Flüssigsalze</invention-title><invention-title mxw-id="PT132363531" lang="EN" load-source="patent-office">High stability diionic liquid salts</invention-title><invention-title mxw-id="PT132363532" lang="FR" load-source="patent-office">Sels liquides diioniques de haute stabilité</invention-title><citations><patent-citations><patcit mxw-id="PCIT242945960" load-source="docdb" ucid="JP-H10213871-A"><document-id format="epo"><country>JP</country><doc-number>H10213871</doc-number><kind>A</kind><date>19980811</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242945961" load-source="docdb" ucid="US-6531241-B1"><document-id format="epo"><country>US</country><doc-number>6531241</doc-number><kind>B1</kind><date>20030311</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242945962" load-source="docdb" ucid="WO-2006012513-A2"><document-id format="epo"><country>WO</country><doc-number>2006012513</doc-number><kind>A2</kind><date>20060202</date></document-id><sources><source name="SEA" category="A" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>ABRAHAM, M. H., CHEM. SOC. REV., vol. 22, 1993, pages 73</text><sources><source mxw-id="PNPL74759636" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ABRAHAM, M. H.; WHITING, G. S.; DOHERTY, R. M.; SHUELY, W. J., J CHROMATOGR., vol. 587, 1991, pages 229 - 236</text><sources><source mxw-id="PNPL74759637" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ANDERSON, J. L.; ARMSTRONG, D. W., ANAL. CHEM., vol. 75, 2003, pages 4851 - 4858</text><sources><source mxw-id="PNPL74759638" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ANDERSON, J. L.; DING, J.; WELTON, T.; ARMSTRONG, D. W., J. AM. CHEM. SOC., vol. 124, 2002, pages 14247 - 14254</text><sources><source mxw-id="PNPL74759639" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ANDERSON, J. L.; DING, R.; ELLERN, A; ARMSTRONG, D. W., J. AM. CHEM. SAC., vol. 127, 2005, pages 593 - 604</text><sources><source mxw-id="PNPL74759640" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ANDERSON, J. L.; PINO, V.; HAGBERG, E. C.; SHEARES, V. V.; ARMSTRONG, D. W., CHEM. COMMUN., 2003, pages 2444 - 2445</text><sources><source mxw-id="PNPL74759641" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ARMSTRONG, D. W.; HE, L.; LIU, L.-S., ANAL. CHEM., vol. 71, 1999, pages 3873 - 3876</text><sources><source mxw-id="PNPL74759642" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BARANYAI, K. J.; DEACON, G. B.; MACFARLANE, D. R.; PRINGLE, J. M.; SCOTT, J. L., AUST. J. CHEM., vol. 57, 2004, pages 145 - 147</text><sources><source mxw-id="PNPL74759643" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BLESSING, R. H., ACTA CRYST., vol. A51, 1995, pages 33 - 38</text><sources><source mxw-id="PNPL74759644" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BONDI, A.-J., J. PHYS. CHEM., vol. 68, 1964, pages 441 - 453</text><sources><source mxw-id="PNPL74759645" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BONHOTE, P.; DIAS, A.-P.; PAPAGEORGIOU, N.; KALYANASUNDARAM, K.; GRATZEL, M., INORG CHEM., vol. 35, 1996, pages 1168</text><sources><source mxw-id="PNPL74759646" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BOUCHE, J.; VERZELE, M., J GAS CHROMATOGR., vol. 6, 1968, pages 501</text><sources><source mxw-id="PNPL74759647" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BOXALL, D. L.; OSTERYOUNG, R. A., J. ELECTROCHEM. SOC., vol. 151, 2004, pages E41 - E45</text><sources><source mxw-id="PNPL74759648" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>BRYCE, M. R., CHEM. SOC. REV., vol. 20, 1991, pages 355 - 390</text><sources><source mxw-id="PNPL74759649" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>CADENA, C.; ANTHONY, J. L.; SHAH, J. K.; MORROW, T. I.; BRENNECKE, J. F.; MAGINN, E. J., J. AM. CHEM. SOC., vol. 126, 2004, pages 5300 - 5308</text><sources><source mxw-id="PNPL74759650" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>CARDA-BROCH, S.; BERTHOD, A.; ARMSTRONG, D. W., ANAL. BIOANAL. CHEM., vol. 375, 2003, pages 191</text><sources><source mxw-id="PNPL74759651" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>CARTER, E. B.; CULVER, S. L.; FOX, P. A.; GOODE, R. D.; NTAI, I.; TICKELL, M. D.; TRAYLOR, R. K.; HOFFMAN, N. W.; DAVIS, J. H., CHEM. COMMUN., 2004, pages 630 - 631</text><sources><source mxw-id="PNPL74759652" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>DEARDEN, J. C., SCI. TOTAL ENVIRON., vol. 59, 1991, pages 109 - 110</text><sources><source mxw-id="PNPL74759653" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>DZYUBA, S. V.; BARTSCH, R. A., CHEM. PHYS. PHYS. CHEM., vol. 3, 2002, pages 161 - 166</text><sources><source mxw-id="PNPL74759654" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>EARLE, M. J.; KATDARE, S. P.; SEDDON, K. R., ORG. LETT., vol. 6, 2004, pages 707 - 710</text><sources><source mxw-id="PNPL74759655" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>EIKE, D.; BRENNECKE, J. F.; MAGINN, E. J., GREEN CHEM., vol. 5, 2003, pages 323</text><sources><source mxw-id="PNPL74759656" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>FLETCHER, K. A.; PANDEY, S., LANGMUIR, vol. 20, 2004, pages 33 - 36</text><sources><source mxw-id="PNPL74759657" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>FORSYTH, S. A.; PRINGLE, J. M.; MACFARLANE, D. R., AUST. J. CHEM., vol. 57, 2004, pages 113 - 119</text><sources><source mxw-id="PNPL74759658" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>GAO, H.; JIANG, T.; HAN, B.; WANG, Y.; DU, J.; LIU, Z.; ZHANG, J., POLYMER, vol. 45, 2004, pages 3017 - 3019</text><sources><source mxw-id="PNPL74759659" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>HAN ET AL.: "Using Geminal Dicationic Ionic Liquids as Solvents for High-Temperature Organic Reactions", ORG. LETT., vol. 7, 2005, pages 4205 - 4208</text><sources><source mxw-id="PNPL74759660" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>HOLBREY, J. D.; REICHERT, W. M.; NIEUWENHUYZEN, M.; JOHNSTON, S.; SEDDON, K. R.; ROGERS, R. D., CHEM. COMMUN., 2003, pages 1636 - 1637</text><sources><source mxw-id="PNPL74759661" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>HU, X.; TANG, Y.; GANTZEL, P.; MEYER, K., ORGANOMETALLICS, vol. 22, 2003, pages 612 - 614</text><sources><source mxw-id="PNPL74759662" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ITOH, H.; NAKA, K.; CHUJO, Y., J AM. CHEM. SOC., vol. 126, 2004, pages 3026 - 3027</text><sources><source mxw-id="PNPL74759663" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>JIN ET AL.: "Polyethylene glycol functionalized dicatinoic ionic liquids with alkyl or polyfluoroalkyl substituents as high temperature lubricants", J. MATER. CHEM., vol. 16, 2006, pages 1529 - 1535, XP002601955, DOI: doi:10.1039/b517888f</text><sources><source mxw-id="PNPL74759664" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>K. GROB; G. GROB; K. GROB, I CHROMATOGR., vol. 156, 1978, pages 1</text><sources><source mxw-id="PNPL74759665" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>K. GROB; G. GROB; K. GROB, J CHROMATOGR., vol. 219, 1981, pages 13</text><sources><source mxw-id="PNPL74759666" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>KAAR, J. L.; JESIONOWSKI, A. M.; BERBERICH, J. A.; MOULTON, R.; RUSSELL, A. J., J. AM. CHEM. SOC., vol. 125, 2003, pages 4125 - 4131</text><sources><source mxw-id="PNPL74759667" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>KATRITZKY, A. R.; JAIN, R.; LOMAKA, A.; PETRUKHIN, R.; KARELSON, M.; VISSER, A. E.; ROGERS, R. D, J. CHEM. INF. COMPUT. SCI., vol. 42, 2002, pages 225 - 231</text><sources><source mxw-id="PNPL74759668" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>LAW, G.; WATSON, P. R., LANGMUIR, vol. 17, 2001, pages 6138 - 6141</text><sources><source mxw-id="PNPL74759669" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>LEE, J. K.; KIM, M-J., J ORG. CHEM., vol. 67, 2002, pages 6845 - 6847</text><sources><source mxw-id="PNPL74759670" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>LIU ET AL.: "Disposable ionic liquid coating for headspace solid-phase microextraction of benzene, toluene, ethyl benzene, and xylenes in plants followed by gas chromatography-- flame ionization detection", J CHROMATOGR. A, vol. 1066, no. 1-2, 2005, pages 27 - 32</text><sources><source mxw-id="PNPL74759671" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>LORD; PAWLISZYM, J. CHROMATOGR. A, vol. 885, 2000, pages 153 - 193</text><sources><source mxw-id="PNPL74759672" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>LUO, H.; DAI, S.; BONNESEN, P. V.; BUCHANAN, A. C.; HOLBREY, J. D.; BRIDGES, N. J.; ROGERS, R. D., ANAL. CHEM.</text><sources><source mxw-id="PNPL74759673" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>MARCILLA, R.; BLAZQUEZ, J. A.; RODRIGUEZ, J.; POMPOSO, J. A.; MECERREYES, D., J POLYM. SCI. PART A: POLYM. CHEM., vol. 42, 2004, pages 208 - 212</text><sources><source mxw-id="PNPL74759674" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>MARTINELANGO ET AL.: "Gas-Phase Ion Association Provides Increased Selectivity and Sensitivity for Measuring Perchlorate by Mass Spectrometry", ANAL. CHEM., vol. 77, 2005, pages 4829 - 4835, XP055047629, DOI: doi:10.1021/ac050479j</text><sources><source mxw-id="PNPL74759675" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>MEVEL MATHIEU ET AL: "Dicationic Lipophosphoramidates as DNA Carriers", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, vol. 18, no. 5, 19 September 2007 (2007-09-19), pages 1604 - 1611, XP002473043, ISSN: 1043-1802, DOI: 10.1021/BC070089Z</text><sources><source mxw-id="PNPL74759676" load-source="docdb" name="SEA" category="XP"/></sources></nplcit><nplcit><text>MULDOON, M. J.; GORDON, C. M., JPOLYM. SCI. PART A. POLYM. CHEM., vol. 42, 2004, pages 3865 - 3869</text><sources><source mxw-id="PNPL74759677" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>NGO, H. L.; LECOMPTE, K.; HARGENS, L.; MCEWEN, A. B., THERMOCHIMICA ACTA, vol. 357, no. 358, 2000, pages 97 - 102</text><sources><source mxw-id="PNPL74759678" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>RICHARD C. LAROCK: "Comprehensive Organic Transformations: a guide to functional group preparations. 2nd Edition.", 1999, WILEY-VCH</text><sources><source mxw-id="PNPL74759679" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>SEDDON, K. R.; STARK, A.; TORRES, M-J., ACS SYMPOSIUM SERIES, vol. 819, 2002, pages 34 - 49</text><sources><source mxw-id="PNPL74759680" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>SIR GEOFFREY ALLEN, COMPREHENSIVE POLYMER SCIENCE - THE SYNTHESIS, CHARACTERIZATION, REACTIONS AND APPLICATIONS OF POLYMERS</text><sources><source mxw-id="PNPL74759681" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>TERAZIMA, M.; NOGAMI, Y.; TOMINAGA, T., CHEMICAL PHYSICAL LETTERS, vol. 332, 2000, pages 503 - 507</text><sources><source mxw-id="PNPL74759682" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VAN HOOK, J. P.; TOBOLSKY, A. V., J. AM. CHEM. SOC., vol. 80, 1958, pages 779 - 782</text><sources><source mxw-id="PNPL74759683" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VAN VALKENBURG, M. E.; VAUGHN, R. L.; WILLIAMS, M.; WILKES, J. S., PROCEEDINGS-- ELECTROCHEMICAL SOCIETY 2002, vol. 19, 2002, pages 112 - 123</text><sources><source mxw-id="PNPL74759684" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VAS, G.; VEKEY, K., J. MASS SPECTROMETERY, vol. 39, 2004, pages 233 - 254</text><sources><source mxw-id="PNPL74759685" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VIJAYARAGHAVAN, R.; MACFARLANE, D. R., CHEM. COMMUN., 2004, pages 700 - 701</text><sources><source mxw-id="PNPL74759686" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VISSER ET AL.: "Task-Specific Ionic Liquids Incorporation Novel Cations for the Coordination and Extraction of Hg2+ and Cd2+: Synthesis, Characterization, and Extraction Studies", ENVIRON. SCI. TECHNOL., vol. 36, 2002, pages 2523 - 29, XP002510141, DOI: doi:10.1021/ES0158004</text><sources><source mxw-id="PNPL74759687" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>VISSER, A. E.; SWATLOSKI, R. P; REICHERT, W. M.; MAYTON, R.; SHEFF, S.; WIERZBICKI, A.; DAVIS, J. H.; ROGERS, R. D., ENVIRON. SCI. TECHNOL., vol. 36, 2002, pages 2523 - 2529</text><sources><source mxw-id="PNPL74759688" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>WASSERSCHEID, P.; HILGERS, C.; KEIM, W., JOURNAL OF MOLECULAR CATALYSIS A, vol. 214, 2004, pages 83 - 90</text><sources><source mxw-id="PNPL74759689" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>WEI, G-T.; YANG, Z.; LEE, C-Y.; YANG, H-Y.; WANG, C. R., J AM. CHEM. SOC., vol. 126, 2004, pages 5036 - 5037</text><sources><source mxw-id="PNPL74759690" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>WELTON, T., CHEM. REV., vol. 99, 1999, pages 2071 - 2083</text><sources><source mxw-id="PNPL74759691" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>WILKES, J. S., JOURNAL OF MOLECULAR CATALYSIS A: CHEMICAL, vol. 214, 2004, pages 11 - 17</text><sources><source mxw-id="PNPL74759692" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>WU, J.; ZHANG, J.; ZHANG, H.; HE, J.; REN, Q.; GUO, M., BIOMACROMOLECULES, vol. 5, 2004, pages 266 - 268</text><sources><source mxw-id="PNPL74759693" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ZHAO, H.; MALHOTRA, S. V., BIOTECHNOLOGY LETTERS, vol. 24, 2002, pages 1257 - 1260</text><sources><source mxw-id="PNPL74759694" load-source="docdb" name="APP"/></sources></nplcit><nplcit><text>ZHOU, Y.; ANTONIETTI, M., J. AM. CHEM. SOC., vol. 125, 2003, pages 14960 - 14961</text><sources><source mxw-id="PNPL74759695" load-source="docdb" name="APP"/></sources></nplcit></non-patent-citations></citations></technical-data><related-documents><relation type="division"><child-doc ucid="EP-13180460-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>13180460</doc-number><kind>A</kind><date>20080131</date></document-id></child-doc><parent-doc ucid="EP-08728652.2"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>08728652.2</doc-number><date>20080131</date></document-id></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919535041" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SIGMA ALDRICH CO</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR919545551" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SIGMA-ALDRICH CO.</last-name></addressbook></applicant><applicant mxw-id="PPAR919007995" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Sigma-Aldrich Co.</last-name><iid>100221206</iid><address><street>3050 Spruce Street</street><city>St Louis, Missouri 63103</city><country>US</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR941138507" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ARMSTRONG DANIEL W</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR941138508" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ARMSTRONG, DANIEL W.</last-name></addressbook></inventor><inventor mxw-id="PPAR919005607" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>The designation of the inventor has not yet been filed</last-name></addressbook></inventor><inventor mxw-id="PPAR941138509" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>ANDERSON JARED</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR941138510" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>ANDERSON, JARED</last-name></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919008699" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Brown, David Leslie</last-name><iid>100028338</iid><address><street>Haseltine Lake LLP Redcliff Quay 120 Redcliff Street</street><city>Bristol BS1 6HU</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS549759324" load-source="docdb">AT</country><country mxw-id="DS549836503" load-source="docdb">BE</country><country mxw-id="DS549836416" load-source="docdb">BG</country><country mxw-id="DS549849406" load-source="docdb">CH</country><country mxw-id="DS549835402" load-source="docdb">CY</country><country mxw-id="DS549759333" load-source="docdb">CZ</country><country mxw-id="DS549836504" load-source="docdb">DE</country><country mxw-id="DS549835403" load-source="docdb">DK</country><country mxw-id="DS549835404" load-source="docdb">EE</country><country mxw-id="DS549914215" load-source="docdb">ES</country><country mxw-id="DS549836417" load-source="docdb">FI</country><country mxw-id="DS549849407" load-source="docdb">FR</country><country mxw-id="DS549836505" load-source="docdb">GB</country><country mxw-id="DS549835405" load-source="docdb">GR</country><country mxw-id="DS549836510" load-source="docdb">HR</country><country mxw-id="DS549759334" load-source="docdb">HU</country><country mxw-id="DS549768936" load-source="docdb">IE</country><country mxw-id="DS549835426" load-source="docdb">IS</country><country mxw-id="DS549849408" load-source="docdb">IT</country><country mxw-id="DS549835427" load-source="docdb">LI</country><country mxw-id="DS549836422" load-source="docdb">LT</country><country mxw-id="DS549758885" load-source="docdb">LU</country><country mxw-id="DS549836423" load-source="docdb">LV</country><country mxw-id="DS549836424" load-source="docdb">MC</country><country mxw-id="DS549758886" load-source="docdb">MT</country><country mxw-id="DS549768945" load-source="docdb">NL</country><country mxw-id="DS549914216" load-source="docdb">NO</country><country mxw-id="DS549768946" load-source="docdb">PL</country><country mxw-id="DS549836425" load-source="docdb">PT</country><country mxw-id="DS549759335" load-source="docdb">RO</country><country mxw-id="DS549768947" load-source="docdb">SE</country><country mxw-id="DS549849409" load-source="docdb">SI</country><country mxw-id="DS549914217" load-source="docdb">SK</country><country mxw-id="DS549758887" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128674137" lang="EN" load-source="patent-office"><p id="pa01" num="0001">The present invention relates to dicationic liquid salts comprising a dicationic species of formula A<sup>+</sup>-B-A<sup>'+</sup> where one of A and A' is an imidazolium cation and the other is a phosphonium cation as defined herein and at least one counter anion. The invention further relates to use of such dicationic liquid salts as solvents, for separating chemical mixtures and for various detection and analytical techniques such as ESI-MS and as a stationary phase in a gas chromatographic column. Further provided are devices for such detection and analytical techniques comprising one or more dicationic liquids salts.</p></abstract><abstract mxw-id="PA128738637" lang="EN" source="EPO" load-source="docdb"><p>The present invention relates to dicationic liquid salts comprising a dicationic species of formula A + -B-A '+  where one of A and A' is an imidazolium cation and the other is a phosphonium cation as defined herein and at least one counter anion. The invention further relates to use of such dicationic liquid salts as solvents, for separating chemical mixtures and for various detection and analytical techniques such as ESI-MS and as a stationary phase in a gas chromatographic column. Further provided are devices for such detection and analytical techniques comprising one or more dicationic liquids salts.</p></abstract><description mxw-id="PDES63960125" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><p id="p0001" num="0001">This application claims priority to <patcit id="pcit0001" dnum="US70153707A"><text>U.S. Patent Application Serial No. 11/701,537, filed 31 January 2007</text></patcit>, incorporated in its entirety herein by reference.</p><heading id="h0001">BACKGROUND OF THE INVENTION</heading><p id="p0002" num="0002">One of the more rapidly growing areas of chemistry research involves ionic liquids (ILs) and room temperature ionic liquids (RTILs). The wide range of possible cation and anion combinations allows for a large variety of tunable interactions and applications. The uses and applications of RTILs have traversed many areas of chemistry and even areas of biochemistry. Reported thermal stability ranges of 300°C in some cases, their ability to solubilize a variety of disparate molecules, and the fact that ionic liquids can be synthesized that are immiscible with both water and nonpolar organic solvents further add to their usefulness. While much work involving RTILs deals with their use as "green" solvents in organic synthesis, their characterization and the understanding of their unique physico-chemical and solvation properties are important areas of ongoing investigation. Some research in the field of ionic liquids has explored their fundamental properties in hopes that it would become apparent which cation-anion combinations give rise to specific and/or desired qualities. Thus far, this approach has met with only limited success.</p><p id="p0003" num="0003">Early work seemed to indicate that the anionic constituents of ionic liquids may have a greater influence on their physical and chemical properties. However, this notion may be due, in part, to the fact that the ionic liquids studied contained not only a variety of different anions, but closely related, structurally similar cations. Indeed, anions such as halides possess higher hydrogen bond basicity character (Cl&gt;Br&gt;I) and readily hydrogen bond to generally form viscous liquids. This is not to say that only coordinating anions produce viscous liquids; it is well known the viscosity of 1-alkyl-3-methylimiazolium ionic liquids are found to increase with increasing alkyl chain length even when paired with non-coordinating anions such as hexafluorophosphate (PF<sub>6</sub><sup>-</sup>) and bis(trifluoromethylsulfonyl)imide (NTf<sub>2</sub><sup>-</sup>). While the cation and its structure can certainly influence the surface tension, melting point, viscosity, density, and thermal stability as well as interact via dipolar, π-π, and eta-π interactions with dissolved molecules, its range of effects has not been studied as extensively as it has for anions.<!-- EPO <DP n="2"> --></p><p id="p0004" num="0004">Despite their touted stability, many of the more common ionic liquids are susceptible to chemical and thermal degradation. Recently, it was reported that when 1-butyl-3-methylimidazolium chloride (BMIM-Cl) is exposed to the atmosphere and heated, it begins to turn from a pale yellow to amber color at 120°C. When heated further, the ionic liquid begins to show obvious signs of decomposition at and above 150°C. Most recently, a new class of "high stability ionic liquids" based on bulky cations and triflate anions was introduced and it was reported that the robustness of some of the more traditional ionic liquids appear to be less than previously thought (in terms of both lower thermal stability and higher volatility). MacFarlane and co-workers reached similar conclusions via use of the 'step tangent method' for thermogravimetric analysis (TGA) to more accurately determine degradation temperatures of imidazolium-based cations. They point out that significant evolution of volatile degradation products takes place well below previously reported degradation temperatures. A maximum operating temperature parameter was proposed to provide a more appropriate estimate of thermal stability using TGA.</p><p id="p0005" num="0005">The techniques of solid phase extraction and solid phase microextraction are known. However, the use of diionic liquid salts and immobilized ionic liquids have not been disclosed in connection with these techniques. Ionic liquids have been used in task-specific liquid-liquid extraction for use in extraction of Hg<sup>2+</sup> and Cd<sup>2+</sup> from water. However, diionic liquid salts have not been used in task-specific solid phase extraction/microextraction, nor have absorbed, adsorbed or immobilized ionic liquids been used in these techniques.</p><p id="p0006" num="0006"><patcit id="pcit0002" dnum="US6531241B"><text>U.S. Patent 6,531,241</text></patcit> reports cyclic delocalized cations joined together by spacer groups.</p><p id="p0007" num="0007">In one embodiment, a dicationic liquid salt comprising a dicationic species corresponding in structure to Formula (III):
<chemistry id="chem0001" num="0001"><img id="ib0001" file="imgb0001.tif" wi="57" he="36" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="3"> -->
and at least one counter anion,<br/>
wherein:
<ul><li><b>X</b> and <b>Y</b> are independently selected from the group consisting of ammonium,</li><li>phosphonium and arsonium;</li><li>each <b>R, R',</b> and <b>R"</b> is independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, and carbocyclyl;<br/>
wherein each <b>R, R',</b> and <b>R"</b> optionally is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, hydroxyl, alkoxy, and carbocyclyl;</li><li><b>B</b> is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and polysiloxyl;<br/>
wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si;<br/>
wherein <b>B</b> is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li><b>n</b> is selected from the group consisting of 1 to 20, inclusive.</li></ul></p><p id="p0008" num="0008">In another embodiment, a dicationic liquid salt is provided. The dicationic liquid salt corresponds in structure to Formula (IV):<br/>
<br/>
        A<sup>+</sup>-B-A'<sup>+</sup>     Formula (IV)<br/>
<br/>
and at least one counter anion,<br/>
wherein:
<ul><li><b>A</b> and <b>A'</b> are each a monoionic group independently selected from the group consisting of ammonium, thionium, phosphonium, arsonium, carbocylyl and heterocyclyl;<br/>
wherein each such substituent is optionally substituted with one or more substituents selected from the group consisting of alkyl, hydroxyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl;<br/>
wherein <b>A</b> and <b>A'</b> are different or <b>A</b> and <b>A'</b> have at least one different substituent;<!-- EPO <DP n="4"> --></li><li><b>B</b> is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and polysiloxyl;<br/>
wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si;<br/>
wherein <b>B</b> is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li><b>n</b> is selected from the group consisting of 1 to 20, inclusive.</li></ul></p><p id="p0009" num="0009">In another embodiment, a solvent is provided. The solvent comprises one or more dicationic liquid salts according to Formula (III) and/or Formula (IV).</p><p id="p0010" num="0010">In another embodiment, a device for chemical separation or analysis is provided. The device comprises a solid support and one or more dicationic liquid salts according to Formula (III) and/or Formula (IV), wherein the one or more dicationic liquid salts is adsorbed, absorbed or immobilized on the solid support.</p><p id="p0011" num="0011">In another embodiment, a method is provided for separating one chemical from a mixture of chemicals. The method comprises the steps of:
<ul><li>providing a mixture of at least one first and at least one second chemical;</li><li>exposing the mixture to a solid support containing one or more dicationic liquid salts according to Formula (III) and/or Formula (IV), wherein the one or more dicationic liquid salts is adsorbed, absorbed or immobilized on the support, and retaining at least a portion of the first chemical on the solid support.</li></ul></p><p id="p0012" num="0012">In another embodiment, a method of detecting an anion by ESI-MS is provided. The method comprises using one or more dicationic liquid salts according to Formula (III)and/or Formula (IV).</p><heading id="h0002">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p0013" num="0013"><figref idrefs="f0001">Figure 1</figref> illustrates the effect of the cation and anion on the surface tension for dicationic ionic liquids.</p><p id="p0014" num="0014"><figref idrefs="f0002">Figure 2</figref> illustrates the effect of the cation and anion on the density for dicationic ionic liquids.</p><p id="p0015" num="0015"><figref idrefs="f0003">Figure 3</figref> is a thermal stability diagram showing the decomposition/volatilization of thin films coated on the walls of fused silica capillaries, heated under a constant flow of helium,<!-- EPO <DP n="5"> --> using an ultra-sensitive flame ionization detector. The plot illustrates the fact that the geminal dicationic ionic liquids (D-G) have much higher thermal stabilities, and/or lower volatilities, than conventional ionic liquids (A-C). A, 1-butyl-3-methylimidazolium chloride (BMIM-Cl); B, BMIM-PF<sub>6</sub>; C, BMIM-NTf<sub>2</sub>; D, C<sub>9</sub>(bpy)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 38); E, C<sub>9</sub>(mim)<sub>2</sub>-NTf<sub>2</sub>, (Diionic liquid 10); F, C<sub>12</sub>(benzim)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 29); G, C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 35).</p><p id="p0016" num="0016"><figref idrefs="f0004">Figure 4</figref> is a positive ion electrospray mass spectrum of mixture 4 indicating the relative abundance of the three substituted dications as well as the loss of a proton on the imidazolium ring thereby allowing the formation of the +1 ion.</p><p id="p0017" num="0017"><figref idrefs="f0005">Figure 5</figref> is a plot illustrating the effect of 1-hexyl-3-vinylimidazolium bis[(trifluoromethane)sulfonyl]imidate film thickness on the peak efficiency (theoretical plates/meter) of naphthalene at 100°C.</p><p id="p0018" num="0018"><figref idrefs="f0006">Figure 6</figref> is a chromatogram showing the separation of fatty acid methyl esters (C<sub>6</sub>-C<sub>24</sub>) on a 15 meter partially cross-linked ionic liquid stationary phase (0.10% nvim-NTf<sub>2</sub> (2)/10% C<sub>9</sub>(vim)2-NTf<sub>2</sub> (5) with 7.5% AIBN). Conditions: 100°C hold 2 minutes, 15°C/min to 260°C.</p><p id="p0019" num="0019"><figref idrefs="f0007">Figure 7</figref> is a chromatogram showing the Separation of PAH and chlorinated pesticide mixture on a 13 meter C<sub>9</sub>(vim)<sub>2</sub>-NTf<sub>2</sub>(7.5% AIBN) more likely cross-linked ionic liquid stationary phase. 1, indene; 2, naphthalene; 3, biphenyl; 4, azulene; 5, acenaphthene; 6, acenaphthylene; 7, heptachlor; 8, fluorene; 9, BHC; 10, dibenzothiophene; 11, DDE; 12; endosulfan; 13, anthracene; 14, dieldrin; 15, 4<i>H</i>-cyclopenta[<i>def</i>]phenanthrene; 16, fluoranthene; 17, DDT; 18, lindane; 19, pyrene; 20, carbazole. Conditions: 175°C. for 1 min; 20°C/min to 335°C. The smaller, unnumbered peaks in this chromatogram are impurities contained in numbered standard materials.</p><p id="p0020" num="0020"><figref idrefs="f0008">Figure 8</figref> is an embodiment of a syringe useful for SPME and SPME/MALDI mass spectrometry.</p><p id="p0021" num="0021"><figref idrefs="f0009">Figure 9</figref> is another embodiment of a syringe useful for SPME and SPME/MALDI mass spectrometry.<!-- EPO <DP n="6"> --></p><heading id="h0003">DETAILED DESCRIPTION</heading><p id="p0022" num="0022">While the specification concludes with the claims particularly pointing and distinctly claiming the invention, it is believed that the present invention will be better understood from the following description.</p><p id="p0023" num="0023">The term "carbocyclyl" (alone or in combination with another term(s)) means a saturated cyclic (<i>i.e</i>., "cycloalkyl"), partially saturated cyclic (<i>i.e.,</i> "cycloalkenyl"), or completely unsaturated (<i>i.e.,</i> "aryl") hydrocarbyl substituent containing from 3 to 14 carbon ring atoms ("ring atoms" are the atoms bound together to form the ring or rings of a cyclic substituent). A carbocyclyl may be a single-ring (monocyclic) or polycyclic ring structure.</p><p id="p0024" num="0024">A carbocyclyl may be a single ring structure, which typically contains from 3 to 7 ring atoms, more typically from 3 to 6 ring atoms, and even more typically 5 to 6 ring atoms. Examples of such single-ring carbocyclyls include cyclopropyl (cyclopropanyl), cyclobutyl (cyclobutanyl), cyclopentyl (cyclopentanyl), cyclopentenyl, cyclopentadienyl, cyclohexyl (cyclohexanyl), cyclohexenyl, cyclohexadienyl, and phenyl.</p><p id="p0025" num="0025">A carbocyclyl may alternatively be polycyclic or contain more than one ring. Examples of polycyclic carbocyclyls include bridged, fused, spirocyclic, and isolated carbocyclyls. In a spirocyclic carbocyclyl, one atom is common to two different rings. An example of a spirocyclic carbocyclyl is spiropentanyl. In a bridged carbocyclyl, the rings share at least two common non-adjacent atoms. Examples of bridged carbocyclyls include bicyclo[2.2.1]heptanyl, bicycle[2.2.1]hept-2-enyl, and adamantanyl. In a fused-ring carbocyclyl system, multiple rings may be fused together, such that two rings share one common bond. Examples of two- or three-fused ring carbocyclyls include naphthalenyl, tetrahydronaphthalenyl (tetralinyl), indenyl, indanyl (dihydroindenyl), anthracenyl, phenanthrenyl, and decalinyl. In an isolated carbocyclyl, the rings are separate and independent, as they do not share any common atoms, but a linker exists between the rings.</p><p id="p0026" num="0026">The term "carbocyclyl" encompasses protonated carbocyclyls, such as
<chemistry id="chem0002" num="0002"><img id="ib0002" file="imgb0002.tif" wi="67" he="19" img-content="chem" img-format="tif"/></chemistry></p><p id="p0027" num="0027">The term "heterocyclyl" (alone or in combination with another term(s)) means a saturated (i.e., "heterocycloalkyl"), partially saturated (i.e., "heterocycloalkenyl"), or completely<!-- EPO <DP n="7"> --> unsaturated (<i>i.e</i>., "heteroaryl") ring structure containing a total of 3 to 14 ring atoms. At least one of the ring atoms is a heteroatom (<i>i.e.,</i> N, P, As, O, S and Si), with the remaining ring atoms being independently selected from the group consisting of carbon, oxygen, nitrogen, and sulfur. A heterocyclyl may be a single-ring (monocyclic) or polycyclic ring structure.</p><p id="p0028" num="0028">The term heterocyclyl encompasses protonated heterocyclyls such as pyridinium, pyridazinium, pyrimidinium, pyrazinium, imidazolium, pyrazolium, thazolium, oxazolium and triazolium.</p><p id="p0029" num="0029">A heterocyclyl may be a single ring, which typically contains from 3 to 7 ring atoms, more typically from 3 to 6 ring atoms, and even more typically 5 to 6 ring atoms. Examples of single-ring heterocyclyls include furanyl, dihydrofuranyl, tetrahydrofuranyl, thiophenyl (thiofuranyl), dihydrothiophenyl, tetrahydrothiophenyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, imidazolyl, imidazolinyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, triazolyl, tetrazolyl, oxazolyl, oxazolidinyl, isoxazolidinyl, isoxazolyl, thiazolyl, isothiazolyl, thiazolinyl, isothiazolinyl, thiazolidinyl, isothiazolidinyl, thiodiazolyl, oxadiazolyl (including 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl, 1,2,5-oxadiazolyl (furazanyl), or 1,3,4-oxadiazolyl), oxatriazolyl (including 1,2,3,4-oxatriazolyl or 1,2,3,5-oxatriazolyl), dioxazolyl (including 1,2,3-dioxazolyl, 1,2,4-dioxazolyl, 1,3,2-dioxazolyl, or 1,3,4-dioxazolyl), oxathiazolyl, oxathiolyl, oxathiolanyl, pyranyl, dihydropyranyl, thiopyranyl, tetrahydrothiopyranyl, pyridinyl (azinyl), piperidinyl, diazinyl (including pyridazinyl (1,2-diazinyl), pyrimidinyl (1,3-diazinyl), or pyrazinyl (1,4-diazinyl)), piperazinyl, triazinyl (including 1,3,5-triazinyl, 1,2,4-triazinyl, and 1,2,3-triazinyl)), oxazinyl (including 1,2-oxazinyl, 1,3-oxazinyl, or 1,4-oxazinyl)), oxathiazinyl (including 1,2,3-oxathiazinyl, 1,2,4-oxathiazinyl, 1,2,5-oxathiazinyl, or 1,2,6-oxathiazinyl)), oxadiazinyl (including 1,2,3-oxadiazinyl, 1,2,4-oxadiazinyl, 1,4,2-oxadiazinyl, or 1,3,5-oxadiazinyl)), morpholinyl, azepinyl, oxepinyl, thiepinyl, and diazepinyl.</p><p id="p0030" num="0030">A heterocyclyl may alternatively be polycyclic or contain more than one ring. Examples of polycyclic heterocyclyls include bridged, fused, and spirocyclic heterocyclyls. In a spirocyclic heterocyclyl, one atom is common to two different rings. In a bridged heterocyclyl, the rings share at least two common non-adjacent atoms. In a fused-ring heterocyclyl, multiple rings may be fused together, such that two rings share one common bond. Examples of fused ring heterocyclyls containing two or three rings include indolizinyl, pyranopyrrolyl, 4H-quinolizinyl, purinyl, naphthyridinyl, pyridopyridinyl (including pyrido[3,4-b]-pyridinyl,<!-- EPO <DP n="8"> --> pyrido[3,2-b]-pyridinyl, or pyrido[4,3-b]-pyridinyl), and pteridinyl. Other examples of fused-ring heterocyclyls include benzo-fused heterocyclyls, such as indolyl, isoindolyl (isobenzazolyl, pseudoisoindolyl), indoleninyl (pseudoindolyl), isoindazolyl (benzpyrazolyl), benzazinyl (including quinolinyl (1-benzazinyl) or isoquinolinyl (2-benzazinyl)), phthalazinyl, quinoxalinyl, quinazolinyl, benzodiazinyl (including cinnolinyl (1,2-benzodiazinyl) or quinazolinyl (1,3-benzodiazinyl)), benzopyranyl (including chromanyl or isochromanyl), benzoxazinyl (including 1,3,2-benzoxazinyl, 1,4,2-benzoxazinyl, 2,3,1-benzoxazinyl, or 3,1,4-benzoxazinyl), and benzisoxazinyl (including 1,2-benzisoxazinyl or 1,4-benzisoxazinyl).</p><p id="p0031" num="0031">The term "ammonium" refers to a positively charged polyatomic cation of the chemical formula NH<sub>4</sub><sup>+</sup>. Ammonium also embraces positively charged or protonated substituted amines (such as protonated tertiary amine) and quaternary ammonium cations, N<sup>+</sup>R<sub>4</sub>, where one or more hydrogen atoms are replaced by organic radical groups (which is symbolized as R above).</p><p id="p0032" num="0032">Similarly, the term "phosphonium" refers to a positively charged polyatomic ion with the chemical formula PH<sub>4</sub><sup>+</sup>. Phosphonium may also be substituted where one or more hydrogen atoms are replaced by organic radical groups.</p><p id="p0033" num="0033">The term "alkylene" (alone or in combination with another term(s)) refers to a divalent alkane-derived radical containing 1-20, preferably 1-15, carbon atoms, from which two hydrogen atoms are taken from the same carbon atom or from different carbon atoms. Examples of alkylene include, but are not limited to ethylene --CH.<sub>2</sub>CH.<sub>2</sub>--, and the like. An alkylene radical can be substituted as described herein.</p><p id="p0034" num="0034">The term "polysiloxyl" (alone or in combination with another term(s)) refers to a divalent radical composed of oxygen and silicon containing 1-20 atoms. Examples include (--Si-O-Si--)<sub>n</sub>; wherein n is from 1-20.</p><p id="p0035" num="0035">All percentages and ratios used herein are by weight of the total composition and all measurements made are at about 25°C and normal pressure unless otherwise designated. All temperatures are in Degrees Celsius unless specified otherwise. The present invention can comprise (open ended) or consist essentially of the components of the present invention as well as other ingredients or elements described herein. As used herein, "comprising" means the elements recited, or their equivalent in structure or function, plus any other element or elements which are not recited. The terms "having" and "including" are also to be construed as open<!-- EPO <DP n="9"> --> ended unless the context suggests otherwise. As used herein, "consisting essentially of" means that the invention may include ingredients in addition to those recited in the claim, but only if the additional ingredients do not materially alter the basic and novel characteristics of the claimed invention. Preferably, such additives will not be present at all or only in trace amounts. However, it may be possible to include up to about 10% by weight of materials that could materially alter the basic and novel characteristics of the invention as long as the utility of the compounds (as opposed to the degree of utility) is maintained. All ranges recited herein include the endpoints, including those that recite a range "between" two values. Terms such as "about," "generally," "substantially," and the like are to be construed as modifying a term or value such that it is not an absolute, but does not read on the prior art. Such terms will be defined by the circumstances and the terms that they modify as those terms are understood by those of skill in the art. This includes, at very least, the degree of expected experimental error, technique error and instrument error for a given technique used to measure a value.</p><p id="p0036" num="0036">A "diionic salt" or "DIS" or "diionic liquid salt" is a salt formed between a dication as described herein and a dianion or two anions or between a dianion as described herein and a dication or two cations. This term is not meant to embrace a single species that has a +2 or -2 charge such as Mg<sup>+2</sup> or SO<sub>4</sub><sup>-2</sup>. Rather it contemplates a single molecule with two discreet mono-ionic groups, usually separated by a bridging group. The two ionic species should be of the same charge. In general, they may be different types of groups or the diionic liquid salts may be "geminal" which means both ionic groups are not only the same charge, but also the same structure.</p><p id="p0037" num="0037">The ionic groups may be chiral or may have one or more chiral substituents. The counterions need not be identical either. In one embodiment, either the "diion" or the salt forming species is chiral, having at least one stereogenic center. In such instances, the diionic liquid salts may be racemic (or in the case of diastereomers, each pair of enantiomers is present in equal amounts) or they may be optically enhanced. "Optically enhanced" in the case of enantiomers means that one enantiomer is present in an amount which is greater than the other. In the case of diastereomers, at least one pair of enantiomers is present in a ratio of other than 1:1. Indeed, the diionic liquid salts may be "substantially optically pure" in which one enantiomer or, if more than one stereogenic center is present, at least one of the pairs of enantiomers, is present in an amount of at least about 90% relative to the other enantiomer. The<!-- EPO <DP n="10"> --> diionic liquid salts of the invention may also be optically pure, i.e., at least about 98% of one enantiomer relative to the other.</p><p id="p0038" num="0038">Usually, the term diionic salt is used to describe a salt molecule, although, as the context suggests, it may be used synonymously with "diionic liquid" ("DIL") and "diionic liquid salt" (DILS"). A "diionic liquid" or "DIL" in accordance with the present invention is a liquid comprised of diionic salts. Thus, sufficient DS molecules are present such that they exist in liquid form at the temperatures indicated herein. This presumes that a single DS molecule is not a liquid. A DL is either a dicationic ionic liquid or a dianionic ionic liquid (a liquid comprising either dicationic salts or dianionic salts as described herein). A "dicationic ionic liquid" (used synonymously with "liquid salts of a dication") in accordance with the present invention is a liquid comprised of molecules which are salts of dicationic species. The salt forming counter-anions may be mono-ionic such as, for example only, Br<sup>-</sup>, or dianionic, such as, again for example only, succinic acid. Any dicationic ionic liquid which is stable and has a solid/liquid transformation temperature of 400°C or lower is contemplated. The same is true for "dianionic ionic liquids" also known as "liquid salts of a dianion," except the charges are reversed. Dicationic liquids and dianionic liquids can also be referred to herein as diionic liquid salts ("DILS" or "DCLS" and "DALS" depending upon charge).</p><p id="p0039" num="0039">In one embodiment, a dicationic ionic liquid or dianionic ionic liquid does not substantially decompose or volatilize (or remain substantially non-volatile) as measured by being immobilized as a thin film in a fused silica capillary or on a silica solid support as described herein, at a temperature of 200°C or lower. Other types of solid supports, such as diatomaceous earth (commonly used in packed GC), carbons (e.g. Carbopack and Carboxen), metal particles (e.g. zirconia, titania, etc.) and polymeric particles (e.g. styrene-divinylbenzene - SDVB), can be used in place of silica. This in addition to particles as described previously. Indeed, any media useful in chromatography can be used. "Substantially" in this context means less than about 10% by weight will decompose or volatilize at about 200°C inside a capillary over the course of about one hour. Moreover, the dicationic ionic liquid in accordance with this embodiment has either a solid/liquid transformation temperature of about 100°C or lower or a liquid range (the range of temperatures over which it is in a liquid form without burning or decomposing) of at least about 200°C.<!-- EPO <DP n="11"> --></p><p id="p0040" num="0040">In one embodiment, the present invention comprises a stable liquid salt of a dication or dianion having a solid/liquid transformation temperature at about 500°C, more preferably at about 400°C or lower. In another embodiment, the present invention comprises a stable liquid salt of a dication or dianion having a solid/liquid transformation temperature at about 100°C or lower. In another embodiment, the present invention comprises a stable liquid salt of a dication or dianion having a solid/liquid transformation temperature at about 60°C or lower. In another embodiment, the present invention comprises a stable liquid salt of a dication or dianion having a solid/liquid transformation temperature at about 25°C or lower.</p><p id="p0041" num="0041">In another embodiment, these dicationic ionic liquids have both a solid/liquid transformation temperature of about 100°C or lower and a liquid range of at least about 200°C.</p><p id="p0042" num="0042">In another aspect of the invention, a dicationic ionic liquid does not substantially volatilize or decompose, as discussed herein, at a temperature of less than about 300°C. "Substantially" in this context means that less than about 10% by weight will decompose or volatilize at about 300°C inside a capillary over the course of about one hour. Moreover, the dicationic ionic liquids in accordance with this embodiment preferably have either a solid/liquid transformation temperature of about 25°C or lower. In another embodiment, the dicationic ionic liquids also have a liquid range of at least about 200°C. In an even more preferred aspect of the invention, the liquid range is about 300°C or above.</p><p id="p0043" num="0043">In a particular embodiment, a dianionic ionic liquid does not substantially decompose or volatilize as measured by being immobilized as a thin film in a fused silica capillary as described herein, at a temperature of about 200°C or lower. Moreover, the dianionic ionic liquid in accordance with this embodiment preferably has either a solid/liquid transformation temperature of about 100°C or lower or a liquid range of at least 200°C.</p><p id="p0044" num="0044">In another embodiment, these dianionic ionic liquids have both a solid/liquid transformation temperature of about 100°C or lower and a liquid range (diionic molecule is stable over the entire temperature range) of at least 200°C.</p><p id="p0045" num="0045">In another aspect of the invention, a dianionic ionic liquid does not substantially volatilize or decompose, as discussed herein, at a temperature of lower than about 300°C. Moreover, the dianionic ionic liquids in accordance with this embodiment preferably have either a solid/liquid transformation temperature of about 25°C or lower. In another embodiment, the<!-- EPO <DP n="12"> --> dianionic ionic liquids also have a liquid range of at least about 200°C. In a particular aspect of the invention, the liquid range is about 300°C or above.</p><p id="p0046" num="0046">Thus a diionic liquid in accordance with the present invention is either a dicationic ionic liquid salt or a dianionic ionic liquid salt which neither substantially decompose nor substantially volatilize, as measured as described herein, at a temperature of about 200°C or lower and have a solid/liquid transformation temperature of about 100°C or a liquid range of at least about 200°C.</p><p id="p0047" num="0047">In other aspects of the invention, these diionic liquids have both solid/liquid transformation temperature of about 100°C or higher and a liquid range of at least about 200°C.</p><p id="p0048" num="0048">In other embodiments in accordance with the present invention, the diionic liquids, either dicationic ionic liquids or dianionic ionic liquids will be stable, that is not substantially volatilized or decomposed, as discussed herein, at a temperature of less than about 300°C and have a solid/liquid transformation temperature of about 25°C or lower. A particular embodiment of the present invention, the diionic liquids have a liquid range of at least about 200°C and more preferably at least about 300°C. Any diionic compound which can form a stable liquid salt that meets the broadest parameters is contemplated.</p><p id="p0049" num="0049">In another embodiment, the present invention provides a stable diionic liquid comprising at least one liquid salt of dianionic molecule or dicationic molecule of the structure of Formula (I) or (II):<br/>
<br/>
        C-A-B-A'     Formula (I),<br/>
<br/>
or<br/>
<br/>
        C'-A-B-A'-C"     Formula (II)<br/>
<br/>
wherein A and A' are ether both anions or both cations, or are both groups which overall have an anionic or cationic charge and which may be the same or different, so long as they both have the same charge (positive or negative); B is a bridging group (also referred to as a chain or bridging moiety) that may be substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic, cyclic or aromatic, and which optionally contains N, O, S and Si atoms; and C, C' and C" are counter ions having a charge which is opposite to that of A and A'. C' and C" are either both mono-anionic or mono-cationic or groups which have a single anionic or cationic charge<!-- EPO <DP n="13"> --> and may be the same or different so long as they both have the same charge (positive or negative), and C is either dianionic or dicationic or contains two groups, each of which has a single anionic or cationic charge.</p><p id="p0050" num="0050">Of particular interest herein are unsymmetric diionic liquid salts in which either A and A' are structurally different or there is an unsymmetric bridging group. As a general matter, "symmetric" diionic liquid salts are geminal and have identical ions, identical groups and a symmetric bridging group. The counter ions in a symmetric diionic liquid salt can be the same or different. Symmetric diionic liquid salts having different counter ions generally have a lower melting temperature as compared to symmetric liquid salts having the same diionic species and the same counter ions. Those ionic liquid salts which are not "symmetric" may also be called "unsymmetric". "Unsymmetric" molecules herein may also be asymmetrical (chiral) as the term is generally understood in chemistry, but they need not be such.</p><p id="p0051" num="0051">In another embodiment, A and A' are cationic groups which are, without limitation, substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic, cyclic or aromatic, ammonium such as quaternary ammonium and protonated tertiary amine, phosphonium or arsonium groups. When A and A' are cationic, C' and C" are anionic counter ions which, without limitation, include a halogen, mono-carboxylate, mono-sulfonate, monosulfate, NTf<sub>2</sub><sup>-</sup>, BF<sub>4</sub><sup>-</sup>, triflate or PF<sub>6</sub><sup>-</sup> and C is a dianionic molecule having two anionic groups, each of which is selected from, without limitation, carboxylate, sulfate or sulfonate groups. In another embodiment, A and A' are anionic groups which are, without limitation, substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic, cyclic or aromatic, carboxylates, sulfonates or sulfates. When A and A' anionic, C' and C" are cationic counter ions which, without limitation, include ammonium groups such as quaternary ammonium and protonated tertiary amine, phosphonium or arsonium groups. C is a dicationic molecule which can be, without limitation, a compound having two cationic groups, each of which is selected from ammonium such as quaternary ammonium and protonated tertiary amine, phosphonium and arsonium.</p><p id="p0052" num="0052">In another embodiment, these dianionic ionic liquids will have both a solid/liquid transformation temperature of about 100°C or lower and a liquid range of at least about 200°C. In a particular embodiment, a diionic liquid salt of Formula (I) or (II) has a solid/liquid transition<!-- EPO <DP n="14"> --> temperature of about 100°C or lower and/or a liquid range of about 200°C or higher and/or are substantially non-volatile and non-decomposable at a temperature below 200°C.</p><p id="p0053" num="0053">Typically, the structural considerations for diionic liquids are the same whether they are dianionic ionic liquids or dicationic ionic liquids. First, the diionic liquids will include a diionic species, either a dianionic or dicationic molecule. The ionic species are normally separated by a chain or bridging moiety or group as discussed herein. Any anion or cation which can provide a dianionic ionic liquid or dicationic ionic liquid is contemplated. These include those that are identified above as A and A'. Possible cations include, without limitation, quaternary ammonium (-N(R)<sub>3</sub>)<sup>+</sup>, protonated tertiary amines (-N(R)<sub>2</sub>H)<sup>+</sup>, phosphonium and arsonium groups. These groups can be aliphatic, cyclic or aromatic. Examples of aliphatic ammonium dications are found in Table 2 and examples of aromatic ammonium dications are found in Table 1. Anions may include, for example, carboxylates, sulfonates or sulfates. Examples of a dicarboxylic acid dianion include, without limitation, succinic acid. nonanedioic acid and dodecanedioic acid. Other non-limiting examples of diionic species (dianions and dications including a generic bridging group) include:
<chemistry id="chem0003" num="0003"><img id="ib0003" file="imgb0003.tif" wi="146" he="45" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0004" num="0004"><img id="ib0004" file="imgb0004.tif" wi="91" he="31" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="15"> -->
<chemistry id="chem0005" num="0005"><img id="ib0005" file="imgb0005.tif" wi="63" he="34" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0006" num="0006"><img id="ib0006" file="imgb0006.tif" wi="76" he="51" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0007" num="0007"><img id="ib0007" file="imgb0007.tif" wi="74" he="33" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0008" num="0008"><img id="ib0008" file="imgb0008.tif" wi="120" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0009" num="0009"><img id="ib0009" file="imgb0009.tif" wi="119" he="30" img-content="chem" img-format="tif"/></chemistry></p><p id="p0054" num="0054">Examples of counter anions which can be used with the species of the invention include, but are not limited to, Br<sup>-</sup>, BF<sub>4</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, TfO<sup>-</sup>,<!-- EPO <DP n="16"> -->
<chemistry id="chem0010" num="0010"><img id="ib0010" file="imgb0010.tif" wi="139" he="40" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0011" num="0011"><img id="ib0011" file="imgb0011.tif" wi="140" he="26" img-content="chem" img-format="tif"/></chemistry>
wherein R is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocylyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonylalkylene, hydroxycarbonyl,
<chemistry id="chem0012" num="0012"><img id="ib0012" file="imgb0012.tif" wi="83" he="28" img-content="chem" img-format="tif"/></chemistry>
wherein<br/>
<b>X<sub>1</sub></b> is C<sub>1</sub>-C<sub>10</sub>-alkylene;<br/>
<b>X<sub>2</sub></b> is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;<br/>
<b>Y<sub>1</sub></b> is selected from the group consisting of hydrogen and alkyl; and<br/>
<b>Y<sub>2</sub></b> is C<sub>1</sub>-C<sub>10</sub>-alkylene.</p><p id="p0055" num="0055">Note that the branched sulfate groups above are examples of unsymmetric diionic molecules in accordance with a particular embodiment of the invention. The value of n is discussed in connection with the length of the bridging group. In addition, hybrid dianions and dications are contemplated. Thus, for illustration only, a dication can be composed of a quaternary ammonium group and an arsonium group and a dianion can be composed of a carboxylate group and a sulfonate. The counter ions may also be different from each other.</p><p id="p0056" num="0056">The bridging group or chain interposed between the two ionic species can be any length or any composition which affords a diionic liquid of suitable properties. These include the groups identified as B herein. There are certain factors that should be considered in selecting such a chain or bridging moiety. First, the larger the diionic molecule in general, the greater the chance that the melting point or temperature of solid/liquid transformation will be elevated. This may be less of a concern where the liquid range need not be extensive and the temperature of<!-- EPO <DP n="17"> --> solid/liquid transformation need not be very low. If, however, one desires a liquid range of about 200°C or higher and/or a solid/liquid transformation temperature of about 100°C or lower, the size of the overall molecule can become a larger factor. Second, the chain should have some flexibility. An excessive degree of unsaturated groups, the use of very rigid and/or stericly bulky groups can adversely impact the ability of the resulting materials to act as solvents and reduce their overall utility. Thus, multiple fused ring structures, such as those found in, for example, cholesterol, and polyunsaturated aliphatic groups with extensive unsaturation should generally be avoided.</p><p id="p0057" num="0057">In general, the length of the bridging group can range from a length equivalent to that of a saturated aliphatic carbon chain of between about 2 and about 40 carbon atoms (e.g., n=C<sub>2</sub>-C<sub>40</sub> when bridging group is composed of carbon). More particularly, the length should be approximately that resulting from a saturated aliphatic carbon chain of about 3 to about 30 carbon atoms in length.</p><p id="p0058" num="0058">The chain or bridging group may be aliphatic, cyclic, or aromatic, or a mixture thereof. It may contain saturated or unsaturated carbon atoms or a mixture of same with, for example, alkoxy groups such as ethoxy, propoxy, isopropoxy, butoxy and the like. It may also include or be made completely from alkoxy groups, glycerides, glycerols and glycols. The chain may contain one or more heteroatom such as O, N, S and/or Si and derivatives such as siloxanes, non-protonated tertiary amines and the like. The chain may be made from one or more cyclic or aromatic groups such as cyclohexane, imidazole, benzene, diphenol, toluene or xylene group or from more complex ring-containing groups such as bisphenol or benzidine. These are merely representative and are not meant to be limiting. Generally, however, the bridging group will not contain an ionically charged species, other than the dianions or dications.</p><p id="p0059" num="0059">In some embodiments, A and A' can be a quaternary ammonium, protonated tertiary amine, phosphonium or arsonium group of the general formula -X<sup>+</sup>RR'R" where X is N, P or As, wherein R, R' and R" can be, but are not limited to, a proton, substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic (such as propyl and butyl or substituted propyl and butyl), cyclic (such as cyclohexane or substituted cyclohexane) or aromatic (such as phenyl or substituted phenyl) group. Thus, the invention provides a diionic liquid in which the dicationic species is described by the following formula:<br/>
<br/>
        RR'R"X<sup>+</sup>-B-X<sup>+</sup>RR'R",<br/>
<br/>
<!-- EPO <DP n="18"> -->wherein R, R' and R" can be the same or different. In a particular embodiment, R, R' and R" are the same. In another embodiment, R, R' and R" are different from each other. In still another embodiment, two of R, R' and R" are the same while the third is different. In embodiments in which R, R' and R" are different, the diionic species can be chiral. In addition, or instead, R and R' are identical and thus the group is not chiral. However, R" might itself be a chiral group.</p><p id="p0060" num="0060">In a particular embodiment, the cationic group X<sup>+</sup>RR'R" is (-P(R)<sub>3</sub>)<sup>+</sup> and the dicationic species has the following formula:
<chemistry id="chem0013" num="0013"><img id="ib0013" file="imgb0013.tif" wi="51" he="25" img-content="chem" img-format="tif"/></chemistry>
wherein each of B, R, R' and R" is as described above.</p><p id="p0061" num="0061">In another embodiment, a dicationic species has an alkyl bridging group and an example of such species is, without limitation:
<chemistry id="chem0014" num="0014"><img id="ib0014" file="imgb0014.tif" wi="60" he="24" img-content="chem" img-format="tif"/></chemistry>
wherein, each of R, R' and R" groups may be the same or different and may be substituted or unsubstituted, saturated or unsaturated, chiral, straight or branched aliphatic chain, cyclic or aromatic group as described herein or consistent herewith. In one embodiment, each of R, R' and R" may be the same or different and may be propyl, butyl, cyclohexane or phenyl. In one embodiment, n ranges from 1 to 36, inclusive; more preferably, n is 3, 6, 9, 10 or 12.</p><p id="p0062" num="0062">In another particular embodiment, the invention provides a diionic liquid having the following formula:
<chemistry id="chem0015" num="0015"><img id="ib0015" file="imgb0015.tif" wi="81" he="25" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="19"> -->
wherein each R, R' and R" are as described above. In an embodiment, each of R, R' and R" independently is hydrogen, propyl, butyl, cyclohexane or phenyl, and n is from 1 to 36, inclusive. In one embodiment, n is 3, 4, 5, 6 or 7.</p><p id="p0063" num="0063">In another embodiment, the invention provides a diionic liquid salt in which the dicationic species is described by one of the above two formula with the exception that P is replaced by another charged species such as N or As , in which case, the number of "R" groups would be adjusted as appropriate.</p><p id="p0064" num="0064">In still another embodiment, the invention provides a diionic liquid salt comprising a dicationic species containing one or more chiral center. A monoionic group may contain a chiral charged atom or at least one functional group containing at least one chiral center.</p><p id="p0065" num="0065">In a particular embodiment, a dicationic liquid salt contains chiral charged atoms having the Formula (III):
<chemistry id="chem0016" num="0016"><img id="ib0016" file="imgb0016.tif" wi="58" he="36" img-content="chem" img-format="tif"/></chemistry>
and at least one counter anion,<br/>
wherein:
<ul><li><b>X</b> and <b>Y</b> are independently selected from the group consisting of ammonium,</li><li>phosphonium and arsonium;</li><li>each <b>R, R',</b> and <b>R"</b> is independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, and carbocyclyl;<br/>
wherein each <b>R, R',</b> and <b>R"</b> optionally is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, hydroxyl, alkoxy, and carbocyclyl;</li><li><b>B</b> is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and polysiloxyl;<br/>
<!-- EPO <DP n="20"> -->wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si;<br/>
wherein <b>B</b> is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li><b>n</b> is selected from the group consisting of 1 to 20, inclusive.</li></ul></p><p id="p0066" num="0066">In a further particular embodiment, R, R' and R" are different; and each R, R' and R" on both sides of the bridging group, B, are the same as described by the following formula:
<chemistry id="chem0017" num="0017"><img id="ib0017" file="imgb0017.tif" wi="51" he="24" img-content="chem" img-format="tif"/></chemistry></p><p id="p0067" num="0067">In a particular embodiment, the dicationic species has an alkylene bridging group and an example of such species is, without limitation:
<chemistry id="chem0018" num="0018"><img id="ib0018" file="imgb0018.tif" wi="61" he="25" img-content="chem" img-format="tif"/></chemistry>
wherein R, R', and R" are different from each other but R, R' and R" on each side of the bridging ethyl group are the same.</p><p id="p0068" num="0068">In a particular embodiment, R is propyl, butyl, cyclohexane or phenyl; R' is phenyl; and R" is 2-methoxyphenyl.</p><p id="p0069" num="0069">In another particular embodiment, at least two of R, R' and R" are covalently bound to each other. For example, R is a propyl and R' is phenyl, here they are bound to each other by a bond.</p><p id="p0070" num="0070">In another particular embodiment, one of more of R, R' and R" are themselves chiral. In such an embodiment, the dicationic species can be chiral even though neither of the phosphorus atoms is a stereogenic center. For example, in one embodiment, R and R' are the same and each contains at least one stereogenic center. Other charged molecules, such as a nitrogen atom or arsenic atom could be used in place of a phorphorus atom in either of the two immediately preceding structures.<!-- EPO <DP n="21"> --></p><p id="p0071" num="0071">In still another embodiment, the dicationic species contains a stereogenic center in the bridging group B. Indeed, it is possible that the bridging group include one or more chiral centers, each of the cations is chiral, and one or more of R, R' and/or R" is or contains a chiral center as well. And the counter ions may be chiral as well.</p><p id="p0072" num="0072">In one embodiment, a dicationic liquid salt of Formula (III) is provided, wherein<br/>
each <b>R, R'</b> and <b>R"</b> is independently selected from the group consisting of hydrogen, propyl, butyl, cyclohexanyl and phenyl;<br/>
<b>X</b> and <b>Y</b> are independently selected from the group consisting of ammonium and phosphonium;<br/>
<b>B</b> is selected from the group consisting of alkylene, alkenylene and alkynylene, wherein each such substituent optionally contains one or more heteroatoms selected from the group consisting of O, N, S or Si.</p><p id="p0073" num="0073">In another embodiment, a dicationic liquid salt of Formula (III) is provided, wherein<br/>
each <b>R</b> is independently selected from the group consisting of hydrogen, propyl, butyl, cyclohexanyl and phenyl;<br/>
each <b>R'</b> is hydrogen or phenyl;<br/>
each <b>R"</b> is hydrogen or 2-methoxyphenyl; and<br/>
<b>X</b> and <b>Y</b> are both phosphonium.</p><p id="p0074" num="0074">It is possible for the dicationic liquid salt of Formula (III) to "unsymmetric" as defined below. For example, in one embodiment, the dicationic liquid salt is unsymmetric because the bridging group, B, is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl and alkoxy; and contains at least one stereogenic center. In another embodiment the dicationic liquid salt is unsymmetric because the bridging group, B, is alkylene, alkenylene, and alkynylene containing one or more heteroatoms selected from the group consisting of O, N, S and Si so as to be unsymmetric.</p><p id="p0075" num="0075">In another embodiment, the dicationic liquid salt of Formula (III) contains at least one unsaturated group so as facilitating cross-linking or immobilization as discussed below.</p><p id="p0076" num="0076">As previously noted, in another embodiment of the invention a diionic liquid salt is provided in which the diionic species is unsymmetric. By "unsymmetric", it is meant that the diionic species include an A and A' (ionic groups, either cationic or anionic) group that are not structurally the same or a bridging group that is unsymmetric. However, the diionic species may<!-- EPO <DP n="22"> --> possess symmetries or asymmetries (<i>i.e</i>., the diionic species may also be asymmetrical). The invention encompasses unsymmetric diionic species due to any compositional and/or structural arrangement.</p><p id="p0077" num="0077">Therefore, in one embodiment a dicationic liquid salt is provided wherein the dicationic liquid salt comprises a dicationic species corresponding in structure to Formula (IV):<br/>
<br/>
        A<sup>+</sup>-B-A'<sup>+</sup>     Formula (IV)<br/>
<br/>
and at least one counter anion,<br/>
wherein:
<ul><li><b>A</b> and <b>A'</b> are each a monoionic group independently selected from the group consisting of ammonium, thionium, phosphonium, arsonium, carbocylyl and heterocyclyl;<br/>
wherein each such substituent is optionally substituted with one or more substituents selected from the group consisting of alkyl, hydroxyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl;<br/>
wherein <b>A</b> and <b>A'</b> are different or <b>A</b> and <b>A'</b> have at least one different substituent;</li><li><b>B</b> is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and polysiloxyl;<br/>
wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si;<br/>
wherein <b>B</b> is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li><b>n</b> is selected from the group consisting of 1 to 20, inclusive.</li></ul></p><p id="p0078" num="0078">In one embodiment, the dicationic species corresponding to Formula (IV) contains A and A', each of which is independently selected from the group consisting of:<!-- EPO <DP n="23"> -->
<chemistry id="chem0019" num="0019"><img id="ib0019" file="imgb0019.tif" wi="158" he="39" img-content="chem" img-format="tif"/></chemistry>
wherein each of R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> is independently selected from the group consisting of a proton (hydrogen), substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic moiety (such as propyl and butyl or substituted propyl and butyl), cycloalkyl (such as cyclohexane or substituted cyclohexane), aromatic moiety (i.e. an aryl such as phenyl or substituted phenyl), cycloalkylalkyl, aralkyl, alkoxy and hydroxyalkyl</p><p id="p0079" num="0079">A diionic species may be considered different because of the substituents. For example, an unsymmetric diionic species of the present invention may have a quaternary ammonium with 3 methyl substitutes on one side of the bridge and a quaternary ammonium with 2 methyl substitutes and one ethyl substitute on the other side of the bridge. Alternatively, a diionic species with two identical ionic groups can be considered unsymmetic if such species contains an unsymmetric bridge.</p><p id="p0080" num="0080">In another embodiment, a dicationic liquid salt of the present invention comprises a dicationic species having different A and A'. Therefore, A is selected from the group consisting of ammonium such as quaternary ammonium and protonated tertiary amine, phosphonium and arsonium; and A' can be any member of the group so long as it is different from A. In a particular embodiment, the present invention provides a diionic liquid salt comprising a diionic species having the following formula:
<chemistry id="chem0020" num="0020"><img id="ib0020" file="imgb0020.tif" wi="61" he="39" img-content="chem" img-format="tif"/></chemistry>
wherein B and each R<sub>1</sub>, each R<sub>2</sub> and each R<sub>3</sub> is as defined previously. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n<!-- EPO <DP n="24"> --> and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each of R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub>, is independently selected from hydrogen, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0081" num="0081">In a particular embodiment, a diionic species comprises an alkyl linkage and an ammonium group and a phosphonium group, each of which is substituted with one or more alkyl. An example of a dicationic liquid salt containing such an unsymmetric ammonium-phosphonium-based dicationic species includes, but is not limited to:
<chemistry id="chem0021" num="0021"><img id="ib0021" file="imgb0021.tif" wi="120" he="51" img-content="chem" img-format="tif"/></chemistry></p><p id="p0082" num="0082">In another embodiment, the present invention provides an "unsymmetric" dicationic liquid comprising an imidazolium group and an ammonium group having the following formula:
<chemistry id="chem0022" num="0022"><img id="ib0022" file="imgb0022.tif" wi="73" he="37" img-content="chem" img-format="tif"/></chemistry>
wherein B, and each R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, R<sub>n</sub> and the anions can be any of those described above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; and each of R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, R and R<sub>n</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0083" num="0083">In a particular embodiment, a dicationic species comprises an alkyl linkage, an alkyl-substituted imidazolium group and an alkyl-substituted phosphonium group. An example of a dicationic liquid salt containing such an unsymmetric imidazolium-phosphonium-based dicationic species includes, but is not limited to:<!-- EPO <DP n="25"> -->
<chemistry id="chem0023" num="0023"><img id="ib0023" file="imgb0023.tif" wi="114" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0084" num="0084">In still another embodiment, the present invention provides an "unsymmetric" dcationic liquid salt comprising a phosphonium group and a pyridinium group having the following formula:
<chemistry id="chem0024" num="0024"><img id="ib0024" file="imgb0024.tif" wi="74" he="39" img-content="chem" img-format="tif"/></chemistry>
wherein B, R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> and the anions can be any of those described above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each of R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> is selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0085" num="0085">In a particular embodiment, a diionic species comprises an alkyl linkage, a pyridinium group and an alkyl-substituted phosphonium group. An example of dicationic liquid salts containing such an unsymmetric phosphonium-pyridinium based dicationic species includes, but is not limited to:<!-- EPO <DP n="26"> -->
<chemistry id="chem0025" num="0025"><img id="ib0025" file="imgb0025.tif" wi="105" he="52" img-content="chem" img-format="tif"/></chemistry></p><p id="p0086" num="0086">In other embodiments, A and A' are the same in Formula (IV), for example, both A and A' can be ammonium or phosphonium, but each is a different ionic group by way of different functional groups or other structural features such as, for example, a position isomer. Therefore, in one embodiment, the present invention provides a dicationic liquid salt comprising an unsymmetric dicationic species in which A and A' contain the same charged atom but the ionic groups are structurally different as a whole. For example, A is a straight or branched chain structure such as quaternary ammonium or protonated tertiary amine, while A' is a ring structure such as an imidazolium or a substituted imidazolium.</p><p id="p0087" num="0087">Thus, in one embodiment an unsymmetric dicationic salt of the present invention contains an ammonium group and an imidazolium group, each of which is optionally substituted with alkyl, hydroxyalkyl or aralkyl. In a particular embodiment, an ammonium-imidazolium based unsymmetric dicationic species comprises an ammonium group and an imidazolium group, each of which is substituted with methyl. Examples of dicationic liquid salts comprising such dicationic species include, but are not limited to:
<chemistry id="chem0026" num="0026"><img id="ib0026" file="imgb0026.tif" wi="93" he="35" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="27"> -->
<chemistry id="chem0027" num="0027"><img id="ib0027" file="imgb0027.tif" wi="103" he="38" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0028" num="0028"><img id="ib0028" file="imgb0028.tif" wi="102" he="37" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0029" num="0029"><img id="ib0029" file="imgb0029.tif" wi="97" he="34" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0030" num="0030"><img id="ib0030" file="imgb0030.tif" wi="93" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0088" num="0088">In another particular embodiment, an ammonium-imidazolium based unsymmetric dicationic species comprises an ammonium group substituted with one or more methyl group and an imidazolium group substituted with butyl. Examples of diionic liquid salts comprising such dicationic species includes, but are not limited to:
<chemistry id="chem0031" num="0031"><img id="ib0031" file="imgb0031.tif" wi="120" he="35" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="28"> -->
<chemistry id="chem0032" num="0032"><img id="ib0032" file="imgb0032.tif" wi="123" he="35" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0033" num="0033"><img id="ib0033" file="imgb0033.tif" wi="120" he="36" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0034" num="0034"><img id="ib0034" file="imgb0034.tif" wi="117" he="35" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0035" num="0035"><img id="ib0035" file="imgb0035.tif" wi="123" he="37" img-content="chem" img-format="tif"/></chemistry></p><p id="p0089" num="0089">In still another particular embodiment, an ammonium-imidazolium based unsymmetric dicationic species comprises an ammonium group substituted with one or more methyl group and an imidazolium group disubstituted with methyl. Examples of diionic liquid salts comprising such dicationic species includes, but are not limited to:<!-- EPO <DP n="29"> -->
<chemistry id="chem0036" num="0036"><img id="ib0036" file="imgb0036.tif" wi="108" he="66" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0037" num="0037"><img id="ib0037" file="imgb0037.tif" wi="95" he="39" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0038" num="0038"><img id="ib0038" file="imgb0038.tif" wi="95" he="35" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0039" num="0039"><img id="ib0039" file="imgb0039.tif" wi="97" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0090" num="0090">In still another particular embodiment, an ammonium-imidazolium based unsymmetric dicationic species comprises an ammonium group substituted with one or more methyl group and an imidazolium group substituted with hydroxyethyl. Examples of diionic liquid salts comprising such dicationic species includes, but are not limited to:<!-- EPO <DP n="30"> -->
<chemistry id="chem0040" num="0040"><img id="ib0040" file="imgb0040.tif" wi="120" he="67" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0041" num="0041"><img id="ib0041" file="imgb0041.tif" wi="114" he="34" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0042" num="0042"><img id="ib0042" file="imgb0042.tif" wi="114" he="34" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0043" num="0043"><img id="ib0043" file="imgb0043.tif" wi="115" he="34" img-content="chem" img-format="tif"/></chemistry></p><p id="p0091" num="0091">In still another particular embodiment, an ammonium-imidazolium based unsymmetric dicationic species comprises an ammonium group substituted with one or more methyl group and an imidazolium group substituted with benzyl. Example of such dication species includes, but are not limited to:<!-- EPO <DP n="31"> -->
<chemistry id="chem0044" num="0044"><img id="ib0044" file="imgb0044.tif" wi="124" he="66" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0045" num="0045"><img id="ib0045" file="imgb0045.tif" wi="123" he="35" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0046" num="0046"><img id="ib0046" file="imgb0046.tif" wi="120" he="34" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0047" num="0047"><img id="ib0047" file="imgb0047.tif" wi="124" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0092" num="0092">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" ammonium-pyrrolidinium based dicationic species having the following formula:<!-- EPO <DP n="32"> -->
<chemistry id="chem0048" num="0048"><img id="ib0048" file="imgb0048.tif" wi="62" he="39" img-content="chem" img-format="tif"/></chemistry>
wherein B, R<sub>n</sub> and each R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and the anions is as defined above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; R<sub>n</sub> and each R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0093" num="0093">In a particular embodiment, an unsymmetric ammonium-imidazolium based dicationic species comprises an alkyl likage, an ammonium group substituted with one or more methyl group and an imidazolium group substituted with alkyl such as methyl, ethyl, propyl and butyl. An example of a diionic liquid salt comprising such dication species includes, but is not limited to:
<chemistry id="chem0049" num="0049"><img id="ib0049" file="imgb0049.tif" wi="87" he="47" img-content="chem" img-format="tif"/></chemistry></p><p id="p0094" num="0094">In other embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" ammonium-pyridinium based dicationic species having the following formula:
<chemistry id="chem0050" num="0050"><img id="ib0050" file="imgb0050.tif" wi="74" he="40" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="33"> -->
wherein B and R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub> is as defined above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each of R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0095" num="0095">In a particular embodiment, an unsymmetric ammonium-pyridinium based dicationic species comprises an alkyl linkage, an ammonium group substituted with one or more methyl group and an unsubstituted pyridinium group. An example of a diionic liquid salt comprising such dicationic species includes, but is not limited to:
<chemistry id="chem0051" num="0051"><img id="ib0051" file="imgb0051.tif" wi="118" he="49" img-content="chem" img-format="tif"/></chemistry></p><p id="p0096" num="0096">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" imidazolium-pyridinium based dicationic species having the following formula:
<chemistry id="chem0052" num="0052"><img id="ib0052" file="imgb0052.tif" wi="89" he="34" img-content="chem" img-format="tif"/></chemistry>
wherein B, R<sub>1</sub> and each R<sub>n</sub> is as defined above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each R<sub>n</sub> and R<sub>1</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0097" num="0097">In a particular embodiment, an unsymmetric imidazolium-pyridinium based dicationic species comprises an alkyl linkage, an unsubstituted pyridinium and an imidazolium<!-- EPO <DP n="34"> --> group substituted with alkyl such as methyl, ethyl, propyl and butyl. An example of a diionic liquid salt comprising such dicationic species includes, but is not limited to:
<chemistry id="chem0053" num="0053"><img id="ib0053" file="imgb0053.tif" wi="104" he="31" img-content="chem" img-format="tif"/></chemistry></p><p id="p0098" num="0098">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" ammonium-ammonium based dicationic species having the following formula:
<chemistry id="chem0054" num="0054"><img id="ib0054" file="imgb0054.tif" wi="61" he="37" img-content="chem" img-format="tif"/></chemistry></p><p id="p0099" num="0099">wherein B and each R<sub>1</sub>, each R<sub>2</sub> and each R<sub>3</sub> is as defined above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each of R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub>, is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl. In a particular embodiment, an unsymmetric ammonium-ammonium based dicationic species comprises an alkyl linkage, a pyrrolidinium group substituted with alkyl such as methyl, ethyl, propyl and butyl.</p><p id="p0100" num="0100">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" pyridinium-pyridinium based dicationic species having the following formula:
<chemistry id="chem0055" num="0055"><img id="ib0055" file="imgb0055.tif" wi="86" he="33" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="35"> -->
wherein B and each R<sub>n</sub> is as defined above, except that each R<sub>n</sub> are different. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each R<sub>n</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0101" num="0101">In a particular embodiment, an unsymmetric pyridinium-pyridinium based dicationic species comprises an alkyl linkage, an unsubstituted pyridinium group and a pyridinium group substituted with alkoxy such as methoxy, ethoxy and propoxy. An example of a diionic liquid salt comprising such dicationic species includes, but is not limited to:
<chemistry id="chem0056" num="0056"><img id="ib0056" file="imgb0056.tif" wi="114" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0102" num="0102">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" imidazolium-imidazolium based dicationic species having the following formula:
<chemistry id="chem0057" num="0057"><img id="ib0057" file="imgb0057.tif" wi="92" he="34" img-content="chem" img-format="tif"/></chemistry>
wherein B and each R<sub>n</sub> and each R<sub>1</sub> is as defined above except that at least one substitution on an imidazolium ring is different than the other imidazolium ring. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each of R<sub>n</sub> and R<sub>1</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0103" num="0103">In a particular embodiment, an unsymmetric imidazolium-imidazolium based dicationic species comprises an alkyl linkage, a benzyl-substituted imidazolium and an alkyl-substituted imidazolium. An example of such dicationic species includes, but is not limited to:<!-- EPO <DP n="36"> -->
<chemistry id="chem0058" num="0058"><img id="ib0058" file="imgb0058.tif" wi="124" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0104" num="0104">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" imidazolium-pyrrolidinium based dicationic species having the following formula:
<chemistry id="chem0059" num="0059"><img id="ib0059" file="imgb0059.tif" wi="78" he="34" img-content="chem" img-format="tif"/></chemistry>
wherein B, R<sub>1</sub> and each R<sub>n</sub> are as defined above. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n, PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; R<sub>1</sub> and each R<sub>n</sub> is independently selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0105" num="0105">In a particular embodiment, an unsymmetric imidazolium-pyrrolidinium based dicationic species comprises an alkyl or PEG linkage, an alkyl-substituted imidazolium and an alkyl-substituted pyrrolidinium. Examples of diionic liquid salts comprising such dicationic species include, but are not limited to:
<chemistry id="chem0060" num="0060"><img id="ib0060" file="imgb0060.tif" wi="102" he="36" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="37"> -->
<chemistry id="chem0061" num="0061"><img id="ib0061" file="imgb0061.tif" wi="102" he="36" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0062" num="0062"><img id="ib0062" file="imgb0062.tif" wi="103" he="51" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0063" num="0063"><img id="ib0063" file="imgb0063.tif" wi="103" he="51" img-content="chem" img-format="tif"/></chemistry></p><p id="p0106" num="0106">In one embodiment, the invention provides a dicationic liquid salt comprising an "unsymmetric" phosphonium-phosphonium based dicationic species having the following formula:
<chemistry id="chem0064" num="0064"><img id="ib0064" file="imgb0064.tif" wi="61" he="39" img-content="chem" img-format="tif"/></chemistry>
wherein B and each R<sub>1</sub>, each R<sub>2</sub> and each R<sub>3</sub> is as defined above, except that at least one of R<sub>1</sub>, R<sub>2</sub> or R<sub>3</sub> is different. In a particular embodiment, B is selected from alkyl linkage such as (-CH<sub>2</sub>-)n,<!-- EPO <DP n="38"> --> PEG linkage such as (-CH<sub>2</sub>-O-CH<sub>2</sub>-)n and an aryl linkage such as phenyl-containing linker, i.e., (-CH<sub>2</sub>-Phenyl-CH<sub>2</sub>-)n wherein n is from 1 to 20, inclusive; each R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub> is selected from H, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</p><p id="p0107" num="0107">In a particular embodiment, an unsymmetric phosphonium-phosphonium based dicationic species comprises an alkyl linkage and alkyl-substituted phosphoniums. An example of a diionic liquid salt comprising such dicationic species includes, but is not limited to:
<chemistry id="chem0065" num="0065"><img id="ib0065" file="imgb0065.tif" wi="109" he="35" img-content="chem" img-format="tif"/></chemistry></p><p id="p0108" num="0108">Unsymmetric dicationic species of the formula RR<sub>1</sub>R<sub>2</sub>X<sup>+</sup>-B-X<sup>+</sup>R'R'<sub>1</sub>R'<sub>2</sub> may possess one or more stereogenic centers. For example, if R, R<sub>1</sub> and R<sub>2</sub> are the same, but R', R<sub>1</sub>' and R<sub>2</sub>' are different from each other, the unsymmetric dicationic species has a stereogenic center located on the charge element of X of -X<sup>+</sup>R'R<sub>1</sub>'R<sub>2</sub>'. In another example, if both R, R<sub>1</sub> and R<sub>2</sub> are different from each other, and R', R<sub>1</sub>' and R<sub>2</sub>' are different from each other, the unsymmetric dicationic species has two stereogenic centers located on each charged element X. As described above, the dicationic species may also contain one or more stereogenic center within the R groups or the bridging group B.</p><p id="p0109" num="0109">In another embodiment, a diionic liquid salt according to Formula IV is provided wherein the bridging group B is unsymmetric such that the dicationic species does not possess symmetry between the two ionic groups In one embodiment, B is an unsymmetric bridging group containing one or more heteroatoms, wherein each of the heteroatoms can be selected from O, N, P, S and Si; and if the heteroatoms are more than two, the heteroatoms can be the same or different. The position of each heteroatom should be selected such that the diionic species does not possess symmetry between the two ionic groups. An example of a dicationic species containing such an unsymmetric bridge includes, but is not limited to:
<chemistry id="chem0066" num="0066"><img id="ib0066" file="imgb0066.tif" wi="135" he="8" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="39"> --></p><p id="p0110" num="0110">In another embodiment, B is an unsymmetric bridging group containing one or more side chain group, wherein the one or more side chain groups can be the same or different. The location of such side chain should be selected such that the diionic species does not possess symmetry between the two ionic groups. An example of a dicationic species containing such an unsymmetric bridge includes, but is not limited to:
<chemistry id="chem0067" num="0067"><img id="ib0067" file="imgb0067.tif" wi="98" he="19" img-content="chem" img-format="tif"/></chemistry></p><p id="p0111" num="0111">The "unsymmetric" diionic salts of the invention, e.g., "unsymmetric" dicationic salts, can be used in a substantially pure form in any of the applications, e.g., the applications disclosed in this application. As compared to corresponding symmetric diionic liquid salts, i.e., diionic liquid salts having the same A or A' groups and B, diionic liquid salts which are not structurally identical on both sides of the bridge or which include an unsymmetric bridging group generally have lower melting temperatures, and advantage for "liquid" salts. In addition, the higher the degree of internal structural dissimilarity as compared to corresponding symmetric diionic salts, generally the lower the melting temperatures will result as compared to those of the corresponding symmetric diionic salts. The trend can be thought of as a continuum from a symmetric molecule on the one end and a group with two different counter ions, two different ions, different substituents, and an unsymmetric bridging group on the other. The former would be expected to have the highest melting point and the latter the relatively lowest. Of course, there can be variations to this trend. For example, a specific counter ion might have a greater effect on decreasing melting point than the use of two different ions.</p><p id="p0112" num="0112">The "unsymmetric" diionic salts of the invention may also be advantageous for uses as solvents. For example, a dicationic species having different A and A' groups offers two sets of possible interactions with other molecules in the solution as compared to only one set in the case of a symmetric diionic species. Indeed, the more unsymmetric, the more the variety of interactions that can result. Thus, the invention provides a use of a diionic liquid of a substantially pure "unsymmetric" diionic salt as described above as a solvent.</p><p id="p0113" num="0113">The "unsymmetric" diionic liquid salts of the invention can also be used in combination with any symmetric diionic species as a mixture. Such mixtures can comprise an<!-- EPO <DP n="40"> --> "unsymmetric" diionic salt of the invention and a symmetric diionic salt of the invention at a ratio such that the mixture has the desired melting temperature and/or desired interactions with other molecules. Thus, in one embodiment, the invention provides a diionic liquid salt comprising at least one of the "unsymmetric" diionic salts as described above and at least one of the symmetric diionic salts of the invention at a suitable proportion. A person skilled in the art would be able to determine the proportion of the symmetric and unsymmetric diionic salts when used as a mixture according to the particular application. In a particular embodiment, in the above described mixture diionic salts are dicationic salts. In still another particular embodiment, in the above described mixture diionic salts contains both at least one dicationic salt and at least one dianionic salt.</p><p id="p0114" num="0114">Diionic liquids of the present invention are generally salts, although they may exist as ions (+1, -1, +2, -2) in certain circumstances. Thus, in most instances, each ion should have at least one counter ion, one for each anion or cation. Charge should be preserved. In the case of a dianionic liquid, two cations (including those identified as C' or C") (or one dication) (including those identified as C) are required and in the case of a dicationic liquid, two anions (including those identified as C' or C") (or one dianion) (including those identified as C) are required. The choice of anion can have an effect of the properties of the resulting compound and its utility as a solvent. And, while anions and cations will be described in the context of a single species used, it is possible to use a mixture of cations to form salts with a dianionic species to form a dianionic ionic liquid. The reverse is true for dications. For clarity sake, the salt-forming ions will be referred to as counter ions herein. The diionic liquid of the present invention can also be a mixture of a dicationic salt and a dianionic salt.</p><p id="p0115" num="0115">Cationic counterions can include any of the dicationic compounds previously identified for use in the production of dicationic ionic liquids. In addition, monoionic counterparts of these may be used. Thus, for example, quaternary ammonium, protonated tertiary amine, phosphonium and arsonium are useful as cationic counter ions for dianionic molecules to form dianionic ionic liquids in accordance with the present invention.</p><p id="p0116" num="0116">Similarly, anionic counterions can be selected from any of the dianionic molecules discussed herein useful in the creation of dianionic ionic liquids. These would include dicarboxylate, disulfonate, and disulfate. The corresponding monoionic compounds may also be used including carboxylate, sulfonate, sulfate and phosphonate. Halogens and halogen-containing<!-- EPO <DP n="41"> --> compounds may be used such as triflate, NTf<sub>2</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, BF<sub>4</sub><sup>-</sup> and the like. The counterions should be selected such that the diionic liquids have good thermal and/or chemical stability and have a solid/liquid transformation temperature and/or a liquid range as described herein. Finally, the ionic groups of the present invention can be substituted or unsubstituted. They may be substituted with halogens, with alkoxy groups, with aliphatic, aromatic, or cyclic groups, with nitrogen-containing species, with silicon-containing species, with oxygen-containing species, and with sulphur-containing species. The degree of substitution and the selection of substituents can influence the properties of the resulting material as previously described in discussing the nature of the bridge or chain. Thus, care should be taken to ensure that excessive steric hindrance and excessive molecular weight are avoided, that resulting materials does not lose its overall flexibility and that nothing will interfere with the ionic nature of the two ionic species.</p><p id="p0117" num="0117">The diionic liquids of the present invention can be used in pure or in substantially pure form as carriers or as solvents. "Substantially" in this context means no more than about 10% of undesirable impurities. Such impurities can be either other undesired diionic salts, reaction by-products, contaminants or the like as the context suggests. In an intended mixture of two or more DILS, neither would be considered an impurity. Because they are non-volatile and stable, they can be recovered and recycled and pose few of the disadvantages of volatile organic solvents. Because of their stability over a wide liquid range, in some instances over 400°C, they can be used in chemical synthesis that require both heating and cooling. Indeed, these solvents may accommodate all of the multiple reaction steps of certain chemical syntheses. Of course, these diionic liquids may be used in solvent systems with co-solvents and gradient solvents and these solvents can include, without limitation, chiral ionic liquids, chiral non-ionic liquids, volatile organic solvents, non-volatile organic solvents, inorganic solvents, water, oils, etc. It is also possible to prepare solutions, suspensions, emulsions, colloids, gels and dispersions using the diionic liquids.</p><p id="p0118" num="0118">In addition to discrete diionic liquid salts, it is also possible to produce polymers of these materials. Polymers may include the diionic salts within the backbone or as pendant groups and they may be cross-linked or non-cross-linked.</p><p id="p0119" num="0119">In addition to being useful as solvents and reaction solvents, the dianionic liquids of the present invention can be used to perform separations as, for example, the stationary phase for<!-- EPO <DP n="42"> --> gas-liquid chromatography. Dicationic ionic liquid salts, which may be used for exemplification include: (1) two vinyl imidazolium or pyrrolidinium dications separated by an alkyl linkage chain (of various length) or (2) one vinyl imidazolium or pyrrolidinium cation separated an alkyl linkage chain (of various length) and connected to a methyl, ethyl, propyl, or butylimidazolium cation or a methyl, ethyl, propyl, or butylpyrrolidinium cation. See below. Any anionic counter ion discussed may be used. Note that the presence of unsaturated groups facilitates cross-linking and/or immobilization.
<chemistry id="chem0068" num="0068"><img id="ib0068" file="imgb0068.tif" wi="87" he="20" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0069" num="0069"><img id="ib0069" file="imgb0069.tif" wi="82" he="20" img-content="chem" img-format="tif"/></chemistry></p><p id="p0120" num="0120">Dianionic anions can also be used with either monocations or dications to form a variety of different ionic liquid combinations. When a dication is used, anyone is used as charge balance must be preserved. The dianionic anions can be of the dicarboxylic acid type (<i>i.e</i>., succinic acid, nonanedioic acid, dodecanedioic acid, etc), as shown below:
<chemistry id="chem0070" num="0070"><img id="ib0070" file="imgb0070.tif" wi="110" he="26" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0071" num="0071"><img id="ib0071" file="imgb0071.tif" wi="125" he="31" img-content="chem" img-format="tif"/></chemistry></p><p id="p0121" num="0121">Diionic liquid salts can be coated on a capillary (or solid support) and optionally, subsequently polymerized and/or cross-linked by, for example, two general methods. In the first method, the ionic liquid is coated via the static coating method at 40°C using coating solution concentrations ranging from 0.15-0.45% (w/w) using solutions of methylene chloride, acetone, ethyl acetate, pentane, chloroform, methanol, or mixtures thereof. After coating of the ionic<!-- EPO <DP n="43"> --> liquid is complete, the column is purged with helium and baked up to 100°C. The efficiency of naphthalene (other molecules such as n-hydrocarbons or Grob Test Mixture can also be used for this purpose) is then evaluated to examine the coating efficiency of the monomer ionic liquid stationary phase. If efficiency is deemed sufficient, the column is then flushed with vapors of azo-tert-butane, a free radical initiator, at room temperature. After flushing with the vapors, the column is then fused at both ends and heated in an oven using a temperature gradient up to 200°C for 5 hours. The column gradually cooled and then re-opened at both ends, and purged with helium gas. After purging with helium gas overnight, the column is then heated and conditioned up to 200°C. After conditioning, the column efficiency is then examined using naphthalene at 100°C and the stationary phase coated layer examined under a microscope. Note that the cross-linking process can, and often does, also cause immobilization. "Immobilized" in the context of the invention means covalently or ionically bound to a support or to another ionic liquid (including diionic liquid salts) or both. This is to be compared with ionic liquids which may be absorbed or adsorbed on a solid support. Solid support in these particular instances were intended to include columns (e.g., the walls of the columns).</p><p id="p0122" num="0122">It is not necessary, however, to cross-link these materials prior to their use in GC. They may be adsorbed or absorbed in a column, or indeed on any solid support. However, at higher temperatures, their viscosity may decrease and they can, in some instances, flow and collect as droplets which can change the characteristics of the column. Immobilization or partial cross-linking also reduces the vapor pressure of the stationary phase film which translates into lower column bleed thereby increasing the useful upper temperature limit of the phase and column.</p><p id="p0123" num="0123">Another method involves adding up to 2% of the monomer weight of 2,2'-azobisisobutyronitrile ("AIBN") free radical initiator to the coating solution of the monomer. The capillary column is then filled with this solution and coated via the static coating method. After coating, the capillary column is then sealed at both ends and placed in an oven and conditioned up to 200°C for 5 hours. The column is gradually cooled and then re-opened at both ends, and purged with helium gas. After purging with helium gas overnight, the column is then heated and conditioned up to 200°C. After conditioning, the column efficiency is then examined using naphthalene at 100°C and the stationary phase coated layer examined under a microscope.<!-- EPO <DP n="44"> --></p><p id="p0124" num="0124">In addition to the free radical polymerization of an alkene, other polymerization reactions involving other functional groups either attached to the aromatic ring of the cation, the linkage chain connecting two cations (to form a dication), or the anion can be achieved. Examples of such reactions may include cationic and anionic chain growth polymerization reactions, Ziegler-Natta catalytic polymerization, and step-reaction polymerization. The use of two different monomers to form copolymers through addition and block copolymerization can also be achieved. Additionally, condensation polymerization can be used to connect through functional groups such as amines and alcohols. All polymerization and cross-linking reactions discussed in the following 2 references can be used: "<nplcit id="ncit0001" npl-type="s"><text>Comprehensive Polymer Science - The Synthesis, Characterization, Reactions and Applications of Polymers" by Sir Geoffrey Allen, FRS</text></nplcit>; and "<nplcit id="ncit0002" npl-type="b"><text>Comprehensive Organic Transformations: a guide to functional group preparations" by Richard C. Larock. 2nd Edition. Wiley-VCH, New York. Copyright, 1999. ISBN: 0471190314</text></nplcit>.</p><p id="p0125" num="0125">The production of these 39 dicationic liquid salts are described. The following materials were used: 1-methylimidazole; 1-methylpyrrolidine; 1-butylpyrrolidine; 1,2-dimethylimidazole; 1-butylimidazole; 1-benzylimidazole; 1,3-dibromopropane; 1,6-dibromohexane; 1,9-dibromononane; 1,12-dibromododecane; 1-bromo-3-chloropropane; hexafluorophosphoric acid, sodium tetrafluoroborate, N-lithiotrifluoromethylsulfonimide, silver nitrate, and phosphorus pentoxide which were all purchased from Aldrich (Milwaukee, Wis.). Hexafluorophosphoric acid is toxic and corrosive and must be handled with care. Acetone, ethyl acetate and 2-propanol were purchased from Fisher Scientific (Fair Lawn, N.J.). Untreated fused silica capillary tubing (0.25-mm i.d.) was purchased from Supelco (Bellefonte, Pa.).</p><p id="p0126" num="0126">The following diionic salts may be produced. (See Tables 1, 2 and 3.)<!-- EPO <DP n="45"> -->
<tables id="tabl0001" num="0001"><img id="ib0072" file="imgb0072.tif" wi="146" he="197" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="46"> -->
<tables id="tabl0002" num="0002"><img id="ib0073" file="imgb0073.tif" wi="144" he="75" img-content="table" img-format="tif"/></tables>
<tables id="tabl0003" num="0003"><img id="ib0074" file="imgb0074.tif" wi="127" he="120" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="47"> -->
<tables id="tabl0004" num="0004"><img id="ib0075" file="imgb0075.tif" wi="132" he="209" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="48"> -->
<tables id="tabl0005" num="0005"><img id="ib0076" file="imgb0076.tif" wi="118" he="118" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="49"> -->
<tables id="tabl0006" num="0006"><img id="ib0077" file="imgb0077.tif" wi="123" he="156" img-content="table" img-format="tif"/></tables></p><p id="p0127" num="0127">Note that some of the salts reflected in Tables 1 and 2 may not reflect the correct number of anions; usually 2 (see Table 3). Note that the names of the compounds found in Tables 1 and 2 are found in Table F. Compounds 1, 5, 9 and 13 were synthesized by reacting one molar equivalent of 1,3-dibromopropane; 1,6-dibromohexane; 1,9-dibromononane; and 1,12-dibromododecane, respectively, with two molar equivalents of 1-methylimidazole at room temperature. Compound 17 was synthesized by reacting one molar equivalent of 1,9-dibromononane with two molar equivalents of 1-butylimidazole at room temperature. Compounds 21 and 24 were synthesized by refluxing one molar equivalent of 1,3-dibromopropane and 1,9-dibromononane, respectively, with 1,2-dimethylimidazole dissolved in 125mL 2-propanol for 24 hours. Compound 28 was synthesized by refluxing one molar<!-- EPO <DP n="50"> --> equivalent of 1,12-dibromododecane with two molar equivalents of 1-benzylimidazole in 100 mL of 2-propanol for 24 hours. Following complete reaction (as monitored by NMR), the products were all purified by extraction with ethyl acetate and dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><p id="p0128" num="0128">Compounds 31 and 34 were produced by refluxing one molar equivalent amount of 1,3-dibromopropane and 1,9-dibromononane with two equivalents of 1-methylpyrrolidine in 100 mL of 2-propanol for 24 hours. Compound 37 was synthesized by refluxing two molar equivalents of 1-butylpyrrolidine with one equivalent of 1,9-dibromononane in 100 mL of 2-propanol for 24 hours. These salts were also extracted with ethyl acetate and dried under vacuum. All metathesis reactions involving N-lithiotrifluoromethylsulfonimide, hexafluorophosphoric acid, and sodium tetrafluoroborate were performed using previously published procedures. Ionic liquids formed via metathesis reactions were tested with silver nitrate to ensure no halide impurities remained.</p><p id="p0129" num="0129">All thirty-nine ionic liquid samples were characterized using <sup>1</sup>H NMR and electrospray ionization (ESI) mass spectrometry. <sup>1</sup>H NMR spectra (400 MHz) were recorded in deuterated DMSO.</p><p id="p0130" num="0130">Surface tension values were measured at room temperature (23°C) using a Model 20 DuNuoy Tensiometer (Fisher Scientific, Fair Lawn, N.J.) equipped with a platinum-iridium ring with a mean circumference of 5.940 cm and a ring/wire radius of 53.21. The densities of the ionic liquids or, more correctly, the temperature of solid/liquid transformation (used synonymously except as indicated otherwise explicitly or by context) were determined at 23°C by placing 2.0 mL of the ionic liquid in a 2.0 mL volumetric tube and weighing by difference. The melting points of the ionic liquids were determined using a Perkin Elmer Pyris 1 Differential Scanning Calorimeter (Boston, Mass.). Typical methods involved using a 10°C/min temperature ramp to determine and identify the first and second order thermal transitions. Melting points could not be easily determined for all compounds. For solid compounds, the melting points were verified using a capillary melting point apparatus. Refractive index measurements were conducted at 23°C using a Bausch &amp; Lomb Abbe-3L refractometer.</p><p id="p0131" num="0131">The preparation of the capillary columns for inverse gas-liquid chromatographic analysis was performed using a previously described procedure. All capillary columns had efficiencies between 2100 to 2500 plates/meter. Characterization of the capillary columns and probe molecule descriptions are listed in supplemental information. Multiple linear regression<!-- EPO <DP n="51"> --> analysis (MLRA) and statistical calculations were performed using the program Analyse-it (Microsoft, USA).</p><p id="p0132" num="0132">Tables 1, 2, and 3 give the structures of the two classes (39 compounds) of geminal dicationic ionic liquids synthesized and characterized. Ionic liquids containing imidazolium-based dication with different alkyl linkage chain lengths connecting the cations and/or different alkyl substituents on the imidazolium moiety comprise one group of ionic liquids. In most cases, each geminal dicationic entity was paired with four different anions (Br<sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, BF<sub>4</sub><sup>-</sup> and PF<sub>6</sub><sup>-</sup>, Table 3). Pyrrolidinium-based geminal dication with different alkyl linkage chain lengths connecting the cationic and/or different alkyl substituents on the pyrrolidinium group are also shown in Table 3. For each dication in this class, separate ionic liquids containing three anions (Br<sup>-</sup>, NTf<sub>2</sub><sup>-</sup> and PF<sub>6</sub><sup>-</sup>) were synthesized. Tables 1 and 2 give the physicochemical properties for these thirty-nine geminal ionic liquids. Surface tension, density, melting point, and refractive index values were recorded for those samples that were liquids at room temperature. For samples that were solids at room temperature, only the melting point was determined. The miscibility/solubility of all ionic liquids in both heptane and water are indicated as well.</p><p id="p0133" num="0133"><i><u>Surface Tension.</u></i> Plots of surface tension data are shown in <figref idrefs="f0001">Figure 1</figref> for several geminal room temperature ionic liquids. The length of the alkyl linkage chain separating the dications is observed to have only small effects on the surface tension. Considering ILs 2, 6, 10 and 14 (Tables 1, 2 and/or 3) which all contain the bis(trifluoromethylsulfonyl)imide (NTf<sub>2</sub><sup>-</sup>) anion and 3-methylimidazolium cations separated by 3, 6, 9 and 12 carbon linkage chains, respectively, it is apparent that increasing the length of the connecting linkage chain slightly decreases the surface tension (∼2.4 dynes/cm). A similar trend is observed for the ionic liquids containing other anions (e.g. BF<sub>4</sub><sup>-</sup>, Br<sup>-</sup>, PF<sub>6</sub><sup>-</sup>). These results are quite different from those obtained for monocationic ionic liquids by Law et. al. It was reported that the surface tension for a series of 1-alkyl-3-methylimidazolium-based ionic liquids containing 4, 8 and 12 carbon alkyl groups in the one position of the imidazole ring (refer to Table 3 for the ring numbering of the imidazolium cation) significantly decreased with increasing alkyl chain length. The largest decrease in surface tension was observed between 1-butyl-3-methylimidazolium hexafluorophosphate and 1-dodecyl-3-methylimidazolium hexafluorophosphate in which the total decrease in surface tension was nearly 20 dynes/cm at 330 K. It was also proposed that for a fixed cation at a specific temperature, the compound with the larger anion would possess a<!-- EPO <DP n="52"> --> higher surface tension. However, our data indicates that this is not true for the geminal dicationic ionic liquids, and if anything, is opposite to what was observed previously for the monocationic-type ionic liquids (Tables 1 and 2).</p><p id="p0134" num="0134">Diionic liquids 17-20 contain nonpolar butyl groups in the three position of the imidazolium rings. The surface tension values are significantly smaller (11%-17%) than those of diionic liquids 9-12 and 13-16 which contain the 3-methylimidazolium dications separated by a nonane and dodecane linkage chain, respectively. This data seems to indicate that the alkyl substituent located on the three position of the imidazolium ring plays a more important role in lowering the surface tension than the alkyl linkage chain that separates the geminal dications.</p><p id="p0135" num="0135">Replacing hydrogen with a methyl group on the two position of the imidazolium ring (refer to Tables 1, 2, and 3) has little effect on the surface tension. In the case of diionic liquids 25 and 26 containing the 2,3-dimethylimidazolium geminal dications separated by a nonane linkage chain with NTf<sub>2</sub><sup>-</sup> and BF<sub>4</sub><sup>-</sup> anions, respectively, the surface tension values are similar to the corresponding 3-methylimidazolium dications (Diionic liquids 10 and 11) also containing the nonane connecting chain. Overall, this data indicates that as the alkyl chain in the 3-position of the imidazolium ring increases in length, the surface tension decreases much more drastically than corresponding increases in the length of the connecting linkage chain.</p><p id="p0136" num="0136"><i><u>Density</u>.</i> As shown in <figref idrefs="f0002">Figure 2</figref>, the densities of the 3-methylimidazolium geminal dicationic ionic liquids were found to be anion dependent and to decrease with increasing length of the hydrocarbon linkage chain. While increases in the linkage chain decreases the density of these ionic liquids, the nature of the anion has a greater influence, with densities in the order of NTf<sub>2</sub><sup>-</sup>&gt; PF<sub>6</sub><sup>-</sup>&gt;Br<sup>-</sup>&gt; BF<sub>4</sub><sup>-</sup> (Tables 1, 2, and <figref idrefs="f0002">Figure 2</figref>). The decrease in density with increasing alkyl chain length has been reported previously for a large series of 1-alkyl-3-methylimidazolium ionic liquids.</p><p id="p0137" num="0137">When the methyl group on the three position of the imidazolium ring is replaced with a butyl group, the density decreases for all ionic liquids in the series, regardless of the anion (compare Diionic liquids 9-12 to 17-20, Table 1). However, by replacing the hydrogen at the two position of the ring with a methyl group, the density does not appear to change (see Diionic liquids 10-11 and 25-26, Table 1).</p><p id="p0138" num="0138"><i><u>Melting Points</u>.</i> From this study, four main factors were found to affect the melting points of these geminal-dicationic ionic liquids. These factors which apply to dianions as well<!-- EPO <DP n="53"> --> are: (1) the length and type of the linkage chain or bridge separating the geminal diions, (2) the nature of the diions (<i>e.g.,</i> imidazolium versus pyrrolidinium), (3) the substituents and their placement on the dianions and (4) the nature of the counter ion.</p><p id="p0139" num="0139">Considering first the 3-methylimidazolium-based dicationic ionic liquids, longer bridging groups generally result in a lowering of the melting points. This observation applies to diionic liquids generally. In all of the above-noted cases except for the geminal dications with NTf<sub>2</sub><sup>-</sup> anions, which were all liquids regardless of the linkage chain used, compounds containing three and six carbon linkage chains were salts with relatively high melting points. By connecting the 3-methylimidazolium dications with a nonane linkage chain, all samples were room temperature ionic liquids except for the hexafluorophosphate salt, which had a melting point of 88°C. When the dications were connected by a dodecane linkage chain, however, all compounds were room temperature ionic liquids. Looking more generally at the dianions and dications that can be used to make diionic liquids in accordance with the present invention, the chain length between the ionic species should be longer than the length of a 2 carbon chain, and no longer than a 40 carbon chain. Preferably, chain lengths are equivalent to the length of a 3 to 30 carbon chain. The degree and types of substituents, if any, may have an effect on length as well, the larger the molecule, generally, the higher its temperature of solid/liquid transformation. Therefore, any chain length, any chain content and any chain substitution pattern may be used, as long as the melting point of the resulting diionic liquid salt is less than about 400°C, preferably about 100°C or lower, preferably about 60°C, more preferably about room temperature or lower (25°C).</p><p id="p0140" num="0140">In addition to the effect of the different length and types of bridges connecting the dications, the anion also played a role in determining the melting point. In nearly very case of the imidazolium dications, the melting points increased in the following order: NTf<sub>2</sub><sup>-</sup>&lt;BF<sub>4</sub><sup>-</sup>&lt;PF<sub>6</sub><sup>-</sup>&lt;Br<sup>-</sup> (Tables 1 and 2).</p><p id="p0141" num="0141">Other anions which can be used to form dicationic ionic liquids include, without limitation, trifilates, carboxylates, sulfonates and sulfates (both mono- and poly-anionic species). Dianionic ionic liquids can be produced from any dianion which can form a stable salt, preferably which has a melting point below about 400°C, more preferably at or below about 100°C, most preferably at or below room temperature (about 25°C). These include dicarboxylate, disulfonate and disulfate. Mixed dianions, one made from, for example, a<!-- EPO <DP n="54"> --> dicarboxylate and a disulfate, are also desirable. Cations or counterions for these include, again without limitation, the dications listed in Tables 1 and 2, as well as their monocationic counterparts. This is as long as they can form a stable diionic salt and have a melting point as described above.</p><p id="p0142" num="0142">The substituents and their position on the imidazolium ring also affected the melting points of these compounds. These same considerations apply to substituted anions as well. Considering Diionic liquids 17-20 which contain the 3-butylimidazolium dications connected by a nonane linkage chain, the melting points were lowered significantly by replacing the methyl group (see Diionic liquids 9-12) with a butyl group. In the case of Diionic liquid 12, which consist of the 3-methylimidazolium dications connected by a nonane linkage chain with the PF<sub>6</sub><sup>-</sup> anion, the melting point is decreased by nearly 60°C by replacing the methyl groups with butyl groups to form Diionic liquid 20. In addition, methylation of the 2-positions of the imidazolium dications significantly increases the melting point of these compounds (see Diionic liquids 21-27, Table 1). In the case of Diionic liquid 21 which contains the 2,3-dimethyimidazolium dication connected by a propane linkage chain, the melting point is nearly 135°C higher than the corresponding 3-methylimidazolium dication also connected by a propane linkage chain (1). Ngo <i>et al.</i> have previously reported the melting points for 1-ethyl-3-methylimidazolium bromide to be 79°C whereas the melting point for 1-ethyl-2,3-dimethylimidazolium bromide was found to be 141 °C, a difference of nearly 62°C. While the methyl group on the two position of the imidazolium ring has little effect on the surface tension and density of the geminal dicationic ionic liquids, it is seen to have a profound effect on their melting points, more so for the dicationic ionic liquids than for the traditional 1-alkyl-3-methylimidazolium ionic liquids.</p><p id="p0143" num="0143">Finally, by replacing the 3-methylimidazolium dication with the 3-benzylimidazolium dication (Diionic liquids 28-30) and connecting them by a dodecane bridge, the melting points appear higher compared to the 3-methylimidazolium series, especially in the case of the bromide salt.</p><p id="p0144" num="0144">In general, the melting points of the pyrrolidinium-based geminal dicationic compounds are significantly higher than their corresponding imidazolium analogues. Indeed, only two of their NTf<sub>2</sub><sup>-</sup> salts can be considered ionic liquids. However, as will be discussed (<i>vide infra</i>)<i>,</i> these particular RTILs may have the greatest thermal stability and other highly useful and interesting properties.<!-- EPO <DP n="55"> --></p><p id="p0145" num="0145">The melting points for the pyrrolidinium-based dications show similar trends to the imidazolium-based salts. In the two cases involving the propane and nonane linkage chains, the melting point decreases as the linkage chain becomes longer. However, in contrast to the imidazolium-based dications, the pyrrolidinium-based dications are still relatively high melting solids when separated by a nonane alkyl chain. Additionally, substituting a butyl group instead of a methyl group on the quaternary amine of the pyrrolidinium cation causes a decrease in the melting point for the bromide dication but an increase in the melting point for the dications containing bis(trifluoromethylsulfonyl)imide and hexafluorophosphate anions.</p><p id="p0146" num="0146">From the data in Tables 1 and 2, it appears that longer alkyl linkage chains and long aliphatic substituents on the quaternary amine produce either low melting salts or room temperature ionic liquids. Further, the NTf<sub>2</sub><sup>-</sup> salts have lower melting points than corresponding salts with other anions. The contributions of the linkage chain (bridge) and other substituents on the geminal dicationic salts, to the number of possible conformational states (and possibly crystal polymorphs) will be considered in the crystal structure section of this paper.</p><p id="p0147" num="0147"><i><u>Solubility</u></i>. The solubility behavior of all thirty-nine geminal dicationic ionic liquids in water and heptane also was explored. None of the dicationic ionic liquids were soluble in heptane. However, most of the ionic liquids containing bromide and tetrafluoroborate anions were soluble in water. Nevertheless, for the tetrafluoroborate ionic liquids, it was found that by using a long linkage chain and a more hydrophobic alkyl substituent on the three positions of the imidazole ring (see Diionic liquids 15 and 19), the solubility of the salt in water decreases. In general, the solubility behavior of the geminal dicationic ionic liquids in both water and heptane was quite similar to the monocationic ionic liquids with NTf<sub>2</sub><sup>-</sup> and PF<sub>6</sub><sup>-</sup> salts being immiscible with water and Br<sup>-</sup> and BF<sub>4</sub><sup>-</sup> salts being miscible with water. Indeed, the monoionic counterparts of the diionic liquid salts of the present invention are a good predicator of the solubility of a diionic liquid salt.</p><p id="p0148" num="0148">In the case of the dicationic ionic liquid 28 which consists of the 3-benzylimidazolium dication separated by a dodecane linkage chain and bromide anion, the hydrophobicity of the dication evidently overrides the coordinating nature of the bromide anion to make this particular ionic liquid insoluble in water. This is a good example that the properties of the individual cations and anions can be balanced and changed in order to produce ionic liquids (or solids) with the desired properties and characteristics.<!-- EPO <DP n="56"> --></p><p id="p0149" num="0149"><i><u>Thermal Stability</u>.</i> The thermal stabilities of the geminal dicationic ionic liquids were found to be significantly higher than what has been observed for many traditional imidazolium-based ionic liquids. Thermal stabilities were measured by immobilizing an approximate 0.15-0.20 microns film of the ionic liquid on the inner wall of a fused silica capillary. The capillary was then heated slowly in an oven and a very sensitive flame ionization detector (or mass spectrometer) used to detect any volatilization or decomposition of the ionic liquid. There are several advantages of using this set-up to measure the thermal stabilities of ionic liquids. The thermal stability is measured in the absence of oxygen by purging the capillary with a continuous flow of an inert gas such as helium, hydrogen, or nitrogen. In addition, the detection limit of the detector is very low (∼10 ppm to 10 ppb, depending on the compound) allowing for very sensitive detection of any thermally induced decomposition/volatilization products from the ionic liquid. Finally, this approach can use mass spectrometry detection to determine the likely volatilization/decomposition products.</p><p id="p0150" num="0150"><figref idrefs="f0003">Figure 3</figref> shows a thermal stability diagram containing three traditional ionic liquids and four dicationic ionic liquids. The traditional ionic liquids have thermal stabilities ranging from about 145°C (1-butyl-3-methylimidazolium chloride) to about 185°C (1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide). However, the thermal stabilities of the geminal dicationic ionic liquids are observed to range from about 330°C to about 400°C, depending on the cation used. The highest thermal stability (&gt;400°C) was obtained with the C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 35) ionic liquid (1-methylpyrrolidinium dication separated by a nonane linkage chain) while the lowest volatilization/decomposition temperature (330°C) was observed for the C<sub>9</sub>(bpy)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 38, 1-butylpyrrolidinium dication separated by a nonane linkage chain) ionic liquid. The maximum thermal stabilities of C<sub>9</sub>(mim)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 10, 1-methylimidazolium dication) and C<sub>12</sub>(benzim)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 29, 3-benzylimidazolium dication separated by a dodecane linkage chain) were observed to be nearly identical (350-360°C). In most cases, slight to moderate decomposition/volatilization of the dicationic ionic liquids were observed at these high temperatures. However, due to charring of the polyimide coating on the outside of the fused silica capillary tubing at these high temperatures, the ionic liquids were only tested up to about 400°C.</p><p id="p0151" num="0151">While the physical and thermal properties of the dicationic ionic liquids are quite impressive, another interesting fact is that some of these compounds possess useful liquid ranges<!-- EPO <DP n="57"> --> in excess of about 400°C and one of these (C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub>) Diionic liquid 35 has a stable liquid range of ∼ -4°C to &gt;400°C. This property will undoubtedly ensure their use for a wide variety of applications in which this large liquid range and high thermal stability can be exploited. In accordance with one aspect of the present invention, the ionic liquids of the present invention, which are salts of a dianion or dication, are stable. Stability in the context of the present invention means that they will neither substantially decompose nor volatilize at a temperature of under about 200°C when measured by inverse gas chromatography as described herein. More preferably, the stable ionic liquids of the present invention which are dianionic or dicationic salts, are stable in that they will not substantially decompose or volatilize at a temperature of under about 300°C.</p><p id="p0152" num="0152">In <figref idrefs="f0003">Figure 3</figref>, it is believed that the detector response shown for compounds D, E and F, between approximately 200°C and approximately 300°C are from impurities and not from the compounds tested. Still, less than 10% of the weight of the material tested decomposes or volatilizes when exposed to about 200°C or in particular embodiments, about 300°C, for an hour, they can be said to be stable in accordance with the present invention.</p><p id="p0153" num="0153">In particular embodiments in accordance with the present invention, dianionic or dicationic ionic liquid salts are provided, which are stable in that they will neither substantially decompose nor substantially volatilize at a temperature of under about 200°C and will have a temperature of solid/liquid transformation of about 400°C or lower. More will have a temperature of solid/liquid transformation of about 100°C or lower, most preferably will have a temperature of solid/liquid transformation of about 25°C or lower.</p><p id="p0154" num="0154">As mentioned previously, the diionic liquids (salts of dianions and dications as described herein) have an important use because of their stability at wide ranges of temperature and unique liquid properties. Many of these liquids have unexpectedly low temperatures of solid-liquid transformation, which from a fundamental standpoint depends upon the energy of their crystal lattice. There are well-known and rather crucial barriers to precisely calculating these energies, i.e., the true determination of atom-atom potentials. On the other hand, the accurate measurement (required for comparison) of solid-liquid transformation temperatures for this family of ionic compounds also have difficulties. The transformation is not sharp in time and the peaks on DSC curves become very broad. Formally speaking, the temperature of this<!-- EPO <DP n="58"> --> transformation can be very different from the true melting point which is the temperature of thermodynamic equilibrium between solid and liquid states.</p><p id="p0155" num="0155"><i><u>Solvation Characteristics</u>.</i> We have previously reported that the Abraham solvation model, a linear free energy approach that utilizes inverse gas-liquid chromatography to describe the solvation properties of a liquid, can be used to characterize room temperature ionic liquids. Described by equation 1, the model provides the so-called "interaction parameters" (<i>r, s, a, b,</i> /) by using multiple linear regression analysis to fit the retention factor (<i>k</i>, determined chromatographically) to the solute descriptors (R<sub>2</sub>, π<sub>2</sub><sup>H</sup> α<sub>2</sub><sup>H</sup>, β<sub>2</sub><sup>H</sup>, log L<sup>16</sup>) for a wide variety of probe solute molecules. <maths id="math0001" num="[1]"><math display="block"><mi>log</mi><mspace width="1em"/><mi mathvariant="italic">k</mi><mo>=</mo><mi mathvariant="normal">c</mi><mo>+</mo><mi mathvariant="italic">r</mi><mo>⁢</mo><msub><mi mathvariant="normal">R</mi><mn mathvariant="normal">2</mn></msub><mo>+</mo><mi mathvariant="normal">s</mi><mo>⁢</mo><msup><msub><mi mathvariant="normal">π</mi><mn mathvariant="normal">2</mn></msub><mi mathvariant="normal">H</mi></msup><mo>+</mo><mi mathvariant="normal">b</mi><mo>⁢</mo><msup><msub><mi mathvariant="normal">β</mi><mn mathvariant="normal">2</mn></msub><mi mathvariant="normal">H</mi></msup><mo>+</mo><mi mathvariant="italic">l</mi><mspace width="1em"/><mi>log</mi><mspace width="1em"/><msup><mi mathvariant="normal">L</mi><mn mathvariant="normal">16</mn></msup></math><img id="ib0078" file="imgb0078.tif" wi="72" he="8" img-content="math" img-format="tif"/></maths><br/>
The solvation properties of four dicationic ionic liquids (see Table 4) were evaluated and the interaction parameters compared to those obtained for their traditional monocationic analogues 1-butyl-3-methylimidazolium and 1-butyl-1-methylpyrrolidinium ionic liquids.<!-- EPO <DP n="59"> -->
<tables id="tabl0007" num="0007"><table frame="all"><title>Table 4: Comparison of interaction parameters between monocationic and dicationic ionic liquids.</title><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry colsep="0" valign="top">Temp (°C)</entry><entry namest="col2" nameend="col10" align="center" valign="top">Interaction Parameters<sup>a</sup></entry></row><row><entry rowsep="0" valign="top">C<sub>4</sub>(mim)<sub>2</sub>-NTf<sub>2</sub></entry><entry colsep="0" align="center" valign="top"><i>c</i></entry><entry colsep="0" align="center" valign="top"><i>r</i></entry><entry colsep="0" align="center" valign="top"><i>s</i></entry><entry colsep="0" align="center" valign="top"><i>a</i></entry><entry colsep="0" align="center" valign="top"><i>b</i></entry><entry colsep="0" align="center" valign="top"><i>l</i></entry><entry colsep="0" align="center" valign="top">n</entry><entry colsep="0" align="center" valign="top">R<sup>2</sup></entry><entry align="center" valign="top">F</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.94 (0.13)</entry><entry>0.25 (0.09)</entry><entry>2.01 (0.12)</entry><entry>2.11 (0.11)</entry><entry>0.50 (0.13)</entry><entry>0.56 (0.03)</entry><entry>33</entry><entry>0.99 (0.11)</entry><entry align="char" char="." charoff="31">356.70</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-2.91 (0.11)</entry><entry>0.22 (0.10)</entry><entry>1.78 (0.11)</entry><entry>1.77 (0.09)</entry><entry>0.45 (0.14)</entry><entry>0.44 (0.03)</entry><entry>32</entry><entry>0.99 (0.09)</entry><entry align="char" char="." charoff="31">370.42</entry></row><row><entry valign="bottom">100</entry><entry>-3.06 (0.13)</entry><entry>0.20 (0.09)</entry><entry>1.69 (0.10)</entry><entry>1.57 (0.08)</entry><entry>0.33 (0.13)</entry><entry>0.37 (0.03)</entry><entry>31</entry><entry>0.98 (0.09)</entry><entry align="char" char="." charoff="31">253.79</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">C<sub>9</sub>(mim)<sub>2</sub>-NTf<sub>2</sub>(10)</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.86 (0.14)</entry><entry>0.16 (0.11)</entry><entry>1.81 (0.14)</entry><entry>1.83 (0.10)</entry><entry>0.47 (0.17)</entry><entry>0.62 (0.04)</entry><entry>32</entry><entry>0.98 (0.12)</entry><entry align="char" char="." charoff="31">257.15</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-2.95 (0.09)</entry><entry>0.11 (0.07)</entry><entry>1.76 (0.08)</entry><entry>1.75 (0.07)</entry><entry>0.20 (0.10)</entry><entry>0.51 (0.02)</entry><entry>33</entry><entry>0.99 (0.07)</entry><entry align="char" char="." charoff="31">644.20</entry></row><row><entry valign="bottom">100</entry><entry>-3.06 (0.08)</entry><entry>0.11 (0.06)</entry><entry>1.64 (0.07)</entry><entry>1.50 (0.06)</entry><entry>0.15 (0.09)</entry><entry>0.43 (0.02)</entry><entry>32</entry><entry>0.99 (0.07)</entry><entry align="char" char="." charoff="31">545.32</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">BMIM-NTf<sub>2</sub><sup>a</sup> (1-butyl-3-methylimidazolium bis[(trifluoromethylsulfonyl)imide]</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.87 (0.10)</entry><entry>0 (0.08)</entry><entry>1.89 (0.10)</entry><entry>2.02 (0.10)</entry><entry>0.36 (0.12)</entry><entry>0.63 (0.03)</entry><entry>33</entry><entry>0.99 (0.09)</entry><entry align="char" char="." charoff="31">459.64</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-3.03 (0.09)</entry><entry>0 (0.08)</entry><entry>1.67 (0.09)</entry><entry>1.75 (0.09)</entry><entry>0.38 (0.11)</entry><entry>0.56 (0.02)</entry><entry>35</entry><entry>0.99 (0.09)</entry><entry align="char" char="." charoff="31">413.65</entry></row><row><entry valign="bottom">100</entry><entry>-3.13 (0.12)</entry><entry>0 (0.09)</entry><entry>1.60 (0.10)</entry><entry>1.55 (0.10)</entry><entry>0.24 (0.12)</entry><entry>0.49 (0.03)</entry><entry>32</entry><entry>0.98 (0.09)</entry><entry align="char" char="." charoff="31">240.13</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub>(35)</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.83 (0.12)</entry><entry>0.27 (0.10)</entry><entry>1.71 (0.12)</entry><entry>1.98 (0.10)</entry><entry>0.32 (0.15)</entry><entry>0.62 (0.03)</entry><entry>30</entry><entry>0.99 (0.10)</entry><entry align="char" char="." charoff="31">377.84</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-2.85 (0.11)</entry><entry>0.34 (0.09)</entry><entry>1.52 (0.11)</entry><entry>1.65 (0.08)</entry><entry>0.35 (0.13)</entry><entry>0.48 (0.03)</entry><entry>32</entry><entry>0.99 (0.09)</entry><entry align="char" char="." charoff="31">419.32</entry></row><row><entry valign="bottom">100</entry><entry>-2.99 (0.10)</entry><entry>0.23 (0.09)</entry><entry>1.49 (0.10)</entry><entry>1.48 (0.08)</entry><entry>0.15 (0.14)</entry><entry>0.42 (0.03)</entry><entry>30</entry><entry>0.99 (0.08)</entry><entry align="char" char="." charoff="31">339.79</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">BMPY-NTf<sub>2</sub><sup>b</sup>(1-butyl-1-methylpyrrolidinium bis[(trifluoromethylsulfonyl)imide]</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.78 (0.11)</entry><entry>0 (0.09)</entry><entry>1.69 (0.11)</entry><entry>2.08 (0.12)</entry><entry>0.16 (0.14)</entry><entry>0.68 (0.03)</entry><entry>34</entry><entry>0.98 (0.11)</entry><entry align="char" char="." charoff="31">321.99</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-2.80 (0.10)</entry><entry>0 (0.08)</entry><entry>1.53 (0.09)</entry><entry>1.78 (0.08)</entry><entry>0 (0.11)</entry><entry>0.56 (0.02)</entry><entry>34</entry><entry>0.99 (0.09)</entry><entry align="char" char="." charoff="31">393.23</entry></row><row><entry valign="bottom">100</entry><entry>-2.92 (0.09)</entry><entry>0 (0.07)</entry><entry>1.44 (0.08)</entry><entry>1.55 (0.07)</entry><entry>0 (0.09)</entry><entry>0.48 (0.02)</entry><entry>32</entry><entry>0.99 (0.08)</entry><entry align="char" char="." charoff="31">358.08</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">C<sub>12</sub>(benzim)<sub>2</sub>-NTf<sub>2</sub>(29)</entry></row></thead><tbody><row><entry rowsep="0">40</entry><entry>-2.94 (0.11)</entry><entry>0.11 (0.08)</entry><entry>1.65 (0.11)</entry><entry>1.96 (0.08)</entry><entry>0.84 (0.13)</entry><entry>0.66 (0.03)</entry><entry>33</entry><entry>0.99 (0.08)</entry><entry align="char" char="." charoff="31">522.89</entry></row><row><entry rowsep="0" valign="middle">70</entry><entry>-3.07 (0.08)</entry><entry>0.07 (0.05)</entry><entry>1.62 (0.08)</entry><entry>1.75 (0.06)</entry><entry>0.57 (0.09)</entry><entry>0.56 (0.02)</entry><entry>30</entry><entry>0.99 (0.06)</entry><entry align="char" char="." charoff="31">888.94</entry></row><row><entry valign="bottom">100</entry><entry>-3.12 (0.09)</entry><entry>0</entry><entry>1.47 (0.09)</entry><entry>1.44 (0.06)</entry><entry>0.52 (0.10)</entry><entry>0.46 (0.02)</entry><entry>30</entry><entry>0.99 (0.07)</entry><entry align="char" char="." charoff="31">478.94</entry></row></tbody></tgroup><tgroup cols="10" rowsep="0"><colspec colnum="1" colname="col1" colwidth="25mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="16mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="16mm"/><colspec colnum="8" colname="col8" colwidth="12mm"/><colspec colnum="9" colname="col9" colwidth="16mm"/><colspec colnum="10" colname="col10" colwidth="18mm"/><tbody><row><entry namest="col1" nameend="col10" align="justify"><sup>a</sup> r = interaction via nonbonding and π-electrons, s = dipolarity/polarizability, a = hydrogen bond basicity,<br/>
b = hydrogen bond acidity, l = dispersion forces, n = number of probe molecules subjected to multiple linear regression analysis, R<sup>2</sup> = statistical correlation coefficient, F = Fisher coefficient. Values in parenthesis are the standard deviations for each interaction parameter.<br/>
<sup>b</sup> Values taken from reference 31</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="60"> --></p><p id="p0156" num="0156">Nearly all interaction parameters of the dicationic ionic liquids C<sub>4</sub>(mim)<sub>2</sub>-NTf<sub>2</sub> and C<sub>9</sub>(mim)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 10) are similar to the corresponding monomer-type ionic liquids, 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide. This is also observed for the pyrrolidinium dication, C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub> (Diionic liquid 35), as it differs from the monomer-type analogue (1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide). This indicates that the well-known and highly useful solvation properties of traditional RTILs are very similar to those of the geminal dicationic RTILs. The only interaction parameter that is statistically different between the three ionic liquids is the "<i>r</i>" interaction parameter, namely the ability of the ionic liquid to undergo π-π. and n-π interactions with probe solute molecules. Because the pyrrolidinium cation is not aromatic, the higher <i>r</i> values may be due to the anion as each anion contains two sulfone groups that are capable of undergoing such interactions. However, this was not observed for the traditional ionic liquids evaluated previously in our study.</p><p id="p0157" num="0157">Finally, the interaction parameters for the 3-benzylimidazolium geminal dication separated by a dodecane linkage chain with the NTf<sub>2</sub><sup>-</sup> anion (Diionic liquid 29) appear similar to those observed previously for 1-benzyl-3-alkyl-imidazolium ionic liquids. However, the hydrogen bond acidity term, <i>b</i>, is larger for the geminal dicationic ionic liquid. This may be due to the increased acidity of the proton at the 2-position of the imidazolium ring induced by the electron withdrawing benzyl group.</p><p id="p0158" num="0158">As noted earlier, the viscosity of some diionic salts decreases sharply with increasing temperature. Consequently at high temperatures, previously uniform coated capillaries, particularly ones that are prepared by adsorption or absorption, rather than immobilization, can experience film disruption (due to flow, etc.). When a uniformly coated GC capillary, for example, slowly changes to a nonuniformly coated entity, the analyte retention times and efficiency tend to decrease.</p><p id="p0159" num="0159">To overcome these issues, where necessary, and in accordance with another aspect of the present invention, there is provided a process which includes the free radical reaction of ionic liquid monomers to provide a more durable and robust stationary phase, as well as the crosslinked and/or immobilized stationary phases and the columns that include same. By partially crosslinking the ionic liquid stationary phase using a small percentage of free radical initiator, high efficiency capillary columns are produced that are able to endure high temperatures with little column bleed. It was found that low to moderate temperature separations (about 30°C to<!-- EPO <DP n="61"> --> about 280°C) can be carried out with high selectivity and efficiency using special partially crosslinked ionic liquid stationary phase mixtures. These stationary phases retain their "gelatinous," "semi liquid," amorphous state. For separations conducted at higher temperatures (about 300°C to about 400°C), more highly cross-linked/immobilized stationary phases are well-suited to provide high selectivity and efficient separations with low column bleed. The effect of different functionalized ionic liquid salt mixtures and initiator concentrations is studied for these two types of stationary phases. The accomplished goal is to maximize their separation efficiency, thermal stability, and column lifetime, without sacrificing the unique selectivity of the stationary phase.</p><p id="p0160" num="0160">The following materials were used to illustrate the unique advantages of cross-linked stationary phases comprising diionic liquid salts in accordance with the present invention: 1-vinylimidazole, 1-bromohexane, 1-bromononane, 1-bromododecane, 1,9-dibromononane, 1,12-dibromododeeane, 1-bromo-6-chlorohexane, 1-methylimidazole, N-lithiotrifluoromethanesulfonimide, 2,2'-Azobisisobutyronitrile (AIBN), dichloromethane, ethyl acetate, and all test solutes were purchased from Aldrich (Milwaukee, Wis.). Untreated fused silica capillary tubing (0.25-mm inner diameter) and a fatty acid methyl ester (FAME) kit containing 19 standards was purchased from Supelco (Bellafonte, Pa.). Structures and physico-chemical properties of the monocation monomers and the dication crosslinkers used are shown in Table A. Monomers 1, 2, and 3 were synthesized by reacting one molar equivalent of 1-vinylimidazole with a slight molar excess of 1-bromohexane, 1-bromononane and 1-bromododecane, respectively. These reactions were performed at room temperature in round bottom flasks lined with aluminum foil to prevent thermal/photo-induced polymerization. Care should be taken when synthesizing and purifying these compounds to minimize excess heat/light during reaction or roto-evaporation to prevent unwanted reaction of the ionic liquid. The resulting bromide salt was evaporated under vacuum to remove the excess 1-bromoalkane. Three 15 mL aliquots of ethyl acetate were used to wash the ionic liquid to remove any other impurities. After evaporating the ethyl acetate under vacuum, the bromide salt was dissolved in water and mixed with one molar equivalent of N-lithiotrifluoromethanesulfonimide, also dissolved in water. After stirring for 12 hours, the water was removed and the remaining ionic liquid thoroughly washed with water using three 50 mL aliquots of water. A portion of the third aliquot of water was subjected to the silver nitrate test to ensure the absence of silver bromide<!-- EPO <DP n="62"> --> precipitate. The monomers were then dried under vacuum and then placed under a P<sub>2</sub>O<sub>5</sub> vacuum in the absence of light.</p><p id="p0161" num="0161">The dication crosslinkers were synthesized using a modified procedure recently reported for a series of geminal dicationic ionic liqids. Compound 4 in Table A is a mixture of C<sub>6</sub>(vim)<sub>2</sub><sup>2+</sup> (m/z=272.1), C<sub>6</sub>vm(im)<sub>2</sub><sup>2+</sup> (m/z=260.1), and C<sub>6</sub>(mim)<sub>2</sub><sup>2+</sup> (m/z =248.1) in a 1:2:1 molar mixture, respectively, as indicated in the electrospray mass spectrum in <figref idrefs="f0004">Figure 4</figref>. When acquired in positive ion mode, the most dominant ions for these three structurally similar compounds appear to be the +1 ion minus a proton. Further experiments conducted in our group in which the C-2 proton on the imidazolium ring (see <figref idrefs="f0004">Figure 4</figref> for numbering of ring system) is deuterated indicates that this proton is lost and causes one of the positive charged aromatic rings to neutralize charge and give rise to the +1 ion (data not shown). This mixture was synthesized by reacting one molar equivalent of 1-bromo-6-chlorohexane with one molar equivalent of 1-methylimidazole in an ice bath overnight. Subsequently, one molar equivalent of 1-vinylimidazole was added dropwise over a period of 30 minutes and the temperature of the mixture increased to 55°C for 3 hours. Three 15 mL aliquots of ethyl acetate were used to extract any excess starting material and the bromide anion was exchanged for the bis[(trifluoromethane)sulfonyl]imide (NTf<sub>2</sub><sup>-</sup>) anion by reaction of two equivalents of N-lithiotrifluoromethanesulfonimide dissolved in water for every one equivalent of the crosslinker salt.</p><p id="p0162" num="0162">In an analogous manner, the remaining crosslinkers 5, 6, 7 and 8 were prepared by reacting one molar equivalent of the dibromoalkane with two molar equivalents of 1-vinylimidazole. Compound 9 was prepared by reacting one molar equivalent of 1-methylimidazole with molar equivalent of 1-bromononane at 100°C for 5 hours. Clean-up and metathesis exchange for the NTf<sub>2</sub><sup>-</sup> anion was performed as described above for the synthesis of the monomer ionic liquids.</p><p id="p0163" num="0163">Capillaries were coated using the static coating method at 40°C. Coating solutions of the monomer and/or crosslinker ionic liquids were prepared at concentrations of 0.20% (w/v) in dichloromethane. Prior to adding the dichloromethane to the monomer and/or crosslinker mixture, 0.7 mg of AIBN (∼3.5% by weight) was added. AIBN is known to undergo decomposition to form cyanoisopropyl radicals which subsequently produce several products by dimerization, disproportionation reactions, or chain reactions. The thermal decomposition<!-- EPO <DP n="63"> --> kinetics of AIBN have been well studied using a variety of spectroscopic and polarographic techniques. Based on an Arrhenius plot, Van Hook and co-workers have proposed a rate expression for the decomposition of AIBN in solution to be: k<sub>d</sub>=1.58 x.10<sup>15</sup> exp(-30.8 kcal./RT). For a temperature of 40°C in which the capillaries are coated with the initiator present in the coating solution, this yields a decomposition rate constant of ∼5.07 x 10<sup>-7</sup> sec<sup>-1</sup>. Due to the fact that this rate constant is so small and that the coating rate is relatively fast, there should be very little polymerization of the monomer/crosslinker mixture during the coating of the capillary.</p><p id="p0164" num="0164">After coating, the ends of the capillary were flame sealed and the capillary placed in a GC oven and heated from 40°C-80°C at 1°C/min. The capillary was then held at 80°C for 5 hours to ensure complete polymerization. Helium carrier gas was then flushed through the capillary at a rate of 1 mL/min and the capillary conditioned from 30°C to 120°C at 3°C/min and held at 120°C for two hours.</p><p id="p0165" num="0165">Solvation thermodynamics can be determined chromatographically by recognizing that the Gibbs free energy change, ΔG° of a solute between the mobile phase and the stationary phase can be described by equation 1: <maths id="math0002" num="[1]"><math display="block"><msup><mi>ΔG</mi><mi>°</mi></msup><mo>=</mo><mo>-</mo><mi mathvariant="italic">RT</mi><mo>⁢</mo><mi>ln</mi><mfenced><mfrac><mi>k</mi><mi mathvariant="normal">Φ</mi></mfrac></mfenced></math><img id="ib0079" file="imgb0079.tif" wi="37" he="12" img-content="math" img-format="tif"/></maths><br/>
where k is the solute retention factor and Φ is the column phase ratio. An expression shown in equation 2 can then be derived and illustrates the dependence of enthalpy, ΔH°, and entropy, ΔS°, on the change of the retention factor with temperature: <maths id="math0003" num="[2]"><math display="block"><mi>ln</mi><mspace width="1em"/><mi>k</mi><mo>=</mo><mo>-</mo><mfenced><mfrac><mrow><mi mathvariant="normal">Δ</mi><mo>⁢</mo><mi>H</mi><mo>⁢</mo><mi>°</mi></mrow><mi>R</mi></mfrac></mfenced><mo>⁢</mo><mfrac><mn>1</mn><mi>T</mi></mfrac><mo>+</mo><mfenced open="[" close="]" separators=""><mfrac><mrow><mi mathvariant="normal">Δ</mi><mo>⁢</mo><mi>S</mi><mo>⁢</mo><mi>°</mi></mrow><mi>R</mi></mfrac><mo>+</mo><mi mathvariant="normal">lnΦ</mi></mfenced></math><img id="ib0080" file="imgb0080.tif" wi="61" he="13" img-content="math" img-format="tif"/></maths><br/>
A van't Hoff plot of ln <i>k</i> versus 1/T provides the entropy (intercept) and enthalpy (slope) and describes a solute's transfer from the gas phase to the ionic liquid stationary phase. In this work, the solvation thermodynamics were determined for seven different probe molecules, listed in Table D, on two cross-linked ionic liquid phases and one ionic liquid stationary phase. As Table D illustrates, the probe molecules evaluated in this study differ in terms of size and the types of functional groups that they possess. For each probe molecule on each stationary phase, three separate van't Hoff plots were constructed so that changes in the probe molecule retention factor could be used to provide an error for each thermodynamic parameter. The probe molecule<!-- EPO <DP n="64"> --> retention factors were determined at six different temperatures to obtain the highest possible correlation coefficient (&gt;0.989).</p><p id="p0166" num="0166">Previously we characterized a large number of room temperature ionic liquids in terms of multiple solvation interactions using the solvation parameter model, shown in equation [3] <maths id="math0004" num="[3]"><math display="block"><mi>log</mi><mspace width="1em"/><mi mathvariant="italic">k</mi><mo>=</mo><mi mathvariant="normal">c</mi><mo>+</mo><mi mathvariant="italic">r</mi><mo>⁢</mo><msub><mi mathvariant="normal">R</mi><mn mathvariant="normal">2</mn></msub><mo>+</mo><mi mathvariant="italic">s</mi><mo>⁢</mo><msup><msub><mi mathvariant="normal">π</mi><mn mathvariant="normal">2</mn></msub><mi mathvariant="normal">H</mi></msup><mo>+</mo><mi>a</mi><mo>⁢</mo><msup><msub><mi mathvariant="normal">α</mi><mn mathvariant="normal">2</mn></msub><mi mathvariant="normal">H</mi></msup><mo>+</mo><mi mathvariant="italic">b</mi><mo>⁢</mo><msup><msub><mi mathvariant="normal">β</mi><mn mathvariant="normal">2</mn></msub><mi mathvariant="normal">H</mi></msup><mo>+</mo><mi mathvariant="italic">l</mi><mspace width="1em"/><mi>log</mi><mspace width="1em"/><msup><mi mathvariant="normal">L</mi><mn mathvariant="normal">16</mn></msup></math><img id="ib0081" file="imgb0081.tif" wi="81" he="8" img-content="math" img-format="tif"/></maths><br/>
This approach utilizes inverse gas-liquid chromatography and allows the use of a large number of probe molecules to deconvolute solute retention in terms of the type and magnitude of individual solvation interactions. The solute descriptors (R<sub>2</sub>, π<sub>2</sub><sup>H</sup>, α<sub>2</sub><sup>H</sup>, β<sub>2</sub><sup>H</sup>, log L<sup>16</sup>) from Equation [3] are obtained from the literature for many probe molecules containing a variety of functional groups. The retention factor is determined chromatographically. The solute descriptors and retention factors are subjected to multiple linear regression analysis to obtain the interaction parameter coefficients (<i>r, s, a, b, l</i>), which ultimately characterize the stationary phase: <i>r</i> is the ability of the diionic liquid containing-stationary phase to interact with π and n electrons of the solute, <i>s</i> is a measure of the dipolarity/polarizability of the diionic liquid containing-stationary phase, a defines the diionic liquid containing-stationary phase hydrogen bond basicity, <i>b</i> is a measure of the hydrogen bond acidity, and <i>l</i> refers to the ability of the diionic liquid containing-stationary phase to separate adjacent members of a homologous series.</p><p id="p0167" num="0167">Test solutes used to determine interaction parameters and solvation thermodynamics were dissolved in dichloromethane. A Hewlett-Packard model 5890 gas chromatograph and a Hewlett-Packard 6890 series integrator were used for all separations. Split injection and flame ionization detection were utilized with injection and detection temperatures of 250°C. Helium was used as the carrier gas with a column inlet pressure of 3.1 psi and flow rate of 1.0 mL/min. Methane was used to determine the dead volume of the column. Multiple linear regression analysis and statistical calculations were performed using the program Analyze-it (Microsoft).</p><p id="p0168" num="0168">Equation 4 can be used to approximate the stationary phase film thickness for gas chromatographic capillaries coated by the static coating method, <maths id="math0005" num="[4]"><math display="block"><msub><mi>d</mi><mi>f</mi></msub><mo>=</mo><mfrac><mrow><msub><mi>d</mi><mi>c</mi></msub><mo>×</mo><mi>c</mi></mrow><mn>400</mn></mfrac></math><img id="ib0082" file="imgb0082.tif" wi="29" he="13" img-content="math" img-format="tif"/></maths><!-- EPO <DP n="65"> --> where: <i>d<sub>f</sub></i> is the film thickness of the ionic liquid stationary phase in micrometers, <i>d<sub>c</sub></i> is the diameter of the capillary (in micrometers), and c is the percentage by weight concentration of the stationary phase dissolved in an appropriate solvent. <figref idrefs="f0005">Figure 5</figref> shows the effect of 1-hexyl-3-vinylimidazolium bis[(trifluoromethane)sulfonyl] imidate film thickness on the peak efficiency of naphthalene at 100°C. As the plot clearly demonstrates, the highest efficiency separations were carried out with a film thickness of ∼0.07 µm (0.10% w/v of ionic liquid in dichloromethane) while the worst efficiency separations were obtained on columns with a film thickness of ∼0.21 µm (0.33% w/v). In this work, all capillaries were coated with a 0.20% (w/v) coating solution yielding a film thickness of approximately 0.125 µm.</p><p id="p0169" num="0169">Using the ionic liquids that contain one or more unsaturated groups (except in compound #10) in Table A, a variety of free radical cross-linking experiments were carried out in chloroform following the method of Muldoon and co-workers to determine which ratios of monocationic/crosslinker monomers result in copolymers that possess the ideal properties for a GC stationary phase. Note further that many of these experiments used combinations of molecules in Table A which have single and molecules in Table A which have multiple, e.g., double, bonds to modify the physical properties, such as viscosity, following cross-linking. For example, some copolymers (i.e., formed from monomers 1 and 5) containing only a few percent by weight crosslinker resemble gum-like polysiloxane phases. However, other highly cross-linked copolymers formed hard plastics and are therefore undesirable for gas-liquid chromatographic separations.</p><p id="p0170" num="0170">Monocationic monomer ionic liquids 1, 2, and 3 contain the 1-vinylimidazolium cation with hexyl, nonyl, and dodecyl alkyl chains, respectively. When polymerized, these ionic liquids form linear polymer chains, as demonstrated previously by Marcilla and co-workers. As illustrated in Table B, these stationary phases exhibited a range of initial separation efficiencies, ranging from 2813 plates/meter for ionic liquid 1 and ∼1900 plates/meter for ionic liquid 3 when conditioned to 120°C. While it appears that the hexyl substituted vinylimidazolium cation produces a more efficient stationary phase coating, subsequent evaluation of the stationary phases using higher conditioning temperatures revealed that the efficiencies of these capillaries decrease rapidly. After conditioning up to 350°C, volatilization of the ionic liquids resulted in efficiencies that dropped to several hundred plates/meter. No retention of naphthalene was<!-- EPO <DP n="66"> --> observed after conditioning the capillaries to 380°C, indicating an insufficient amount of ionic liquid remained on the capillary wall.</p><p id="p0171" num="0171">To produce a more thermally robust ionic liquid matrix, geminal dicationic vinylimidazolium crosslinkers with different length alkyl chains separating the dications were mixed with the monocationic monomers. These mixtures are shown in Table B under the heading "partially/fully crosslinked matrices." From our previous solution-based polymerization experiments, it was found that the concentration of crosslinker is crucial for the formation of a matrix exhibiting ideal stationary phase properties (data not shown). Compound 4 (see Table A), is a mixture of three dicationic ionic liquids separated by a six carbon linkage chain. Electrospray mass spectrometry indicated that for every one of the 1,6-di(3-methylimidazolium)hexane[C<sub>6</sub>(mim)<sub>2</sub><sup>2+</sup>] dications and 1,6-di(3-vinylimidazolium)hexane [C<sub>6</sub>(vim)<sub>2</sub><sup>2+</sup>] dications, there are two of the 1-(3-vinylimidazolium)-6-(3'-methylimidazolium)hexane [C<sub>6</sub>vm(im)<sub>2</sub><sup>2+</sup>] dications. When a column was prepared by polymerizing/immobilization only this mixture, the initial efficiency after conditioning to 120°C was nearly 3000 plates/meter (Table B). Moreover, the efficiency dropped much less after conditioning the capillary at higher temperatures. For example, the efficiency of Compound 4 after conditioning at 350°C was 1365 plates/meter whereas the efficiencies of the monocationic ionic liquids without crosslinker ranged from 120 to 197 plates/meter after the same conditioning step. Clearly, by crosslinking the ionic liquids, the efficiency and thermal stability of the stationary phase is preserved at higher temperatures.</p><p id="p0172" num="0172">A series of different crosslinked ILs were also synthesized using various ratios of 1-vinyl-3-hexylimidazolium bis[(trifluoromethane)sulfonyl]imidate (1) and the dication mixture 4, described above. The highest efficiencies were obtained with crosslinking mixtures formed with equal percentages of the monocationic and crosslinking monomers whereas copolymers formed with a higher concentration of crosslinker exhibited lower efficiencies (see Table B). The effect of the alkyl side chain of the monocationic monomer was investigated by preparing equal molar ratios of the crosslinking mixture 4 with two other monocationic monomers, 1-vinyl-3-nonylimidazolium bis[(trifluoromethane)sulfonyl]imidate (2) and 1-vinyl-3-dodecylimidazolium bis[(trifluoromethane)sulfonyl]imidate (3). As Table B illustrates, there is very little difference between these different composition crosslinked matrices in terms of separation efficiency and loss of efficiency at high temperatures. Recall that previously it was noted that when the<!-- EPO <DP n="67"> --> monocationic monomers were polymerized without crosslinker, the length of the alkyl group appeared to have an effect on the separation efficiency/thermal stability of the stationary phase at higher temperatures. This demonstrates that the length of the alkyl group on the monocationic monomer plays less of a role in the loss of separation efficiency at high temperatures when it is part of a crosslinked stationary phase.</p><p id="p0173" num="0173">Ionic liquid stationary phases based only on crosslinking monomers were also evaluated. As shown in Table B, one mixture was based on the crosslinking of vinylimidazolium dications separated by a nonane linkage chain (0.20%, 5) while the second mixture consisted of ionic liquids 5, 6, 7 and 8, namely dicationic ionic liquid monomers separated by a nonane, decane, undecane, and dodecane linkage chain, respectively. This mixture of four crosslinkers, abbreviated as C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> in Table 4, was made due to the fact that compounds 6 and 8 are supercooled solids at room temperature and, therefore, are not ideal monomers for creating "gummy" or "waxy" stationary phases. This mixture consists of 10.88% by weight of Compound 5, 9.29% of Compound 6, 19.59% of Compound 7, and 60.24% of Compound 8.</p><p id="p0174" num="0174">A couple of interesting trends were observed for the highly crosslinked ionic liquid stationary phases that were not observed for the monocationic linear or partially crosslinked materials. First, although the separation efficiency of the completely crosslinked stationary phases was low after conditioning to 380°C, the ionic liquid stationary phase was still present as a thin film in the capillary when viewed under microscope after prolonged exposure to this temperature. In contrast, only a few partially crosslinked stationary phases (see Table B) provided retention of naphthalene after high temperature conditioning. All stationary phases formed using monocationic monomers alone appeared to have decomposed and/or volatilized completely from the capillary wall after conditioning to 380°C.</p><p id="p0175" num="0175">The most impressive and interesting characteristic of the completely crosslinked ionic liquid stationary phases is their apparent ability to exhibit a substantial increase in efficiency after conditioning at high temperatures. Examples of this arc found in Table B under the heading "Crosslinked Ionic Liquid Matrix." In one such example, a crosslinked matrix previously described containing a mixture of four dicationic crosslinkers, C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> was formed and the efficiency of this stationary phase was observed to undergo a 200%-250% increase in efficiency when the column was conditioned from 300°C to 350°C (see Table B).<!-- EPO <DP n="68"> --> This trend was observed on all highly crosslinked stationary phases examined and appears to be independent of the initial AIBN concentration in the coating solution (see Table C).</p><p id="p0176" num="0176">The fact that the efficiencies of the highly crosslinked stationary phases increase in this narrow temperature range is not well understood, but certainly makes them very useful for high temperature separations. Clearly, by exhibiting this behavior, these stationary phases appear to exhibit the smallest decrease in efficiency up to temperatures around 350°C. For low to moderate temperature separations (25°C to 285°C), the partially crosslinked stationary phases, particularly those containing equal weight percentages of ionic liquids 2 and 5, provide the highest efficiency separations up to 285°C with little column bleed at temperatures at and above 250°C. Meanwhile, the completely crosslinked stationary phases provides the highest efficiency separations with little column bleed up to temperatures around 300°C-380°C. Therefore, these two optimized types of immobilized ionic liquid stationary phases are specifically proposed for normal GC temperature ranges and higher GC temperatures, respectively. Low to moderate temperature separations are optimal with partial crosslinking of the stationary phase whereas high temperature separations require more extensive crosslinking to maintain acceptable efficiency and low column bleed.</p><p id="p0177" num="0177">The two optimized crosslinked stationary phases chosen for the moderate (0.10% 2 and 0.10% 5) and high temperature (0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub>) separations, were further studied to determine the effect of AIBN initiator concentration on their separation efficiency and thermal stability. As shown in Table B, each copolymer was formed using a different concentration of AIBN in the coating solution. These concentrations ranged from 10.0% (w/w of AIBN to ionic liquid) to 0.5%. For the partially crosslinked stationary phase, a higher weight percentage of initiator results in a slightly more efficient stationary phase (i.e., 3296 plates/meter for 0.5% AIBN to 3817 plates/meter for 10.0% AIBN). In addition, the efficiencies of the 7.0% and 10.0% by weight initiator copolymers decrease less rapidly at higher temperatures (&gt;250°C) compared to those ionic liquid matrices produced with lower initiator concentrations. After the stationary phase is subjected to a temperature ramp up to 385°C, only the two copolymers formed with 7.0% and 10.0% initiator provide retention of naphthalene, however with very low efficiency. The other two crosslinked stationary phases were no longer observed in the capillary after high temperature conditioning (385°C) and therefore provided no retention.<!-- EPO <DP n="69"> --></p><p id="p0178" num="0178">In the case of the highly crosslinked stationary phase (0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub>), a nearly opposite trend to that observed for the partially crosslinked ionic liquids was observed (Table B). The efficiencies of the columns after the first conditioning step are higher for the copolymers formed with lower AIBN concentration. However, it was still found that a higher weight percentage of AIBN results in a smaller decrease of efficiency at higher temperatures compared to the copolymers formed with lower percentages of AIBN. All of the highly crosslinked stationary phases were found to retain naphthalene after conditioning at 385°C. As discussed previously, the highly crosslinked stationary phases exhibit an increase in the separation efficiency for naphthalene after being conditioned to 350°C as compared to being conditioned at only 300°C. The magnitude of this increase does not appear to be directly related to the initiator concentration. For example, the efficiency increase exhibited by the copolymer formed with 3.5% AIBN is ∼171% higher after the 350°C program compared to the 300°C program whereas that for the 10% AIBN is ∼250% higher. As previously observed for the partially crosslinked ionic liquids, the overall decrease in efficiency is lowest for copolymers formed with higher AIBN concentrations.</p><p id="p0179" num="0179">This indicates that at high temperatures the most efficient stationary phases appear to be those that are crosslinked with a weight percentage of AIBN greater than 7.0%. In contrast, for lower/normal temperature separations, the choice of the monocationic monomer and crosslinker plays a more important role in the stationary phase efficiency and higher initiator concentration tends to prevent large decreases in efficiency with increasing temperature (see Table B).</p><p id="p0180" num="0180">It has been demonstrated previously that room temperature ionic liquids act as broadly applicable, superb gas chromatographic stationary phases in that they exhibit a dual nature retention behavior. Consequently, ionic liquid stationary phases have been shown to separate, with high efficiency, both polar and nonpolar molecules on a single column. By producing stationary phases that are either partially or highly crosslinked, it is of interest to ensure that the solvation thermodynamics and solvation interactions inherent to ionic liquids are still retained by their immobilized analogues.</p><p id="p0181" num="0181">The thermodynamics (Table D) and solvation interactions (Table E) for the two optimized crosslinked and a neat ionic liquid were determined as previously described in the Experimental Section. As can be seen from the data in these tables, both the free energy of<!-- EPO <DP n="70"> --> transfer of solute and particularly their interaction parameters are similar for both the crosslinked and neat monomeric ionic liquid stationary phases. While the enthalpies of solvation for all probe molecules differed only slightly between the three ionic liquids, a larger difference was observed for the entropies of solvation on the highly crosslinked stationary phase for certain solutes, i.e., 2-chloroaniline, ethyl phenyl ether, and decane. The entropies of solvation were somewhat more negative for these molecules indicating that they are part of a more ordered environment with the highly crosslinked stationary phase. These results also indicate that solvation by these three ionic liquid-based stationary phases has a substantial entropic component that contributes to large differences in solute free energy of transfer (see values for 2-chloroaniline and decane in Table D).</p><p id="p0182" num="0182">The solvation interaction parameters given in Table E indicate that the neat and two crosslinked ionic liquids are very similar in terms of selectivity. All three stationary phases interact weakly via nonbonding and π-electrons (<i>r</i>-term). The hydrogen bond basicity (a) and dispersion forces (<i>l</i>) were the same within experimental error for all three stationary phases. The partially crosslinked and neat ionic liquids possessed the same magnitude of dipolar interactions which were somewhat lower than those exhibited by the highly crosslinked ionic liquid (see Table E). Within experimental error, all three ionic liquids possessed the same ability to undergo hydrogen bond acidity (b) interactions.</p><p id="p0183" num="0183">The unique selectivity of ionic liquid stationary phases in the separation of a wide variety of analyte molecules including alcohols, alkanes, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and chlorinated pesticides have been demonstrated. The fact that the selectivity of the ionic liquid stationary phases is preserved after crosslinking the matrix is demonstrated in <figref idrefs="f0006">Figures 6</figref> and <figref idrefs="f0007">7</figref>. <figref idrefs="f0006">Figure 6</figref> shows a separation of 19 fatty acid methyl esters (FAMEs) on a 15 meter column coated with a partially crosslinked IL stationary phase. This separation is performed in 12 minutes using the temperature ramp described. <figref idrefs="f0007">Figure 7</figref> illustrates the separation of a mixture of PAHs and chlorinated pesticides on a 12 meter highly crosslinked stationary phase. The 9 minute, high temperature GC separation is carried out using a temperature program up to 335°C with little observed column bleed. While the selectivity of these ionic liquids is little different from that observed previously with the neat ionic liquids, the fact that separations can now be accomplished at higher temperatures with little column bleed,<!-- EPO <DP n="71"> --> high efficiency, and little shifting of the retention time after exposure to extreme temperatures further demonstrates the effectiveness of the immobilized ionic liquid.</p><p id="p0184" num="0184">This work addresses the fundamental issues relating to the use of ionic liquid stationary phases at high temperatures and column ruggedness. Specifically, it was demonstrated that by employing ionic liquid monocationic monomers and dicationic crosslinkers, an immobilized GC stationary phase can be developed. The cross-linked stationary phases retain the dual nature selectivity behavior inherent to all ionic liquid stationary phases. In addition, the columns can be used at high temperatures with low column bleed while simultaneously providing high efficiency separations. Two types of stationary phases were identified in this work and differ in terms of their maximum/minimum operating temperatures. Partially crosslinked stationary phases are best for separations conducted at temperatures from ambient to 280°C while a mostly crosslinked stationary phase is best suited for temperatures over 300°C. While the moderate to high temperature range of the mostly crosslinked stationary phase may overlap with the partially crosslinked matrix, lower efficiency separations were observed with the mostly crosslinked stationary phase at low temperatures. Moreover, a dramatic increase in efficiency of the mostly crosslinked stationary phase at high temperatures further adds to its effectiveness and usefulness for a variety of applications in high temperature gas chromatography studies.</p><p id="p0185" num="0185">Of course, ionic liquids and in particular the diionic liquid salts of the present invention can be used in other separation and analytical techniques. Their range of applicability is in no way limited to chromatography. One technique in which these materials can be used in Solid Phase Extraction ("SPE"). In SPE, a sample contains an impurity or some other compound or analyte to be separated, identified and/or quantified. This sample can be placed into a container in which diionic liquid salts of the present invention can be present in, and more broadly, ionic liquids in an immobilized form. Ionic liquid materials can be bound (immobilized) to the walls of the container, adsorbed, absorbed onto a bead or other structure so as to form a bead or other structure which may rest at the bottom of the container or be packed throughout the container much as a liquid chromatography column can be packed with stationary phase. Alternatively, the ionic liquids and in particular diionic liquid salts of the present invention can be immobilized by cross-linking or an analogous immobilization reaction as described herein on some sort of other solid support such as a bead, particles, and/or other chromatographic media<!-- EPO <DP n="72"> --> used in chromatography. These beads can also be placed at the bottom of, or can fill a container, much as a packed column used for liquid chromatography. Of course, the solid support can be any structure placed any where within the container.</p><p id="p0186" num="0186">In a particularly preferred embodiment, the container is actually a syringe where the ionic liquid and/or diionic liquid salts are affixed or disposed in one fashion or another at the base of the syringe, much as a filter. When the needle of the syringe is placed in a sample and the plunger is withdrawn, vacuum is formed drawing sample up into the barrel of the syringe. This material would pass through at least one layer of ionic liquid and, in particular, diionic liquid salts in accordance with the present invention, which would bind at least one of the components of the liquid. The sample liquid could then be spilled out or the plunger depressed to eject it, the latter forcing the sample back through the ionic liquid or diionic liquid salts positioned at the bottom of the barrel.</p><p id="p0187" num="0187">The liquid can be analyzed either for the presence of certain materials or the absence of the material retained by the ionic liquid or diionic liquid salts of the present invention. Alternatively, the retained materials can be removed (such as by placing the materials in a different solvent) or not and analyzed analytically by other means. The same technique may be used in a preparative fashion and/or as a means of bulk purification as well.</p><p id="p0188" num="0188">Another technique in which immobilized ionic liquids and diionic liquid salts of the present invention may be used is solid phase microextraction or SPME. Broadly speaking, in these techniques, a separation material (in this case an ionic liquid or in particular a diionic liquid salt in accordance with the present invention or ionic liquids mixed with adsorbents, particles and other chromatographic media) is absorbed, adsorbed or immobilized in one way or another on a fiber (e.g., polydimethylsiloxane/divinylbenzene (PDMS/DVB) fiber) or some other solid support which is applied to the plunger as a coating or as a sheet generally attached to a plunger in a microsyringe such as usually used in gas chromatography. The diionic liquid salts of the invention can also be immobilized and attached directly without any separate solid support other than the plunger. This can be done using, for example, a film directly. In the case of the invention, immobilized ionic liquids and absorbed, adsorbed and immobilized diionic liquid salts are contemplated. The plunger is depressed, exposing the fiber and the fiber is then dipped into the sample of interest. The plunger can then be withdrawn to pull the fiber back into the barrel of the syringe, or at least the barrel of the needle for protection and transport. The syringe can<!-- EPO <DP n="73"> --> then be injected through the septum of a gas chromatograph or some other device and the fiber thereby inserted into the column by redepressing the plunger of the microsyringe. The heat used in GC then volatilizes or otherwise drives the bound sample off where it is carried by the mobile phase through the GC column, allowing for separation and/or identification. It can also be eluted by a liquid mobile phase in an HPLC injector or unbuffer capillary electrophoresis. Immobilized ionic liquids and diionic liquid salts of the present invention may also be used in conjunction with the coated stir bar technology, which is a higher capacity version of SPME. Some embodiments of this coated stir bar technology are sold under the trademark TWISTER.</p><p id="p0189" num="0189">More specifically, solid phase microextraction is a technique in which a small amount of extracting phase (in this case an ionic liquid and preferably a diionic liquid salt in accordance with the present invention) is disposed on a solid support, which was then exposed to a sample for a period of time. In situations where the sample is not stirred, a partitioning equilibrium between a sample matrix and the extraction phase is reached. In cases where convection is constant, a short time pre-equilibrium extraction is realized and the amount of analyte extracted is related to time. Quantification can then be performed based on the timed accumulation of analysis in the coating. These techniques are usually performed using open bed extraction concepts such as by using coated fibers (e.g., fused silica similar to that used in capillary GC or capillary electrophoresis, glass fibers, wires, metal or alloy fibers, beads, etc.), vessels, agitation mechanism discs and the like. However, in-tube approaches have also been demonstrated. In-tube approaches require the extracting phase to be coated on the inner wall of the capillary and the sample containing the analyte of interest is subject to the capillary and the analytes undergo partitioning to the extracting phase. Thus, material can be coated on the inner wall of a needle, for example, and the needle injected without the need for a separate solid support.</p><p id="p0190" num="0190"><figref idrefs="f0008">Figure 8</figref> shows an example of an SPME device 1. A stainless steel microtube 40 having an inside diameter slightly larger than the outside diameter of, for example, a fuse silica rod 60 is used. Other inert metals, such as Nitinol (nickel/titanium alloy) can be also employed in SPME instead of stainless steel. Typically, the first 5 mm is removed from a 1.5 cm long fiber, which is then inserted into the microtubing. High temperature epoxy glue is used to permanently mount the fiber. Fibers can also be crimped to the syringe plunger without using adhesives. Sample injection is then very much like standard syringe injection. Movement of the<!-- EPO <DP n="74"> --> plunger 30 allows exposure of the fiber 60 during extraction and desorption and its protection in the needle 20 during storage and penetration of the septum. 10 shows the barrel of the microsyringe, 50 shows the extreme end of the stainless steel microtube in which the silicon fiber is mounted.</p><p id="p0191" num="0191">Another embodiment of a syringe useful for SPME in accordance with the present invention is illustrated in <figref idrefs="f0009">Figure 9</figref>. Syringe 2 can be built from a short piece of stainless steel microtubing 130 to hold the fiber. Another piece of larger tubing 120 works as the needle. A septum 110 is used to seal the connection between the microtubing 130 and the needle 120. The silica fiber 140 is exposed through one end of the microtubing 130 and the other end is blocked by a plunger 100. Withdrawing plunger 100 retracts microtubing 130 and the fiber 140 into the barrel of the device, the needle 120. Depressing plunger 100 reverses this process. These are but exemplary structures and any syringe device, including those containing a needle or tube with the ionic liquid immobilized on the inner surface thereof are also contemplated.</p><p id="p0192" num="0192">Any monoionic liquid or diionic liquid salt may be used in accordance with the present invention. Diionic liquids such as those shown immediately below can be absorbed or adsorbed onto a solid support as previously described.
<chemistry id="chem0072" num="0072"><img id="ib0083" file="imgb0083.tif" wi="63" he="14" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0073" num="0073"><img id="ib0084" file="imgb0084.tif" wi="128" he="14" img-content="chem" img-format="tif"/></chemistry></p><p id="p0193" num="0193">In addition, ionic liquids, both monoionic and diionic liquid salts in accordance with the present invention can be immobilized by being bound or cross-linked to themselves and/or to a solid support as previously discussed in connection with manufacturing capillary GC columns. To do so, however, the species used should have at least one unsaturated group disposed to allow reaction resulting in immobilization. See, for example, the monocationic and dicationic species immediately below.
<chemistry id="chem0074" num="0074"><img id="ib0085" file="imgb0085.tif" wi="67" he="14" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="75"> -->
<chemistry id="chem0075" num="0075"><img id="ib0086" file="imgb0086.tif" wi="141" he="14" img-content="chem" img-format="tif"/></chemistry></p><p id="p0194" num="0194">Other cationic species, such as those including -P<sup>+</sup>RR'R", as well as those employing anions are also contemplated. Another type of SPME technique is known as task specific SPME or TSSPME. Task specific SPME allows for the separation or removal, and therefore the detection of particular species. These can include, for example, mercury and cadmium, although the technique is equally applicable to other materials. The concept is exactly the same as previously described with regard to SPME. However, in this instance, the ionic liquids or diionic liquids used are further modified such that they will specifically interact with a particular species. Those shown below, for example, may be used in the detection of cadmium and mercury (Cd<sup>2+</sup> or Hg<sup>2+</sup>). The first monocationic material can be coated, absorbed or adsorbed onto a fiber as previously discussed. A diionic liquid salt can also be absorbed or adsorbed in known fashion. The second and third ionic liquid materials illustrated below, the first monoionic and the second dicationic, by virtue of the presence of unsaturated groups, can be more easily immobilized on a solid support using techniques analogous to those described previously with regard to cross-linking in connection with manufacturing capillary GC columns.
<chemistry id="chem0076" num="0076"><img id="ib0087" file="imgb0087.tif" wi="84" he="15" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0077" num="0077"><img id="ib0088" file="imgb0088.tif" wi="71" he="17" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0078" num="0078"><img id="ib0089" file="imgb0089.tif" wi="124" he="15" img-content="chem" img-format="tif"/></chemistry></p><p id="p0195" num="0195">Finally, a particular sample can be suspended in a matrix that includes ionic liquids and preferably diionic liquid salts in accordance with the present invention. This matrix can be loaded or immobilized on the fiber of an SPME syringe as described above and then injected into a mass spectrometer to practice a technique known as SPME/MALDI mass spectrometry. The<!-- EPO <DP n="76"> --> matrix is exposed to a UV laser. This causes the volatilization or release of the sample much as heat does in a GC. This allows the sample to enter mass spectrometer where it can be analyzed. Ionic materials which can be used as a matrix include, without limitation:
<chemistry id="chem0079" num="0079"><img id="ib0090" file="imgb0090.tif" wi="30" he="14" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0080" num="0080"><img id="ib0091" file="imgb0091.tif" wi="72" he="17" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0081" num="0081"><img id="ib0092" file="imgb0092.tif" wi="103" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0082" num="0082"><img id="ib0093" file="imgb0093.tif" wi="40" he="12" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0083" num="0083"><img id="ib0094" file="imgb0094.tif" wi="99" he="20" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0084" num="0084"><img id="ib0095" file="imgb0095.tif" wi="47" he="14" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="77"> -->
<tables id="tabl0008" num="0008"><table frame="all"><title>Table A: Structure and physico-chemical properties of the monomers/crosslinkers used in this study.</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="12mm"/><colspec colnum="2" colname="col2" colwidth="92mm"/><colspec colnum="3" colname="col3" colwidth="22mm"/><colspec colnum="4" colname="col4" colwidth="19mm"/><colspec colnum="5" colname="col5" colwidth="23mm"/><thead><row><entry align="center" valign="top">#</entry><entry align="center" valign="top">Ionic Liquid</entry><entry align="center" valign="top">Molecular Weight (g/mol)</entry><entry align="center" valign="top">Density (g/cm<sup>3</sup>)</entry><entry align="center" valign="top">Refractive Index</entry></row></thead><tbody><row><entry morerows="1" rowsep="1" align="center" valign="middle"><b>1</b></entry><entry align="center" valign="middle"><chemistry id="chem0085" num="0085"><img id="ib0096" file="imgb0096.tif" wi="54" he="18" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">459.1</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.36</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.443</entry></row><row><entry align="center" valign="middle">hvim-NTf<sub>2</sub><sup>a</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle"><b>2</b></entry><entry align="center" valign="middle"><chemistry id="chem0086" num="0086"><img id="ib0097" file="imgb0097.tif" wi="66" he="15" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">501.2</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.28</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.445</entry></row><row><entry align="center" valign="middle">nvim-NTf<sub>2</sub><sup>b</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle"><b>3</b></entry><entry align="center" valign="middle"><chemistry id="chem0087" num="0087"><img id="ib0098" file="imgb0098.tif" wi="78" he="16" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">543.3</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.23</entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">1.448</entry></row><row><entry align="center" valign="middle">dvim-NTf<sub>2</sub><sup>c</sup></entry></row><row><entry morerows="5" align="center" valign="middle"><b>4</b></entry><entry align="center" valign="middle"><chemistry id="chem0088" num="0088"><img id="ib0099" file="imgb0099.tif" wi="75" he="18" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">832.1</entry><entry morerows="5" valign="middle" align="char" char=".">1.53</entry><entry morerows="5" valign="middle" align="char" char=".">1.449</entry></row><row><entry rowsep="0" align="center" valign="middle">C<sub>6</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>d</sup></entry></row><row><entry align="center" valign="middle"><chemistry id="chem0089" num="0089"><img id="ib0100" file="imgb0100.tif" wi="72" he="19" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" valign="middle" align="char" char=".">820.1</entry></row><row><entry rowsep="0" align="center" valign="middle">C<sub>6</sub>vm(im)<sub>2</sub>-NTf<sub>2</sub><sup>e</sup></entry></row><row><entry align="center" valign="middle"><chemistry id="chem0090" num="0090"><img id="ib0101" file="imgb0101.tif" wi="72" he="19" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" valign="middle" align="char" char=".">808.1</entry></row><row><entry align="center" valign="middle">C<sub>6</sub>(mim)<sub>2</sub>-NTf<sub>2</sub><sup>f</sup></entry></row><row><entry valign="middle"/><entry align="center" valign="middle">C<sub>6</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> : C<sub>6</sub>vm(im)<sub>2</sub>-NTf<sub>2</sub> : C<sub>6</sub>(mim)<sub>2</sub>-NTf<sub>2</sub> 1 : 2 : 1</entry><entry valign="middle" align="char" char="."/><entry valign="middle" align="char" char="."/><entry valign="middle" align="char" char="."/></row><!-- EPO <DP n="78"> --><row><entry morerows="1" rowsep="1" align="center" valign="middle">5</entry><entry align="center" valign="middle"><chemistry id="chem0091" num="0091"><img id="ib0102" file="imgb0102.tif" wi="72" he="16" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" align="center" valign="middle">874.3</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.47</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.457</entry></row><row><entry align="center" valign="middle">C<sub>9</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>g</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle">6</entry><entry align="center" valign="middle"><chemistry id="chem0092" num="0092"><img id="ib0103" file="imgb0103.tif" wi="79" he="16" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" align="center" valign="middle">888.3</entry><entry morerows="1" rowsep="1" align="center" valign="middle">--</entry><entry morerows="1" rowsep="1" align="center" valign="middle">--</entry></row><row><entry align="center" valign="middle">C<sub>10</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>h,*</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle">7</entry><entry align="center" valign="middle"><chemistry id="chem0093" num="0093"><img id="ib0104" file="imgb0104.tif" wi="82" he="16" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" align="center" valign="middle">902.3</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.44</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.457</entry></row><row><entry align="center" valign="middle">C<sub>11</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>i</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle">8</entry><entry align="center" valign="middle"><chemistry id="chem0094" num="0094"><img id="ib0105" file="imgb0105.tif" wi="84" he="15" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" align="center" valign="middle">916.3</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.42</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.458</entry></row><row><entry align="center" valign="middle">C<sub>12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>j,*</sup></entry></row><row><entry morerows="1" rowsep="1" align="center" valign="middle">9</entry><entry align="center" valign="middle"><chemistry id="chem0095" num="0095"><img id="ib0106" file="imgb0106.tif" wi="56" he="17" img-content="chem" img-format="tif"/></chemistry></entry><entry morerows="1" rowsep="1" align="center" valign="middle">489.3</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.30</entry><entry morerows="1" rowsep="1" align="center" valign="middle">1.434</entry></row><row><entry align="center" valign="middle">nmim-NTf<sub>2</sub><sup>k</sup></entry></row><row><entry align="center" valign="middle">10</entry><entry align="center" valign="middle"><chemistry id="chem0096" num="0096"><img id="ib0107" file="imgb0107.tif" wi="42" he="18" img-content="chem" img-format="tif"/></chemistry></entry><entry align="center" valign="middle"/><entry align="center" valign="middle"/><entry align="center" valign="middle"/></row></tbody></tgroup></table></tables><!-- EPO <DP n="79"> -->
<tables id="tabl0009" num="0009"><img id="ib0108" file="imgb0108.tif" wi="139" he="220" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="80"> -->
<tables id="tabl0010" num="0010"><table frame="all"><title>Table C: Effect of AIBN initiator concentration on efficiency (theoretical plates/meter) as a function of conditioning of the crosslinked stationary phase. The percentage of AIBN initiator indicated is based on the weight percent of the ionic liquid.</title><tgroup cols="9"><colspec colnum="1" colname="col1" colwidth="26mm"/><colspec colnum="2" colname="col2" colwidth="27mm"/><colspec colnum="3" colname="col3" colwidth="26mm"/><colspec colnum="4" colname="col4" colwidth="28mm"/><colspec colnum="5" colname="col5" colwidth="28mm"/><colspec colnum="6" colname="col6" colwidth="28mm"/><colspec colnum="7" colname="col7" colwidth="28mm"/><colspec colnum="8" colname="col8" colwidth="27mm"/><colspec colnum="9" colname="col9" colwidth="28mm"/><thead><row><entry rowsep="0" valign="top"/><entry namest="col2" nameend="col5" align="center" valign="top"><b>Partially Crosslinked Ionic Liquid Matrix</b></entry><entry namest="col6" nameend="col9" align="center" valign="top"><b>Crosslinked Ionic Liquid Matrix</b></entry></row><row><entry valign="top"/><entry align="center" valign="top">0.10% 2</entry><entry align="center" valign="top">0.10% 2</entry><entry align="center" valign="top">0.10% 2</entry><entry align="center" valign="top">0.10% 2</entry><entry morerows="2" rowsep="1" align="center" valign="top">020% C<sub>5-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> 0,5%AIBN</entry><entry morerows="2" rowsep="1" align="center" valign="top">0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> 3,5%AIBN</entry><entry morerows="2" rowsep="1" align="center" valign="top">0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTF<sub>2</sub> 7.05%AIBN</entry><entry morerows="2" rowsep="1" align="center" valign="top">0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> 10.0%AIBN</entry></row><row><entry valign="top"/><entry align="center" valign="top">0.10% 5</entry><entry align="center" valign="top">0.10% 5</entry><entry align="center" valign="top">0.10% 5</entry><entry align="center" valign="top">0.10% 5</entry></row><row><entry valign="top"/><entry align="center" valign="top">0.5% AIBN</entry><entry align="center" valign="top">3.5%AIBN</entry><entry align="center" valign="top">7.0%AIBN</entry><entry align="center" valign="top">10.0%AIBN</entry></row></thead><tbody><row><entry align="center" valign="middle">30°C-120°C 3°C/min Hold 2 hours</entry><entry align="center" valign="middle">3296</entry><entry align="center" valign="middle">3566</entry><entry align="center" valign="middle">3831</entry><entry align="center" valign="middle">3817</entry><entry align="center" valign="middle">3426</entry><entry align="center" valign="middle">3155</entry><entry align="center" valign="middle">2792</entry><entry align="center" valign="middle">2905</entry></row><row><entry align="center" valign="middle">100°C-200°C 3°C/min Hold 5 hours</entry><entry align="center" valign="middle">3215</entry><entry align="center" valign="middle">3277</entry><entry align="center" valign="middle">3703</entry><entry align="center" valign="middle">3529</entry><entry align="center" valign="middle">2697</entry><entry align="center" valign="middle">2379</entry><entry align="center" valign="middle">2275</entry><entry align="center" valign="middle">2309</entry></row><row><entry align="center" valign="middle">150°C-250°C 3°C/min Hold 3 hours</entry><entry align="center" valign="middle">3090</entry><entry align="center" valign="middle">3016</entry><entry align="center" valign="middle">3069</entry><entry align="center" valign="middle">3027</entry><entry align="center" valign="middle">1723</entry><entry align="center" valign="middle">1598</entry><entry align="center" valign="middle">1682</entry><entry align="center" valign="middle">1398</entry></row><row><entry align="center" valign="middle">200°C-285°C 3°C/min Hold 2 hours</entry><entry align="center" valign="middle">2210</entry><entry align="center" valign="middle">2536</entry><entry align="center" valign="middle">2375</entry><entry align="center" valign="middle">2559</entry><entry align="center" valign="middle">950</entry><entry align="center" valign="middle">711</entry><entry align="center" valign="middle">865</entry><entry align="center" valign="middle">649</entry></row><row><entry align="center" valign="middle">200°C - 300°C 3°C/min Hold 1 hour</entry><entry align="center" valign="middle">1317</entry><entry align="center" valign="middle">2024</entry><entry align="center" valign="middle">2298</entry><entry align="center" valign="middle">2009</entry><entry align="center" valign="middle">676</entry><entry align="center" valign="middle">554</entry><entry align="center" valign="middle">768</entry><entry align="center" valign="middle">603</entry></row><row><entry align="center" valign="middle">200°C-350°C 3°C/min Hold 1 hour</entry><entry align="center" valign="middle">112</entry><entry align="center" valign="middle">146</entry><entry align="center" valign="middle">598</entry><entry align="center" valign="middle">1214</entry><entry align="center" valign="middle">1593</entry><entry align="center" valign="middle">950</entry><entry align="center" valign="middle">1664</entry><entry align="center" valign="middle">1506</entry></row><row><entry align="center" valign="middle">285°C - 385°C 3°C/min Hold 20 min</entry><entry align="center" valign="middle">--</entry><entry align="center" valign="middle">--</entry><entry align="center" valign="middle">140</entry><entry align="center" valign="middle">68</entry><entry align="center" valign="middle">178</entry><entry align="center" valign="middle">239</entry><entry align="center" valign="middle">490</entry><entry align="center" valign="middle">453</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="81"> -->
<tables id="tabl0011" num="0011"><img id="ib0109" file="imgb0109.tif" wi="138" he="223" img-content="table" img-format="tif"/></tables><!-- EPO <DP n="82"> -->
<tables id="tabl0012" num="0012"><table frame="all"><title><b>Table E: Comparison of interaction parameters of one neat and two crosslinked ionic liquids.</b></title><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><colspec colnum="5" colname="col5" colwidth="18mm"/><colspec colnum="6" colname="col6" colwidth="18mm"/><colspec colnum="7" colname="col7" colwidth="18mm"/><colspec colnum="8" colname="col8" colwidth="14mm"/><colspec colnum="9" colname="col9" colwidth="18mm"/><colspec colnum="10" colname="col10" colwidth="14mm"/><thead><row><entry colsep="0" align="center">Temp (°C)</entry><entry namest="col2" nameend="col10" align="center">Interaction Parameters<sup>a</sup></entry></row><row><entry rowsep="0" align="center">0.20% nmim-NTf<sub>2</sub> (9)</entry><entry colsep="0" align="center"><i>c</i></entry><entry colsep="0" align="center"><i>r</i></entry><entry colsep="0" align="center"><i>s</i></entry><entry colsep="0" align="center"><i>a</i></entry><entry colsep="0" align="center"><i>b</i></entry><entry colsep="0" align="center"><i>l</i></entry><entry colsep="0" align="center">n</entry><entry colsep="0" align="center">R<sup>2</sup></entry><entry align="center">F</entry></row></thead><tbody><row><entry rowsep="0" align="center">40</entry><entry align="center">-2.98 (0.11)</entry><entry align="center">0 (0.09)</entry><entry align="center">1.62 (0.10)</entry><entry align="center">1.91 (0.10)</entry><entry align="center">0.36 (0.13)</entry><entry align="center">0.75 (0.03)</entry><entry align="center">32</entry><entry align="center">0.99 (0.10)</entry><entry align="char" char="." charoff="38">477.86</entry></row><row><entry rowsep="0" align="center" valign="middle">70</entry><entry align="center">-3.05 (0.08)</entry><entry align="center">0 (0.07)</entry><entry align="center">1.54 (0.07)</entry><entry align="center">1.57 (0.07)</entry><entry align="center">0.18 (0.10)</entry><entry align="center">0.63 (0.02)</entry><entry align="center">32</entry><entry align="center">0.99 (0.07)</entry><entry align="char" char="." charoff="38">660.78</entry></row><row><entry align="center" valign="bottom">100</entry><entry align="center">-3.47 (0.11)</entry><entry align="center">0 (0.09)</entry><entry align="center">1.52 (0.10)</entry><entry align="center">1.43 (0.09)</entry><entry align="center">0.12 (0.13)</entry><entry align="center">0.60 (0.03)</entry><entry align="center">30</entry><entry align="center">0.99 (0.09)</entry><entry align="char" char="." charoff="38">304.17</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><colspec colnum="5" colname="col5" colwidth="18mm"/><colspec colnum="6" colname="col6" colwidth="18mm"/><colspec colnum="7" colname="col7" colwidth="18mm"/><colspec colnum="8" colname="col8" colwidth="14mm"/><colspec colnum="9" colname="col9" colwidth="18mm"/><colspec colnum="10" colname="col10" colwidth="14mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">0.10% C<sub>9</sub>(vim)-NTf<sub>2</sub> (2); 0.10% C<sub>9</sub>(vim)<sub>2</sub>-NTf<sub>2</sub> (5): 3.5% AIBN</entry></row></thead><tbody><row><entry rowsep="0" align="center">40</entry><entry align="center">-2.95 (0.11)</entry><entry align="center">0 (0.10)</entry><entry align="center">1.60 (0.11)</entry><entry align="center">1.84 (0.10)</entry><entry align="center">0.45 (0.15)</entry><entry align="center">0.71 (0.03)</entry><entry align="center">32</entry><entry align="center">0.99 (0.10)</entry><entry align="char" char="." charoff="38">404.82</entry></row><row><entry rowsep="0" align="center" valign="middle">70</entry><entry align="center">-3.05 (0.08)</entry><entry align="center">0 (0.07)</entry><entry align="center">1.57 (0.08)</entry><entry align="center">1.53 (0.07)</entry><entry align="center">0.37 (0.10)</entry><entry align="center">0.60 (0.02)</entry><entry align="center">32</entry><entry align="center">0.99 (0.07)</entry><entry align="char" char="." charoff="38">639.52</entry></row><row><entry align="center" valign="bottom">100</entry><entry align="center">-3.49 (0.12)</entry><entry align="center">0 (0.09)</entry><entry align="center">1.54 (0.11)</entry><entry align="center">1.41 (0.09)</entry><entry align="center">0.31 (0.14)</entry><entry align="center">0.54 (0.03)</entry><entry align="center">30</entry><entry align="center">0.98 (0.09)</entry><entry align="char" char="." charoff="38">299.60</entry></row></tbody></tgroup><tgroup cols="10"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><colspec colnum="5" colname="col5" colwidth="18mm"/><colspec colnum="6" colname="col6" colwidth="18mm"/><colspec colnum="7" colname="col7" colwidth="18mm"/><colspec colnum="8" colname="col8" colwidth="14mm"/><colspec colnum="9" colname="col9" colwidth="18mm"/><colspec colnum="10" colname="col10" colwidth="14mm"/><thead><row><entry namest="col1" nameend="col10" align="left" valign="top">0.20% C<sub>9-12</sub>(vim)<sub>2</sub>-NTf<sub>2</sub><sup>b</sup> ; 3.5% AIBN</entry></row></thead><tbody><row><entry rowsep="0" align="center">40</entry><entry align="center">-3.31 (0.10)</entry><entry align="center">0 (0.09)</entry><entry align="center">1.92 (0.10)</entry><entry align="center">1.94 (0.09)</entry><entry align="center">0.59 (0.13)</entry><entry align="center">0.68 (0.03)</entry><entry align="center">32</entry><entry align="center">0.99<sup>.</sup> (0.09)</entry><entry align="char" char="." charoff="38">573.26</entry></row><row><entry rowsep="0" align="center" valign="middle">70</entry><entry align="center">-3.55 (0.12)</entry><entry align="center">0 (0.10)</entry><entry align="center">1.88 (0.11)</entry><entry align="center">1.71 (0.09)</entry><entry align="center">0.46 (0.15)</entry><entry align="center">0.59 (0.03)</entry><entry align="center">32</entry><entry align="center">0.99 (0.10)</entry><entry align="char" char="." charoff="38">305.25</entry></row><row><entry align="center" valign="bottom">100</entry><entry align="center">-3.65 (0.13)</entry><entry align="center">0 (0.11)</entry><entry align="center">1.73 (0.13)</entry><entry align="center">1.46 (0.12)</entry><entry align="center">0.32 (0.18)</entry><entry align="center">0.48 (0.04)</entry><entry align="center">30</entry><entry align="center">0.98 (0.11)</entry><entry align="char" char="." charoff="38">254.83</entry></row></tbody></tgroup><tgroup cols="10" rowsep="0"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="16mm"/><colspec colnum="4" colname="col4" colwidth="18mm"/><colspec colnum="5" colname="col5" colwidth="18mm"/><colspec colnum="6" colname="col6" colwidth="18mm"/><colspec colnum="7" colname="col7" colwidth="18mm"/><colspec colnum="8" colname="col8" colwidth="14mm"/><colspec colnum="9" colname="col9" colwidth="18mm"/><colspec colnum="10" colname="col10" colwidth="14mm"/><tbody><row><entry namest="col1" nameend="col10" align="justify"><sup>a</sup> r= interaction via nonbonding and π-electrons, 5 = dipolarity/polarizability,<br/>
a = hydrogen bond basicity, b = hydrogen bond acidity, l = dispersion forces, n = number of probe molecules subjected to multiple linear regression analysis, R<sup>2</sup> = statistical correlation coefficient, F = Fisher coefficient. Values in parenthesis are the standard deviations for each interaction parameter.<br/>
<sup>b</sup> This mixture consists of a combination of a homologous series of ionic liquids that are 10.88% by weight of 5, 9.29% of 6, 19.59% of 7, and 60.24% of 8.</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0013" num="0013"><table frame="all"><title>Table F: Names of Compounds Found in Tables 1 and 2</title><tgroup cols="2" colsep="0"><colspec colnum="1" colname="col1" colwidth="37mm"/><colspec colnum="2" colname="col2" colwidth="114mm" colsep="1"/><tbody><row><entry>C<sub>3</sub>(mim)<sub>2</sub>-Br</entry><entry valign="bottom">1,3-di(3-methylimidazolium)propane di-bromide</entry></row><row><entry>C<sub>3</sub>(mim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,3-di(3-Methylimidazolium)propane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>3</sub>(mim)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1,3-di(3-methylimidazolium)propane di-tetrafluoroborate</entry></row><row><entry>C<sub>3</sub>(mim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,3-(3-methylimidazolium)propane di-hexafluorophosphate</entry></row><row><entry>C<sub>6</sub>(mim)<sub>2</sub>-Br</entry><entry valign="bottom">1,6-di(3-methylimidazolium)hexane di-bromide</entry></row><row><entry>C<sub>6</sub>(mim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,6-di(3-methylimidazolium)hexane di-bis[(tritluoromethyl)sulfonyl]imida</entry></row><row><entry>C<sub>6</sub>(mim)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1.6-di(3-methylimidazolium)hexane di-tetrafluoroborate</entry></row><row><entry>C<sub>6</sub>(mim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,6-di(3-methylimidazolium)hexane di-hexafluorophosphate</entry></row><row><entry>C<sub>9</sub>(mim)<sub>2</sub>-Br</entry><entry valign="bottom">1,9-di(3-methylimidazolium)nonane di-bromide</entry></row><row><entry>C<sub>9</sub>(mim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,9-di(3-methylimidazolium)nonane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>9</sub>(mim)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1,9-di(3-methylimidazolium)nonane di-tetrafluoroborate</entry></row><row><entry>C<sub>9</sub>(mim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,9-di(3-methylimidazolium)nonane di-hexafluorophosphate</entry></row><!-- EPO <DP n="83"> --><row><entry>C<sub>12</sub>(mim)<sub>2</sub>-Br</entry><entry valign="bottom">1,12-di(3-methylimidazolium)dodecane di-bromide</entry></row><row><entry>C<sub>12</sub>(mim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,12-di(3-methylimidazolium)dodecane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>12</sub>(mim)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1.12-di(3-methylimidazolium)dodecane di-tetrafluoroborate</entry></row><row><entry>C<sub>12</sub>(mim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,12-di(3-methylimidazolium)dodecane di-hexafluorophosphate</entry></row><row><entry>C<sub>9</sub>(bim)<sub>2</sub>-Br</entry><entry valign="bottom">1,9-di(3-butylimidazolium)monane di-bromide</entry></row><row><entry>C<sub>9</sub>(bim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,9-di(3-butylimidazolium)monane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>9</sub>(bim)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1,9-di(3-butylimidazolium)nonane di-tetrafluoroborate</entry></row><row><entry>C<sub>9</sub>(bim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,9-di(3-butylimidazolium)nonane di-hexafluorophosphate</entry></row><row><entry>C<sub>3</sub>(m<sub>2</sub>im)<sub>2</sub>-Br</entry><entry valign="bottom">1,3-di(2,3-dimethylimidaolium)propane di-bromide</entry></row><row><entry>C<sub>3</sub>(m<sub>2</sub>im)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,3-di(2,3-dimethylimidazolium)propane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>3</sub>(m<sub>2</sub>im)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,3-di(2,3-dimethylimidazolium)propane di-hexafluorophosphate</entry></row><row><entry>C<sub>9</sub>(m<sub>2</sub>im)<sub>2</sub>-Br</entry><entry valign="bottom">1,9-di(2,3-dimethylimidazolium)nonane di-bromide</entry></row><row><entry>C<sub>9</sub>(m<sub>2</sub>im)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,9-di(2,3-dimethylimidazolium)nonane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>9</sub>(m<sub>2</sub>im)<sub>2</sub>-BF<sub>4</sub></entry><entry valign="bottom">1,9-di(2,3-dimethylimidazolium)nonane di-tetrafluoroborate</entry></row><row><entry>C<sub>9</sub>(m<sub>2</sub>im)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,9-di(2,3-dimethylimidazolium)nonane di-hexafluorophosphate</entry></row><row><entry>C<sub>12</sub>(benzam)<sub>2</sub>-Br</entry><entry valign="bottom">1,12-di(3-benzylimidazolium)dodecane di-bromide</entry></row><row><entry>C<sub>12</sub>(benzim)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,12-di(3-benzylimidazolium)dodecane di-bis[(trifluoromothyl)sulfonyl]imidate</entry></row><row><entry>C<sub>12</sub>(benzim)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,12-di(3-benzylimidazolium)dodecane di-hexafluorophosphate</entry></row><row><entry>C<sub>3</sub>(mpy)<sub>2</sub>-Br</entry><entry valign="bottom">1,3-di(methylpyrrolidinium)propane di-bromide</entry></row><row><entry>C<sub>3</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,3-di(methylpyrrolidinium)propane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>3</sub>(mpy)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,3-di(methylpyrrolidinium)propane di-hexafluorophosphate</entry></row><row><entry>C<sub>9</sub>(mpy)<sub>2</sub>-Br</entry><entry valign="bottom">1,9-di(methylpyrrolidinium)nonane di-bromide</entry></row><row><entry>C<sub>9</sub>(mpy)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,9-di(methylpyrrolidinium)nonane di-bis[(trifluoromethyl)sulfonyl]imidate</entry></row><row><entry>C<sub>9</sub>(mpy)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,9-di(methylpyrrolidinium)nonane di-hexafluorophosphate</entry></row><row><entry>C<sub>9</sub>(bpy)<sub>2</sub>-Br</entry><entry valign="bottom">1,9-di(butylpyrrolidinium)nonane di-bromide</entry></row><row><entry>C<sub>9</sub>(bpy)<sub>2</sub>-NTf<sub>2</sub></entry><entry valign="bottom">1,9-di(butylpyrrolidinium)nonane di-bis[(trifluoromethyl)sulfonyl]imida</entry></row><row><entry>C<sub>9</sub>(bpy)<sub>2</sub>-PF<sub>6</sub></entry><entry valign="bottom">1,9-di(butylpyrrolidinium)nonane di-hexafluorophosphate</entry></row></tbody></tgroup></table></tables></p><p id="p0196" num="0196">The invention provides a method of detecting a charged molecule having a single charge (+1 or -1) using electrospray ionization-mass spectrometry (ESI-MS). In the method a suitable amount of the diionic species of the invention having the opposite charges of the molecule of interest is added to the sample. The diionic species and the charged molecule form a<!-- EPO <DP n="84"> --> salt complex. The salt complex is generally a solid. Because the diionic species has two charges, when complexed with the charged molecule, the complex has a net charge. The complex is then detected using ESI-MS. The formation of the complex converts the charged molecule into an ion having a higher mass to charge ratio m/z, which can be transferred by ESI more efficiently due to mass discrimination. The present invention thus provides an ESI-MS method with substantially improved selectivity and sensitivity. Preferred is the use of dicationic species.</p><p id="p0197" num="0197">In one embodiment, the method of the invention includes selecting a diionic species that has a desired composition and structure, e.g., desired charged group or a desired mass or a combination thereof. The charged group can be selected based on the composition and structure of the charged molecule to be detected. Preferably, the diionic species is specific for the charged molecule to be detected. Thus, it is preferable that the diionic species is such that it binds strongly with the charged molecule to be detected. More preferably, the charged group of the diionic species is such that it does not bind strongly with other charged molecules different from the molecule of interest in the sample. Employing a diionic species that is specific for a charged molecule of interest allows high selectivity in detecting the charged molecule. Use of the diionic species having two different ionic groups may offer particular advantage in tailoring the affinities for different molecules for detection.</p><p id="p0198" num="0198">The mass of the diionic species is preferably selected to achieve optimal detection by the mass spectrometer. In general, a diionic species having a large mass is used. The diionic species is preferably such that the complex has a m/z higher than 50. Most commercial single quadruple mass spectrometers are designed to have their optimum performance at m/z values significantly higher than 100. In another preferred embodiment, the diionic species is selected such that the complex has a m/z significantly higher than 100, e.g., at least about 200, at least about 300, or at least about 400. A person skilled in the art will understand that the mass of the diionic species depends on the sizes of the charged groups as well as the bridging group. One or more of these can be varied to obtain a diionic species of desired mass.</p><p id="p0199" num="0199">In another embodiment, the method of the invention includes selecting a diionic salt that dissociates with high yield. This can be achieved by selecting a diionic salt containing suitable counter ions. In cases where a diionic salt having desired ionic groups but less desirable counter ions, it can be converted to a diionic salt containing the desired counter ions by anion<!-- EPO <DP n="85"> --> exchange. In a specific embodiment, a fluoride salt is used, which if not yet available, can be converted from a dihalide, a bromide or a iodide salt by anion exhange.</p><p id="p0200" num="0200">In another embodiment, the method further includes a step of performing ion chromatography prior to the addition of the diionic species.</p><p id="p0201" num="0201">Several dicationic species were used in detecting perchlorate (ClO<sub>4</sub><sup>-</sup>). In a preferred embodiment, the invention provides a method of detecting a charged molecule of -1 charge other than perchlorate (ClO<sub>4</sub><sup>-</sup>) by mass spectrometry using a dicationic species of the invention. In another embodiment, the invention provides a method of detecting perchlorate (ClO<sub>4</sub><sup>-</sup>) by mass spectrometry using a dicationic species of the invention which is not one of the dicationic species I-X disclosed in reference 58. In still another embodiment, the invention provides a method of detecting a charged molecule of -1 charge by mass spectrometry using a "unsymmetric" dicationic species of the invention. In still another embodiment, the invention provides a method of detecting a charged molecule of -1 charge by mass spectrometry using a chiral dicationic species of the invention.</p><p id="p0202" num="0202">In another preferred embodiment, the invention provides a method of detecting a charged molecule of +1 charge by mass spectrometry using a dianionic species of the invention. Any one of the dianionic species described above can be used.</p><p id="p0203" num="0203">In still another preferred embodiment, the invention provides a method of detecting a plurality of different charged molecules of +1 or -1 charge by mass spectrometry using a plurality of different diionic species of the invention. Each of the diionic species is selected to specifically bind one of the different charged molecules. Preferably, the different diionic species have different masses such that the complexes formed with their respective charged molecules can be detected separately.</p><p id="p0204" num="0204">Mass spectrometry can be carried out using standard procedures know in the art.</p><p id="p0205" num="0205">In another aspect of the present invention, there are provided a mixture comprising both the diionic liquid salts of the invention and traditional stationary phase material such as but not limited to polysiloxanes, PEGS, methylpolysiloxanes, phenyl substituted methylpolysiloxance, nirile substituted methylpolysiloxance, carbowax. Such mixture (mixed stationary phase or "MSP") can be used as a stationary phases in chromatography such as gas chromatography, liquid chromatography and high performance liquid chromatography as well as in SPE and SPME. Both dicationic salt and dianionic salt can be used for this purpose. The<!-- EPO <DP n="86"> --> MSPs can be non-cross-linked (e.g. absorbed or adsorbed on a solid support or column), can be "partially" cross-linked or "more highly" cross-linked (i.e., immobilized on a solid support or column). The diionic liquid salts may also be cross-linked or otherwise reacted with the traditional stationary phase material or merely mixed therewith.</p><p id="p0206" num="0206">Thus, in one embodiment, the invention provides MSPs comprising at least one of the diionic liquid salts of the invention and at least one traditional stationary phase material at a suitable proportion. Appropriate combinations of the diionic liquid salt(s) and the traditional stationary phase material(s) for producing the MSP is based on the particular application as are the proportions of the diionic liquid salt(s) and the traditional stationary phase materials(s) in the MSP. In a preferred embodiment, the ration of the diionic liquid salt and the traditional stationary phase material in the MSP is from about 1:9 (i.e., about 10% of diionic liquid salt and about 90% of traditional stationary phase material) to about 9:1 (i.e., about 90% of diionic liquid salt and about 10% of traditional stationary phase material), about 1:3 (i.e., about 25% of diionic liquid salt and about 75% of traditional stationary phase material) to about 3:1 (i.e., about 75% of diionic liquid salt and about 25% of traditional stationary phase material), about 1:2 (i.e., about 33% of diionic liquid salt and about 67% of traditional stationary phase material) to about 2:1 (i.e., about 67% of diionic liquid salt and about 33% of traditional stationary phase material), or about 1:1 (i.e., about 50% of diionic liquid salt and about 50% of traditional stationary phase material) (w/w). Chromatography employing MSP may perform better, e.g., having higher selectivity, than chromatography employing diionic liquid salts or the traditional stationary phase alone. As an example, an MSP comprising a simple mixture of about 67% (dibutyl imidazolium)<sub>2</sub>(CH<sub>2</sub>)<sub>9</sub> and about 33% of methylpolysiloxance with about 5% phenyl substitution was prepared and used to coat a column. This MSP was shown to exhibit better separation of an essential oil. Cross-linked version of the MSP can also be used.</p><p id="p0207" num="0207">In addition, the invention also provides methods of preparing MSPs, solid supports and/or columns containing same, the MSPs, solid supports, syringes, tubes, pipettes tips, needles, vials, and columns themselves, and the use of columns and solid supports containing such MSPs in chromatography and other analytical or separation techniques such as those described elsewhere.<!-- EPO <DP n="87"> --></p><heading id="h0004">EXAMPLES</heading><heading id="h0005">EXAMPLE 1 - <i>Compound #2</i></heading><p id="p0208" num="0208">Synthesis of 2 involved adding 15.0 mL (0.148 mol) of 1,3-dibromopropane dropwise to 23.5 mL (0.295 mol) of 1-methylimidazole in a round bottom flask under constant stirring at room temperature. The reaction was complete within 2 hours. The bromide salt was dissolved in 100 mL water and extracted with three 25 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum. Synthesis of the NTf<sub>2</sub><sup>-</sup> salt consisted of dissolving 10 grams (0.03 mol) of the bromide salt in 100-150 mL water. Two molar equivalents (0.06 mol, 3.92 grams) of N-lithiotrifluoromethylsulfonimide were dissolved in 50 mL of water in a separate beaker and added directly to the bromide salt. The solution was allowed to stir for 12 hours. The top water layer was removed to leave the ionic liquid. Three additional 30 mL aliquots of water were added and extracted with the ionic liquid until the ionic liquid passed the silver nitrate test. The ionic liquid was then dried using rotary evaporation and then further dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0006">EXAMPLE <i>2 - Compound #7:</i></heading><p id="p0209" num="0209">Synthesis of 7 involved adding 15.0 mL (0.098 mol) of 1,6-dibromohexane dropwise to 15.6 mL (0.196 mol) of 1-methylimidazole in a round bottom flask under constant stirring at room temperature. The reaction was complete within 2 hours. The bromide salt was dissolved in 100 mL water and extracted with three 25 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum. Anions were exchanged by dissolving 10 grams (0.024 mol) of the bromide salt in ∼150 mL acetone. Two molar equivalents of sodium tetrafluoroborate (0.049 mol, 5.38 grams) were then directly added to the acetone mixture. After allowing 24 hours for complete mixing, sodium bromide was filtered off to leave the pure ionic liquid. The sample was then subjected to silver nitrate to ensure no silver bromide precipitate was present. Acetone was removed under vacuum and the remaining ionic liquid dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0007">EXAMPLE <i>3 - Compound</i> #<i>17:</i></heading><p id="p0210" num="0210">Synthesis of 17 involved adding 15.0 mL (0.074 mol) of 1,9-dibromononae dropwise to 19.4 mL (0.148 mol) of 1-butylimidazole in a round bottom flask under constant stirring at<!-- EPO <DP n="88"> --> room temperature. The reaction was complete after 5 hours. The resulting viscous liquid was dissolved in 100 mL water and extracted with three 35 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0008">EXAMPLE 4 - <i>Compound #25:</i></heading><p id="p0211" num="0211">Synthesis of 25 involved dissolving 13.1 mL (0.148 mol) of 1,2-dimethylimidazole in 125 mL 2-propanol and adding 15.0 mL (0.074 mol) of 1,9-dibromononane dropwise in a round bottom flask equipped with a condenser and refluxing at 95°C for 24 hours. After removal of 2-propanol under vacuum, the bromide salt was dissolved in 100 mL water and extracted with three 35 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum. Synthesis of the NTf<sub>2</sub><sup>-</sup> salt consisted of dissolving 10 grams (0.02 mol) of the bromide salt in 100-150 mL water. Two molar equivalents (0.04 mol, 11.48 grams) of N-lithiotrifluoromethylsulfonimide were dissolved in 50 mL of water in a separate beaker and added directly to the bromide salt. The solution was allowed to stir for 12 hours. The top water layer was removed to leave the ionic liquid. Three additional 30 mL aliquots of water were added and extracted with the ionic liquid until the ionic liquid passed the silver nitrate test. The ionic liquid was then dried using rotary evaporation and then further dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0009">EXAMPLE 5 - <i>Compound #29:</i></heading><p id="p0212" num="0212">Synthesis of 29 involved dissolving 25.0 g (0.158 mol) of 1-benzylimidazole in 100 mL 2-propanol and adding 25.9 grams (0.079 mol) of 1,12-dibromododecane in a round bottom flask equipped with a condenser and refluxing at 95°C for 24 hours. Due to the hydrophobicity of the salt, it was found to be quite insoluble in water. Therefore, it was washed with ethyl acetate (∼75 mL) and then dried under P<sub>2</sub>O<sub>5</sub>. Because the bromide salt as not soluble in water, 10.0 grams (0.016 mol) was dissolved in methanol with stirring. To another beaker was added 8.9 grams (0.031 mol) of N-lithiotrifluoromethylsulfonimide with approximately 50 mL of water. The two contents were mixed the mixture allowed to stir for nearly 5 hours. The methanol-water solution was then removed and the liquid washed with water and then further dried under vacuum and under P<sub>2</sub>O<sub>5</sub>.<!-- EPO <DP n="89"> --></p><heading id="h0010">EXAMPLE 6 - <i>Compound</i> #<i>31:</i></heading><p id="p0213" num="0213">Synthesis of 31 involved dissolving 13.0 mL (0.128 mol) of 1,3-dibromopropane in 100 mL 2-propanol and adding 26.6 mL (0.256 mol) of 1-methylpyrrolidine in a round bottom flask equipped with a condenser and refluxing at 95°C for 24 hours. After removal of 2-propanol under vacuum, the bromide salt was dissolved in 100 mL water and extracted with three 35 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0011">EXAMPLE <i>7 - Compound #35:</i></heading><p id="p0214" num="0214">Synthesis of 35 involved dissolving 12.0 mL (0.059 mol) of 1,9-dibromononane in 100 mL 2-propanol and adding 12.3 mL (0.118 mol) of 1-methylpyrrolidine in a round bottom flask equipped with a condenser and refluxing at 95°C for 24 hours. After removal of 2-propanol under vacuum, the bromide salt was dissolved in 100 mL water and extracted with three 35 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum. Synthesis of the NTf<sub>2</sub><sup>-</sup> salt consisted of dissolving 10 grams (0.02 mol) of the bromide salt in 100-150 mL water. Two molar equivalents (0.04 mol, 11.48 grams) of N-lithiotrifluoromethylsulfonimide were dissolved in 50 mL of water in a separate beaker and added directly to the bromide salt. The solution was allowed to stir for 12 hours. The top water layer was removed to leave the ionic liquid. Three additional 30 mL aliquots of water were added and extracted with the ionic liquid until the ionic liquid passed the silver nitrate test. The ionic liquid was then dried using rotary evaporation and then further dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0012">EXAMPLE 8 - <i>Compound #38:</i></heading><p id="p0215" num="0215">Synthesis of 38 involved dissolving 13.0 mL (0.064 mol) of 1,9-dibromononane in 100 mL 2-propanol and adding 20.0 mL (0.128 mol) of 1-butylpyrrolidine in a round bottom flask equipped with a condenser and refluxing at 95°C for 24 hours. After removal of 2-propanol under vacuum, the bromide salt was dissolved in 100 mL water and extracted with three 35 mL aliquots of ethyl acetate. Water was removed under vacuum heating and the remaining salt was dried under a P<sub>2</sub>O<sub>5</sub> vacuum. Synthesis of the NTf<sub>2</sub><sup>-</sup> salt consisted of dissolving 10 grams (0.019 mol) of the bromide salt in 100-150 mL water. Two molar equivalents (0.037 mol, 10.62 grams)<!-- EPO <DP n="90"> --> of N-lithiotrifluoromethylsulfonimide were dissolved in 50 mL of water in a separate beaker and added directly to the bromide salt. The solution was allowed to stir for 12 hours. The top water layer was removed to leave the ionic liquid. Three additional 30 mL aliquots of water were added and extracted with the ionic liquid until the ionic liquid passed the silver nitrate test. The ionic liquid was then dried using rotary evaporation and then further dried under a P<sub>2</sub>O<sub>5</sub> vacuum.</p><heading id="h0013">EXAMPLE 9 - Procedure for the synthesis of dicationic phosphonium liquid salt.</heading><p id="p0216" num="0216">1,10-decane-tripropyl phosphonium bromide
<chemistry id="chem0097" num="0097"><img id="ib0110" file="imgb0110.tif" wi="95" he="34" img-content="chem" img-format="tif"/></chemistry>
was synthesized according to the following procedure. The preceding ionic liquid was synthesized according to the following procedure: In a round bottom flask (100 mL), 1,10-dibromodecane (3.7 g) was dissolved in isopropyl alcohol (50-75 mL). At room temperature, tripropylphosphine (6.5 mL) was added to the solution. The resulting solution was stirred and heated under reflux for 48 hrs. After this time, the solution was cooled to room temperature. Rotoevaporation of the solvent followed by drying in vacuum over phosphorous pentoxide, yielded a white crystalline product with a melting point of approximately 50°C.</p><heading id="h0014">EXAMPLE 10 - Synthesis of "unsymmetric" diionic liquid salts.</heading><p id="p0217" num="0217">The following compounds are used for the synthesis: the alkyl linkage compounds:
<chemistry id="chem0098" num="0098"><img id="ib0111" file="imgb0111.tif" wi="51" he="14" img-content="chem" img-format="tif"/></chemistry>
The aryl linkage compounds:
<chemistry id="chem0099" num="0099"><img id="ib0112" file="imgb0112.tif" wi="135" he="29" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="91"> -->
The PEG linkage compounds:
<chemistry id="chem0100" num="0100"><img id="ib0113" file="imgb0113.tif" wi="134" he="17" img-content="chem" img-format="tif"/></chemistry></p><p id="p0218" num="0218">The "unsymmetric" dicationic ILs are synthesized from dibromo-linkers according to the following steps:</p><p id="p0219" num="0219">First, the monocation intermediate is synthesized by reacting with the linkage compound that is in excess during the reaction to decrease the symmetric dicationic byproduct. For an example, the synthesis of ammonium-based monocation is shown in Scheme 1.
<chemistry id="chem0101" num="0101"><img id="ib0114" file="imgb0114.tif" wi="135" he="55" img-content="chem" img-format="tif"/></chemistry></p><p id="p0220" num="0220">Then, the unsymmetrical dicationic ionic compound with the desired anion is synthesized by the metathesis reaction from the dibromide compound that is obtained as an example of ammonium-imidazolium based diionic liquid salt in Scheme 2.<!-- EPO <DP n="92"> -->
<chemistry id="chem0102" num="0102"><img id="ib0115" file="imgb0115.tif" wi="141" he="73" img-content="chem" img-format="tif"/></chemistry></p><p id="p0221" num="0221">Next, the unsymmetrical dicationic liquid salts are synthesized from the linkage compound having both bromo- and hydroxyl-groups, shown as an example of pyrrolidinium-imidazolium-based dicationic liquid salt in Scheme 3.
<chemistry id="chem0103" num="0103"><img id="ib0116" file="imgb0116.tif" wi="141" he="91" img-content="chem" img-format="tif"/></chemistry></p><p id="p0222" num="0222">REFERENCES
<ol><li>1. <nplcit id="ncit0003" npl-type="s"><text>Welton, T. Chem. Rev. 1999, 99, 2071-2083</text></nplcit>.<!-- EPO <DP n="93"> --></li><li>2. <nplcit id="ncit0004" npl-type="s"><text>Cadena, C.; Anthony, J. L.; Shah, J. K.; Morrow, T. I.; Brennecke, J. F.; Maginn, E. J. J. Am. Chem. Soc. 2004, 126, 5300-5308</text></nplcit>.</li><li>3. <nplcit id="ncit0005" npl-type="s"><text>Visser, A. E.; Swatloski, R. P.; Reichert, W. M.; Mayton, R.; Sheff, S.; Wierzbicki, A.; Davis, J. H.; Rogers, R. D. Environ. Sci. Technol. 2002, 36, 2523-2529</text></nplcit>.</li><li>4. <nplcit id="ncit0006" npl-type="s"><text>Anderson, J. L.; Armstrong, D. W., Anal. Chem. 2003, 75, 4851-4858</text></nplcit>.</li><li>5. <nplcit id="ncit0007" npl-type="s"><text>Anderson, J. L.; Pino, V.; Hagberg, E. C.; Sheares, V. V.; Armstrong, D. W., Chem. Commun. 2003, 2444-2445</text></nplcit>.</li><li>6. <nplcit id="ncit0008" npl-type="s"><text>Fletcher, K. A.; Pandey, S. Langmuir 2004, 20, 33-36</text></nplcit>.</li><li>7. <nplcit id="ncit0009" npl-type="s"><text>Zhou, Y.; Antonietti, M., J. Am. Chem. Soc. 2003, 125, 14960-14961</text></nplcit>.</li><li>8. <nplcit id="ncit0010" npl-type="s"><text>Luo, H.; Dai, S.; Bonnesen, P. V.; Buchanan, A. C.; Holbrey, J. D.; Bridges, N. J.; Rogers, R. D. Anal. Chem.</text></nplcit> In press</li><li>9. <nplcit id="ncit0011" npl-type="s"><text>Wu, J.; Zhang, J.; Zhang, H.; He, J.; Ren, Q.; Guo, M., Biomacromolecules 2004, 5, 266-268</text></nplcit>.</li><li>10. <nplcit id="ncit0012" npl-type="s"><text>Vijayaraghavan, R.; MacFarlane, D. R., Chem. Commun. 2004, 700-701</text></nplcit>.</li><li>11. <nplcit id="ncit0013" npl-type="s"><text>Boxall, D. L.; Osteryoung, R. A., J. Electrochem. Soc. 2004, 151, E41-E45</text></nplcit></li><li>12. <nplcit id="ncit0014" npl-type="s"><text>Earle, M. J.; Katdare, S. P.; Seddon, K. R., Org. Lett. 2004, 6, 707-710</text></nplcit>.</li><li>13. <nplcit id="ncit0015" npl-type="s"><text>Carter, E. B.; Culver, S. L.; Fox, P. A.; Goode, R. D.; Ntai, I.; Tickell, M. D.; Traylor, R. K.; Hoffman, N. W.; Davis, J. H. Chem. Commun. 2004, 630-631</text></nplcit>.</li><li>14. <nplcit id="ncit0016" npl-type="s"><text>Wasserscheid, P.; Hilgers, C.; Keim, W., Journal of Molecular Catalysis A 2004, 214, 83-90</text></nplcit>.</li><li>15. <nplcit id="ncit0017" npl-type="s"><text>Gao, H.; Jiang, T.; Han, B.; Wang, Y.; Du, J.; Liu, Z.; Zhang, J., Polymer 2004, 45, 3017-3019</text></nplcit>.</li><li>16. <nplcit id="ncit0018" npl-type="s"><text>Kaar, J. L.; Jesionowski, A. M.; Berberich, J. A.; Moulton, R.; Russell, A. J., J. Am. Chem. Soc. 2003, 125, 4125-4131</text></nplcit>.</li><li>17. <nplcit id="ncit0019" npl-type="s"><text>Zhao, H.; Malhotra, S. V. Biotechnology Letters 2002, 24, 1257-1260</text></nplcit>.</li><li>18. <nplcit id="ncit0020" npl-type="s"><text>Lee, J. K.; Kim, M-J., J Org. Chem. 2002, 67, 6845-6847</text></nplcit>.</li><li>19. <nplcit id="ncit0021" npl-type="s"><text>Wilkes, J. S., Journal of Molecular Catalysis A: Chemical 2004, 214, 11-17</text></nplcit>.</li><li>20. <nplcit id="ncit0022" npl-type="s"><text>Bonhote, P.; Dias, A.-P.; Papageorgiou, N.; Kalyanasundaram, K.; Gratzel, M. Inorg Chem. 1996,35,1168</text></nplcit>.</li><li>21. <nplcit id="ncit0023" npl-type="s"><text>Wei, G-T.; Yang, Z.; Lee, C-Y.; Yang, H-Y.; Wang, C. R., J. Am. Chem. Soc. 2004, 126, 5036-5037</text></nplcit>.</li><li>22. <nplcit id="ncit0024" npl-type="s"><text>Itoh, H.; Naka, K.; Chujo, Y., J Am. Chem. Soc. 2004, 126, 3026-3027</text></nplcit>.<!-- EPO <DP n="94"> --></li><li>23. <nplcit id="ncit0025" npl-type="s"><text>Katritzky, A. R.; Jain, R.; Lomaka, A.; Petrukhin, R.; Karelson, M.; Visser, A. E.; Rogers, R. D, J. Chem. Inf. Comput. Sci. 2002, 42, 225-231</text></nplcit>.</li><li>24. <nplcit id="ncit0026" npl-type="s"><text>Eike, D.; Brennecke, J. F.; Maginn, E. J., Green Chem. 2003, 5, 323</text></nplcit>.</li><li>25. <nplcit id="ncit0027" npl-type="s"><text>Forsyth, S. A.; Pringle, J. M.; MacFarlane, D. R., Aust. J. Chem. 2004, 57, 113-119</text></nplcit>.</li><li>26. <nplcit id="ncit0028" npl-type="s"><text>Dzyuba, S. V.; Bartsch, R. A., Chem. Phys. Phys. Chem. 2002, 3, 161-166</text></nplcit>.</li><li>27. <nplcit id="ncit0029" npl-type="s"><text>Seddon, K. R.; Stark, A.; Torres, M-J., ACS Symposium Series 2002, 819 (Clean Solvents: Alternative Media for Chemical Reactions and Processing), 34-49</text></nplcit>.</li><li>28. <nplcit id="ncit0030" npl-type="s"><text>Carda-Broch, S.; Berthod, A.; Armstrong, D. W., Anal. Bioanal. Chem. 2003, 375, 191</text></nplcit>.</li><li>29. <nplcit id="ncit0031" npl-type="s"><text>Baranyai, K. J.; Deacon, G. B.; MacFarlane, D. R.; Pringle, J. M.; Scott, J. L., Aust. J. Chem. 2004, 57, 145-147</text></nplcit>.</li><li>30. <nplcit id="ncit0032" npl-type="s"><text>Van Valkenburg, M. E.; Vaughn, R. L.; Williams, M.; Wilkes, J. S. Proceedings-Electrochemical Society 2002, 2002-19 (Molten Salts XIII), 112-123</text></nplcit>.</li><li>31. <nplcit id="ncit0033" npl-type="s"><text>Anderson, J. L.; Ding, J.; Welton, T.; Armstrong, D. W., J. Am. Chem. Soc. 2002, 124, 14247-14254</text></nplcit>.</li><li>32. <nplcit id="ncit0034" npl-type="s"><text>Blessing, R. H., Acta Cryst. 1995, A51, 33-38</text></nplcit>.</li><li>33. All software and sources of the scattering factors are contained in the SHELXTL (version 5.1) program library (<nplcit id="ncit0035" npl-type="s"><text>G. Sheldrick, Bruker Analytical X-Ray Systems, Madison, W</text></nplcit>is.).</li><li>34. <nplcit id="ncit0036" npl-type="s"><text>Law, G.; Watson, P. R., Langmuir 2001, 17, 6138-6141</text></nplcit>.</li><li>35. <nplcit id="ncit0037" npl-type="s"><text>Ngo, H. L.; LeCompte, K.; Hargens, L.; McEwen, A. B., Thermochimica Acta 2000, 357-358,97-102</text></nplcit></li><li>36. <nplcit id="ncit0038" npl-type="s"><text>Hu, X.; Tang, Y.; Gantzel, P.; Meyer, K., Organometallics 2003, 22, 612-614</text></nplcit>.</li><li>37. <nplcit id="ncit0039" npl-type="s"><text>Bryce, M. R., Chem. Soc. Rev. 1991, 20, 355-390</text></nplcit>.</li><li>38. <nplcit id="ncit0040" npl-type="s"><text>Holbrey, J. D.; Reichert, W. M.; Nieuwenhuyzen, M.; Johnston, S.; Seddon, K. R.; Rogers, R. D., Chem. Commun. 2003, 1636-1637</text></nplcit>.</li><li>39. <nplcit id="ncit0041" npl-type="s"><text>Dearden, J. C., Sci. Total Environ. 1991, 59, 109-110</text></nplcit>.</li><li>40. <nplcit id="ncit0042" npl-type="s"><text>Bondi, A.-J., J. Phys. Chem. 1964, 68, 441-453</text></nplcit>.</li><li>41. <nplcit id="ncit0043" npl-type="s"><text>Anderson, J. L.; Ding, R.; Ellern, A,; Armstrong, D. W. J. Am. Chem. Sac. 2005, 127, 593-604</text></nplcit>.</li><li>42. <nplcit id="ncit0044" npl-type="s"><text>Terazima, M.; Nogami, Y.; Tominaga, T. Chemical Physical Letters 2000, 332, 503-507</text></nplcit>.</li><li>43. <nplcit id="ncit0045" npl-type="s"><text>Van Hook, J. P.; Tobolsky, A. V. J. Chem. Soc. 1958, 80, 779-782</text></nplcit>.<!-- EPO <DP n="95"> --></li><li>44. <nplcit id="ncit0046" npl-type="s"><text>Anderson, J. L.; Ding, J.; Welton, T.; Armstrong, D. W. J. Am. Chem. Soc. 2002, 124, 14247-14254</text></nplcit>.</li><li>45. <nplcit id="ncit0047" npl-type="s"><text>Abraham, M. H. Chem. Soc. Rev. 1993, 22, 73</text></nplcit>.</li><li>46. <nplcit id="ncit0048" npl-type="s"><text>Abraham, M. H.; Whiting, G. S.; Doherty, R. M.; Shuely, W. J. J Chromatogr. 1991, 587, 229-236</text></nplcit>.</li><li>47. <nplcit id="ncit0049" npl-type="s"><text>Bouche, J.; Verzele, M. J Gas Chromatogr. 1968, 6, 501</text></nplcit>.</li><li>48. <nplcit id="ncit0050" npl-type="s"><text>Muldoon, M. J.; Gordon, C. M. J Polym. Sci. Part A. Polym. Chem. 2004, 42, 3865-3869</text></nplcit>.</li><li>49. <nplcit id="ncit0051" npl-type="s"><text>Marcilla, R.; Blazquez, J. A.; Rodriguez, J.; Pomposo, J. A.; Mecerreyes, D. J Polym. Sci. Part A: Polym. Chem. 2004, 42, 208-212</text></nplcit>.</li><li>50. <nplcit id="ncit0052" npl-type="s"><text>Armstrong, D. W.; He, L.; Liu, L.-S. Anal. Chem. 1999, 71, 3873-3876</text></nplcit></li><li>51. <nplcit id="ncit0053" npl-type="s"><text>Anderson, J. L.; Armstrong, D. W. Anal. Chem. 2003, 75, 4851-4858</text></nplcit>.</li><li>52. <nplcit id="ncit0054" npl-type="s"><text>Lord &amp; Pawliszym, J. Chromatogr. A 885 (2000) 153-193</text></nplcit>.</li><li>53. <nplcit id="ncit0055" npl-type="s"><text>Visser et al. "Task-Specific Ionic Liquids Incorporation Novel Cations for the Coordination and Extraction of Hg2+ and Cd2+: Synthesis, Characterization, and Extraction Studies," Environ. Sci. Technol. (2002) 36, 2523-29</text></nplcit>.</li><li>54. <nplcit id="ncit0056" npl-type="s"><text>Liu et al. "Disposable ionic liquid coating for headspace solid-phase microextraction of benzene, toluene, ethyl benzene, and xylenes in plants followed by gas chromatographyflame ionization detection, "J. Chromatogr. A (2005), 1066 (1-2), 27-32</text></nplcit>.</li><li>55. <nplcit id="ncit0057" npl-type="s"><text>Vas, G.; Vekey, K., J. Mass Spectrometery (2004) 39, 233-254</text></nplcit>.</li><li>56. <nplcit id="ncit0058" npl-type="s"><text>Han et al., 2005 "Using Geminal Dicationic Ionic Liquids as Solvents for High-Temperature Organic Reactions," Org. Lett. 7:4205-4208</text></nplcit>.</li><li>57. <nplcit id="ncit0059" npl-type="s"><text>Jin et al., 2006, "Polyethylene glycol functionalized dicatinoic ionic liquids with alkyl or polyfluoroalkyl substituents as high temperature lubricants" J. Mater. Chem. 16:1529-1535</text></nplcit>.</li><li>58. <nplcit id="ncit0060" npl-type="s"><text>Martinelango et al., 2005, "Gas-Phase Ion Association Provides Increased Selectivity and Sensitivity for Measuring Perchlorate by Mass Spectrometry" Anal. Chem. 2005, 77: 4829-4835</text></nplcit></li><li>59. <nplcit id="ncit0061" npl-type="s"><text>K. Grob, G. Grob and K. Grob, I Chromatogr. 156: 1 (1978</text></nplcit>).</li><li>60. <nplcit id="ncit0062" npl-type="s"><text>K. Grob, G. Grob and K. Grob, J Chromatogr. 219: 13 (1981</text></nplcit>).</li></ol><!-- EPO <DP n="96"> -->
The following numbered paragraphs define particular embodiments of the present invention.
<ol><li>1. A dicationic liquid salt comprising a dicationic species corresponding in structure to Formula (III):
<chemistry id="chem0104" num="0104"><img id="ib0117" file="imgb0117.tif" wi="50" he="31" img-content="chem" img-format="tif"/></chemistry>
and at least one counter anion,<br/>
wherein:
<ul><li>X and Y are independently selected from the group consisting of ammonium,</li><li>phosphonium and arsonium;</li><li>each R, R', and R" is independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, and carbocyclyl;</li><li>wherein each R, R', and R" optionally is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, hydroxyl, alkoxy, and carbocyclyl;</li><li>B is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl- CH<sub>2</sub>-)<sub>n</sub>, and</li><li>polysiloxyl;</li><li>wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si;</li><li>wherein B is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li>n is selected from the group consisting of 1 to 20, inclusive.</li></ul></li><li>2. The dicationic liquid salt of paragraph 1, wherein R, R' and R" each represent a different substituent.</li><li>3. The dicationic liquid salt of paragraph 1, wherein one or more of R, R', and R" contain at least one stereogenic center.<!-- EPO <DP n="97"> --></li><li>4. The dicationic liquid salt of paragraph 1, wherein B is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl and alkoxy; and contains at least one stereogenic center.</li><li>5. The dicationic liquid salt of paragraph 1, wherein the salt is capable of facilitating cross- linking.</li><li>6. The dicationic.liquid salt of paragraph 1, wherein:
<ul><li>each R, R' and R" is independently selected from the group consisting of hydrogen, propyl, butyl, cyclohexanyl and phenyl;</li><li>X and Y are independently selected from the group consisting of ammonium and phosphonium;</li><li>B is selected from the group consisting of alkylene, alkenylene and alkynylene, wherein each such substituent optionally contains one or more heteroatoms selected from the group consisting of O, N, S or Si.</li></ul></li><li>7. The dicationic liquid salt of paragraph 1, wherein<br/>
each R is independently selected from the group consisting of hydrogen, propyl, butyl, cyclohexanyl and phenyl;<br/>
each R' is hydrogen or phenyl;<br/>
each R" is hydrogen or 2-methoxyphenyl; and<br/>
X and Y are both phosphonium.</li><li>8. The dicationic liquid salt of paragraph 1 , wherein B is unsymmetric.</li><li>9. The dicationic liquid salt of paragraph 8, wherein B is alkylene, alkenylene, and alkynylene containing one or more heteroatoms selected from the group consisting of O, N, S and Si so as to be unsymmetric.</li><li>10. The dicationic liquid salt of paragraph 8, wherein B is substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl and alkoxy, so as to be unsymmetric.</li><li>11. A dicationic liquid salt comprising a dicationic species corresponding in structure to Formula (IV):<br/>
<br/>
<!-- EPO <DP n="98"> -->        A<sup>+</sup>-B-A'<sup>+</sup>     Formula (IV)<br/>
<br/>
and at least one counter anion,<br/>
wherein:
<ul><li>A and A' are each a monoionic group independently selected from the group consisting of ammonium, thionium, phosphonium, arsonium, carbocylyl and</li><li>heterocyclyl;</li><li>wherein each such substituent is optionally substituted with one or more substituents selected from the group consisting of alkyl, hydroxyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl;</li><li>wherein A and A' are different or A and A' have at least one different substituent;</li><li>B is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and</li><li>polysiloxyl;</li><li>wherein alkylene, alkenylene, and alkynylene optionally contain one or</li><li>more heteroatoms selected from the group consisting of O, N, S or Si;</li><li>wherein B is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, and alkoxy;</li><li>n is selected from the group consisting of 1 to 20, inclusive.</li></ul></li><li>12. The dicationic liquid salt of paragraph 11, wherein the salt is capable of cross-linking.</li><li>13. The dicationic liquid salt of paragraph 11, wherein at least one of A, B and A' contain at least one stereogenic center, thereby having at least a pair of optical isomers.</li><li>14. The dicationic liquid salt of paragraph 13, wherein at least one of the optical isomers is present in an amount that is greater than the other optical isomer.</li><li>15. The dicationic liquid salt of paragraph 13, wherein at least one of the optical isomers is present in an amount of about 90% or more compared to the other optical isomer.<!-- EPO <DP n="99"> --></li><li>16. The dicationic liquid salt of paragraph 11, wherein A and A' are independently selected from the group consisting of:
<chemistry id="chem0105" num="0105"><img id="ib0118" file="imgb0118.tif" wi="141" he="39" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0106" num="0106"><img id="ib0119" file="imgb0119.tif" wi="26" he="30" img-content="chem" img-format="tif"/></chemistry>
wherein each R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> is independently selected from the group consisting of hydrogen, alkyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl.</li><li>17. The dicationic liquid salt of paragraph 16, wherein the dicationic species corresponds to a formula selected from the group consisting of
<chemistry id="chem0107" num="0107"><img id="ib0120" file="imgb0120.tif" wi="62" he="28" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0108" num="0108"><img id="ib0121" file="imgb0121.tif" wi="73" he="30" img-content="chem" img-format="tif"/></chemistry>
and<!-- EPO <DP n="100"> -->
<chemistry id="chem0109" num="0109"><img id="ib0122" file="imgb0122.tif" wi="62" he="25" img-content="chem" img-format="tif"/></chemistry>
wherein B is alkylene, (-CH<sub>2</sub>-O-CH<sub>2</sub>-)<sub>n</sub> or (-CH<sub>2</sub>-aryl-CH<sub>2</sub>-)<sub>n</sub>; B is optionally substituted; and<br/>
n is selected from the group consisting of 1 to 20, inclusive.</li><li>18. The dicationic liquid salt of paragraph 17, wherein the dicationic species is selected from the group consisting of:
<chemistry id="chem0110" num="0110"><img id="ib0123" file="imgb0123.tif" wi="125" he="30" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0111" num="0111"><img id="ib0124" file="imgb0124.tif" wi="61" he="30" img-content="chem" img-format="tif"/></chemistry></li><li>19. The dicationic liquid salt of paragraph 18, wherein the at least one counter anion is selected from the group consisting of Br<sup>-</sup>, BF<sub>4</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, TfO<sup>-</sup>,
<chemistry id="chem0112" num="0112"><img id="ib0125" file="imgb0125.tif" wi="83" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0113" num="0113"><img id="ib0126" file="imgb0126.tif" wi="72" he="17" img-content="chem" img-format="tif"/></chemistry>
wherein R is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocylyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonyl alkylene, hydroxycarbonyl,<!-- EPO <DP n="101"> -->
<chemistry id="chem0114" num="0114"><img id="ib0127" file="imgb0127.tif" wi="71" he="24" img-content="chem" img-format="tif"/></chemistry>
wherein<br/>
X<sub>1</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene;<br/>
X<sub>2</sub> is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;<br/>
Y<sub>1</sub> is selected from the group consisting of hydrogen and alkyl; and<br/>
Y<sub>2</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene.</li><li>20. The dicationic liquid salt of paragraph 19, where there are at least two counter anions.</li><li>21. The dicationic liquid salt of paragraph 16, wherein the dicationic species corresponds to a formula selected from the group consisting of:
<chemistry id="chem0115" num="0115"><img id="ib0128" file="imgb0128.tif" wi="61" he="25" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0116" num="0116"><img id="ib0129" file="imgb0129.tif" wi="51" he="25" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="102"> -->
<chemistry id="chem0117" num="0117"><img id="ib0130" file="imgb0130.tif" wi="61" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0118" num="0118"><img id="ib0131" file="imgb0131.tif" wi="72" he="20" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0119" num="0119"><img id="ib0132" file="imgb0132.tif" wi="51" he="23" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0120" num="0120"><img id="ib0133" file="imgb0133.tif" wi="70" he="19" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0121" num="0121"><img id="ib0134" file="imgb0134.tif" wi="73" he="21" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0122" num="0122"><img id="ib0135" file="imgb0135.tif" wi="65" he="23" img-content="chem" img-format="tif"/></chemistry>
wherein:
<ul><li>B is alkylene, (-CH<sub>2</sub>-O-CH<sub>2</sub>-)<sub>n</sub> or (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>; and B is optionally substituted; and</li><li>wherein alkylene optionally contains at least one heteroatom selected from the group consisting of O, S, N and Si.</li><li>n is selected from the group consisting of 1 to 20, inclusive.</li></ul></li><li>22. The dicationic liquid salt of paragraph 21, wherein the dicationic species is selected from the group consisting of:<!-- EPO <DP n="103"> -->
<chemistry id="chem0123" num="0123"><img id="ib0136" file="imgb0136.tif" wi="77" he="19" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0124" num="0124"><img id="ib0137" file="imgb0137.tif" wi="73" he="21" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0125" num="0125"><img id="ib0138" file="imgb0138.tif" wi="91" he="23" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0126" num="0126"><img id="ib0139" file="imgb0139.tif" wi="74" he="26" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0127" num="0127"><img id="ib0140" file="imgb0140.tif" wi="87" he="21" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0128" num="0128"><img id="ib0141" file="imgb0141.tif" wi="55" he="23" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0129" num="0129"><img id="ib0142" file="imgb0142.tif" wi="81" he="19" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0130" num="0130"><img id="ib0143" file="imgb0143.tif" wi="91" he="26" img-content="chem" img-format="tif"/></chemistry><!-- EPO <DP n="104"> -->
<chemistry id="chem0131" num="0131"><img id="ib0144" file="imgb0144.tif" wi="86" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0132" num="0132"><img id="ib0145" file="imgb0145.tif" wi="87" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0133" num="0133"><img id="ib0146" file="imgb0146.tif" wi="88" he="37" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0134" num="0134"><img id="ib0147" file="imgb0147.tif" wi="69" he="22" img-content="chem" img-format="tif"/></chemistry>
and
<chemistry id="chem0135" num="0135"><img id="ib0148" file="imgb0148.tif" wi="67" he="37" img-content="chem" img-format="tif"/></chemistry></li><li>23. The dicationic liquid salt of paragraph 22, wherein the at least one counter anion is selected from the group consisting of Br<sup>-</sup>, BF<sub>4</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, TfO<sup>-</sup>,
<chemistry id="chem0136" num="0136"><img id="ib0149" file="imgb0149.tif" wi="82" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0137" num="0137"><img id="ib0150" file="imgb0150.tif" wi="86" he="17" img-content="chem" img-format="tif"/></chemistry>
wherein R is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocylyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonylalkylene, hydroxycarbonyl,<!-- EPO <DP n="105"> -->
<chemistry id="chem0138" num="0138"><img id="ib0151" file="imgb0151.tif" wi="72" he="24" img-content="chem" img-format="tif"/></chemistry>
wherein<br/>
X<sub>1</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene;<br/>
X<sub>2</sub> is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;<br/>
Y<sub>1</sub> is selected from the group consisting of hydrogen and alkyl; and<br/>
Y<sub>2</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene.</li><li>24. The dicationic liquid salt of paragraph 23, where there are at least two counter anions.</li><li>25. The dicationic liquid salt of paragraph 16, wherein the dicationic species corresponds to the following formula:
<chemistry id="chem0139" num="0139"><img id="ib0152" file="imgb0152.tif" wi="58" he="25" img-content="chem" img-format="tif"/></chemistry></li><li>26. The dicationic liquid salt of paragraph 25, wherein the dicationic species is:
<chemistry id="chem0140" num="0140"><img id="ib0153" file="imgb0153.tif" wi="87" he="26" img-content="chem" img-format="tif"/></chemistry></li><li>27. The dicationic liquid salt of paragraph 26, wherein the at least one counter anion is selected the group consisting of Br<sup>-</sup>, BF<sub>4</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, TfO<sup>-</sup>,<!-- EPO <DP n="106"> -->
<chemistry id="chem0141" num="0141"><img id="ib0154" file="imgb0154.tif" wi="82" he="24" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0142" num="0142"><img id="ib0155" file="imgb0155.tif" wi="83" he="17" img-content="chem" img-format="tif"/></chemistry>
wherein R is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocylyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonylalkylene, hydroxycarbonyl,
<chemistry id="chem0143" num="0143"><img id="ib0156" file="imgb0156.tif" wi="72" he="24" img-content="chem" img-format="tif"/></chemistry>
wherein<br/>
X<sub>1</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene;<br/>
X<sub>2</sub> is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;<br/>
Y<sub>1</sub> is selected from the group consisting of hydrogen and alkyl; and<br/>
Y<sub>2</sub> is C<sub>1</sub>-C<sub>10</sub>-alkylene.</li><li>28. The dicationic liquid salt of paragraph 27, where there are at least two counter anions.</li><li>29. A solvent comprising one or more polyionic liquid salts of paragraph 1 or 11.</li><li>30. A device for chemical separation or analysis comprising a solid support and one or more polyionic liquid salts of paragraph 1 or 11, wherein the one or more polyionic liquid salts is adsorbed, absorbed or immobilized on the solid support.</li><li>31. The device of paragraph 30, wherein the solid support is packed in a chromatographic column.</li><li>32. The device of paragraph 30, wherein the solid support is a capillary column.</li><li>33. The device of paragraph 30, further comprising a syringe having a hollow needle defining an inner space, the needle being disposed at an end of a barrel and a plunger disposed within the barrel, the solid support being attached to the syringe such that it is<!-- EPO <DP n="107"> --> retracted into the inner space of the needle when the plunger is retracted from the barrel and exposed from within the needle when the plunger is inserted into the barrel.</li><li>34. The device of paragraph 33, wherein said syringe is a microsyringe.</li><li>35. The device of paragraph 30, wherein the one or more polyionic liquid salts is immobilized on the solid support and wherein the one or more polyionic liquid salts includes at least one unsaturated group which can facilitate cross-linking or immobilization.</li><li>36. A method for separating one chemical from a mixture of chemicals comprising:
<ul><li>providing a mixture of at least one first and at least one second chemical;</li><li>exposing the mixture to a solid support containing one or more polyionic liquid salts of paragraph 1 or paragraph 11, wherein the one or more polyionic liquid salts is adsorbed,</li><li>absorbed or immobilized on the support, and retaining at least a portion of the first chemical on the solid support.</li></ul></li><li>37. The method of paragraph 36, wherein the solid support is a column and the mixture is passed through the column such that elution of the first chemical is prevented or delayed.</li><li>38. The method of paragraph 37, wherein the column is a capillary column.</li><li>39. The method of paragraph 36, wherein the mixture is carried in a gaseous mobile phase.</li><li>40. The method of paragraph 36, wherein the solid support is attached to a microsyringe having a hollow needle defining an inner space, the needle being disposed at an end of a barrel and a plunger disposed within the barrel, the solid support being attached to the microsyringe such that it may be retracted into the inner space of the needle when the plunger is retracted from the barrel and exposed from within the needle when the plunger is inserted into the barrel, exposing the solid support from within the needle into the mixture, and retracting the solid support from the mixture, wherein it includes at lease some amount of the first chemical.<!-- EPO <DP n="108"> --></li><li>41. A method of detecting an anion by ESI-MS, the method comprising using one or more dicationic liquid salts of paragraph 1 or paragraph 11.</li><li>42. The method of paragraph 41, wherein the one or more dicationic liquid salt is a fluoride salt.</li></ol></p></description><claims mxw-id="PCLM56983186" lang="EN" load-source="patent-office"><!-- EPO <DP n="109"> --><claim id="c-en-0001" num="0001"><claim-text>A dicationic liquid salt comprising a dicationic species corresponding in structure to Formula (IV):<br/>
<br/>
        A<sup>+</sup>-B-A'<sup>+</sup>     Formula (IV)<br/>
<br/>
and at least one counter anion, wherein:
<claim-text>B is a divalent fragment composed of one or more moieties selected from the group consisting of alkylene, alkenylene, alkynylene, (-CH<sub>2</sub>-carbocyclyl-CH<sub>2</sub>-)<sub>n</sub>, and polysiloxyl, wherein alkylene, alkenylene, and alkynylene optionally contain one or more heteroatoms selected from the group consisting of O, N, S or Si, and wherein B is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl and alkoxy;</claim-text>
<claim-text>n is selected from the group consisting of 1 to 20, inclusive; and either
<claim-text>1) A and A' are each a monoionic group, one being phosphonium and the other imidazolium, wherein each such substituent is optionally substituted with one or more substituents selected from the group consisting of alkyl, hydroxyl, alkoxy, cycloalkyl, aryl, hydroxyalkyl, cycloalkylalkyl and aralkyl; or</claim-text>
<claim-text>2) A is one and A' is the other of:
<chemistry id="chem0144" num="0144"><img id="ib0157" file="imgb0157.tif" wi="77" he="40" img-content="chem" img-format="tif"/></chemistry>
wherein each R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub> and R<sub>n</sub> is independently selected from the group consisting of hydrogen, substituted or unsubstituted, saturated or unsaturated, straight or branched<!-- EPO <DP n="110"> --> aliphatic moiety, cycloalkyl, aromatic moiety, cycloalkylalkyl, aralkyl, alkoxy and hydroxyalkyl.</claim-text></claim-text></claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The dicationic liquid salt of Claim 1, wherein the dicationic species comprises an alkyl linkage, an alkyl-substituted imidazolium group and an alkyl-substituted phosphonium group.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>The dicationic liquid salt of Claim 1, wherein the salt is capable of cross-linking.</claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>The dicationic liquid salt of Claim 1, wherein the dicationic species is
<chemistry id="chem0145" num="0145"><img id="ib0158" file="imgb0158.tif" wi="81" he="25" img-content="chem" img-format="tif"/></chemistry></claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>The dicationic liquid salt of Claim 4, wherein the at least one counter anion is selected from the group consisting of Br<sup>-</sup>, BF<sub>4</sub><sup>-</sup>, PF<sub>6</sub><sup>-</sup>, NTf<sub>2</sub><sup>-</sup>, TfO<sup>-</sup>,
<chemistry id="chem0146" num="0146"><img id="ib0159" file="imgb0159.tif" wi="98" he="30" img-content="chem" img-format="tif"/></chemistry>
<chemistry id="chem0147" num="0147"><img id="ib0160" file="imgb0160.tif" wi="98" he="19" img-content="chem" img-format="tif"/></chemistry>
wherein
<claim-text>R is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocyclyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonylalkylene, hydroxycarbonyl,<!-- EPO <DP n="111"> -->
<chemistry id="chem0148" num="0148"><img id="ib0161" file="imgb0161.tif" wi="78" he="26" img-content="chem" img-format="tif"/></chemistry>
wherein</claim-text>
<claim-text><b>X<sub>1</sub></b> is C<sub>1</sub>-C<sub>10</sub>-alkylene;</claim-text>
<claim-text><b>X<sub>2</sub></b> is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;</claim-text>
<claim-text><b>Y<sub>1</sub></b> is H or and alkyl; and</claim-text>
<claim-text><b>Y<sub>2</sub></b> is C<sub>1</sub>-C<sub>10</sub>-alkylene.</claim-text></claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>The dicationic liquid salt of Claim 5, which comprises at least two counter anions.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>A solvent comprising one or more dicationic liquid salts of Claim 1.</claim-text></claim><claim id="c-en-0008" num="0008"><claim-text>A device for chemical separation or analysis comprising a solid support and one or more dicationic liquid salts of Claim 1, wherein the one or more dicationic liquid salts is adsorbed, absorbed or immobilized on the solid support.</claim-text></claim><claim id="c-en-0009" num="0009"><claim-text>The device of Claim 8, wherein the solid support is packed in a chromatographic column.</claim-text></claim><claim id="c-en-0010" num="0010"><claim-text>The device of Claim 8, wherein the solid support is a capillary column.</claim-text></claim><claim id="c-en-0011" num="0011"><claim-text>The device of Claim 8, further comprising<br/>
a syringe having a hollow needle defining an inner space, wherein the needle is disposed at an end of a barrel and<br/>
a plunger disposed within the barrel,<br/>
wherein the solid support is attached to the syringe such that it is retracted into the inner space of the needle when the plunger is retracted from the barrel and exposed from within the needle when the plunger is inserted into the barrel.</claim-text></claim><claim id="c-en-0012" num="0012"><claim-text>The device of Claim 11, wherein said syringe is a microsyringe.<!-- EPO <DP n="112"> --></claim-text></claim><claim id="c-en-0013" num="0013"><claim-text>The device of Claim 8, wherein the one or more dicationic liquid salts is immobilized on the solid support, and wherein the one or more dicationic liquid salts include at least one unsaturated group which can facilitate cross-linking or immobilization.</claim-text></claim><claim id="c-en-0014" num="0014"><claim-text>A method for separating one chemical from a mixture of chemicals comprising:
<claim-text>providing a mixture of at least one first chemical and at least one second chemical; and</claim-text>
<claim-text>exposing the mixture to a solid support containing one or more dicationic liquid salts of Claim 1,</claim-text>
<claim-text>wherein the one or more dicationic liquid salts is adsorbed, absorbed or immobilized on the support, and retaining at least a portion of the first chemical on the solid support.</claim-text></claim-text></claim><claim id="c-en-0015" num="0015"><claim-text>The method of Claim 14, wherein the solid support is a column, for example a capillary column, and the mixture is passed through the column such that elution of the first chemical is prevented or delayed.</claim-text></claim><claim id="c-en-0016" num="0016"><claim-text>The method of Claim 14, wherein the mixture is carried in a gaseous mobile phase.</claim-text></claim><claim id="c-en-0017" num="0017"><claim-text>The method of Claim 14, wherein the solid support is attached to a microsyringe having a hollow needle defining an inner space, the needle being disposed at an end of a barrel and a plunger disposed within the barrel, the solid support being attached to the microsyringe such that it may be retracted into the inner space of the needle when the plunger is retracted from the barrel and exposed from within the needle when the plunger is inserted into the barrel, exposing the solid support from within the needle into the mixture, and retracting the solid support from the mixture, wherein it includes at lease some amount of the first chemical.</claim-text></claim><claim id="c-en-0018" num="0018"><claim-text>A method of detecting an anion by ESI-MS, the method comprising using one or more dicationic liquid salts of Claim 1.</claim-text></claim><claim id="c-en-0019" num="0019"><claim-text>The method of Claim 18, wherein the one or more dicationic liquid salt is a fluoride salt.</claim-text></claim></claims><drawings mxw-id="PDW16671464" load-source="patent-office"><!-- EPO <DP n="113"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="147" he="126" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="114"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="145" he="135" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="115"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="148" he="158" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="116"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="163" he="137" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="117"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="152" he="119" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="118"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="156" he="162" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="119"> --><figure id="f0007" num="7"><img id="if0007" file="imgf0007.tif" wi="146" he="158" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="120"> --><figure id="f0008" num="8"><img id="if0008" file="imgf0008.tif" wi="157" he="150" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="121"> --><figure id="f0009" num="9"><img id="if0009" file="imgf0009.tif" wi="130" he="174" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="158" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="161" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
